Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,42296,0.256915180550907,0.00542288161764925,0.246286332580314,0.267544028521499,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,42047,0.315826611406576,0.00764882853304457,0.300834907481808,0.330818315331343,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42170,0.381833112380759,0.00475710920761034,0.372509178333843,0.391157046427675,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,42262,0.288111834170616,0.00676772455813286,0.274847094036676,0.301376574304557,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,42137,0.19233608618419,0.00487071337500223,0.182789487969185,0.201882684399194,1.1125369292536e-308
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42100,0.11508136028966,0.00313557900939815,0.108935625431239,0.12122709514808,3.50765419135474e-281
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,42267,-0.148537220419241,0.00409208249908373,-0.156557702117445,-0.140516738721037,1.63820763232382e-275
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,42145,0.237370410325913,0.00677876966792703,0.224084021776776,0.25065679887505,3.06669922469743e-257
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.117735320341798,0.00352458990768855,0.110827124122728,0.124643516560868,3.04265696282471e-235
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,39649,0.278459188887646,0.00912839583799446,0.260567533045177,0.296350844730115,2.69297089782379e-196
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42016,0.12086941069477,0.00399541433788391,0.113038398592517,0.128700422797022,1.54879224202025e-194
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,0.159369242324336,0.00529984961193257,0.148981537084948,0.169756947563724,2.10652611579934e-192
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41900,0.213981676296953,0.00716566864445685,0.199936965753818,0.228026386840088,1.03792581302287e-189
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.106660524440907,0.00359961125382107,0.0996052863834178,0.113715762498396,5.54103484273805e-187
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,42145,-0.15566610331303,0.00528286713280527,-0.166020522893328,-0.145311683732732,5.03771424398608e-185
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.104247541549448,0.00353823439453633,0.0973126021361571,0.111182480962739,5.52586939461524e-185
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.137026813271625,0.00470263582782463,0.127809647049089,0.146243979494161,4.0066444769802e-181
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.246154806327246,0.00847154136350829,0.22955058525477,0.262759027399722,4.25091604226375e-179
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,0.158029870550094,0.00557675036479778,0.14709943983509,0.168960301265098,1.49963224315687e-171
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,42185,0.130649841247201,0.00465438004080622,0.121527256367221,0.139772426127182,1.39340643100443e-168
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42249,0.175224910269595,0.00634281083934508,0.162793001024479,0.187656819514712,1.64584836113998e-163
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,41843,0.376573029495317,0.0137125908322765,0.349696351464055,0.403449707526579,1.60528241017455e-161
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.101263830478813,0.00369093675609207,0.0940295944368721,0.108498066520753,2.32694028770939e-161
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,42163,0.256098063645743,0.00936355050770777,0.237745504650636,0.274450622640851,2.29125125867357e-160
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.206532825680506,0.00757271997900086,0.191690294521665,0.221375356839348,1.81312319828885e-159
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.256316872345325,0.00941613394917821,0.237861249804935,0.274772494885714,6.99952678189666e-159
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,0.0900312220457027,0.00335354122874489,0.0834582812373627,0.0966041628540427,1.08690054732766e-154
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,42070,0.165669281270184,0.00621446197295538,0.153488935803191,0.177849626737176,1.24962338356487e-152
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,39958,0.251853813451597,0.00949924058428363,0.233235301906401,0.270472324996793,2.43360974850791e-150
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,39966,0.113662596569443,0.00431691858597031,0.105201436140941,0.122123756997945,2.34178269919529e-148
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.139888253909612,0.00543211387611087,0.129241310712435,0.15053519710679,8.99586885679925e-143
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGRN,Agrin,42185,0.10132523181768,0.00396744050555344,0.0935490484267954,0.109101415208565,1.46191406725557e-140
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,42296,0.0971066282274573,0.00382411732462902,0.0896113582711844,0.10460189818373,4.81773251129137e-139
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,42145,-0.10582742204645,0.00423087414251091,-0.114119935365771,-0.0975349087271287,4.98384262843824e-135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.40343118389569,0.0161861467022191,0.37170633635934,0.435156031432039,4.64812663248073e-134
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,42216,0.165832143029652,0.00666757615349713,0.152763693768798,0.178900592290507,1.42032143894771e-133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELN,Elastin,39958,0.0955632598690834,0.0038470398988549,0.0880230616673278,0.103103458070839,1.09008666393258e-132
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,39736,0.321836717119729,0.0130826803676224,0.296194663599189,0.347478770640269,3.60612652632491e-130
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.228098310300234,0.00932406255416416,0.209823147694073,0.246373472906396,2.62736903000779e-129
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FURIN,Furin,42181,0.0896004429364402,0.00366472521050152,0.0824175815238573,0.0967833043490232,3.10990275329106e-129
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,-0.079381723478813,0.00325475153368615,-0.0857610364848379,-0.0730024104727882,1.26455404397304e-128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.221409351462895,0.00907651659853826,0.20361937892976,0.23919932399603,1.30940562716278e-128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,42296,0.113105718051058,0.0046968892991822,0.103899815024661,0.122311621077455,1.58139275836679e-125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,0.0823552050530461,0.00344415747421383,0.075604656403587,0.0891057537025052,8.38970001002019e-124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,0.0591126915062837,0.00249858293658309,0.0542154689505808,0.0640099140619865,2.69945080599938e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42185,0.171930500861878,0.00731989444028554,0.157583507758919,0.186277493964838,1.28613637562619e-119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.135489435653709,0.00579267522961877,0.124135792203656,0.146843079103762,1.15436962813319e-118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,39736,0.0734381831852693,0.00314581545039609,0.067272384902493,0.0796039814680456,1.01819503847388e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,42129,0.0807334311239049,0.00348850392914195,0.0738959634227866,0.0875708988250231,3.07176192199603e-116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,42296,0.116627898043378,0.00505505773853725,0.106719984875845,0.126535811210911,1.41073070627999e-115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42296,0.192721752550045,0.0083977513549902,0.176262159894264,0.209181345205825,2.13064545602512e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0602214756593699,0.00263266947108868,0.0550614434960361,0.0653815078227037,1.14717152173837e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.140857849602368,0.00620856326294911,0.128689065606988,0.153026633597748,7.76052188959836e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,39979,-0.173578270631827,0.00765578100709175,-0.188583601405727,-0.158572939857928,2.38212422240541e-111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,-0.162423227992159,0.00720604706087943,-0.176547080231482,-0.148299375752835,1.82427925044287e-110
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.161898801516115,0.00726706944813963,0.147655345397762,0.176142257634469,5.69513303069106e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,41991,0.127409894072839,0.00576182788754239,0.116116711413256,0.138703076732423,1.89445123972318e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,42249,0.112749459239177,0.00510662315553678,0.102740477854325,0.122758440624029,3.59068381069008e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42262,0.0695234755464111,0.00315193688294976,0.0633456792558296,0.0757012718369926,5.68217305003535e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,42247,0.295164091883912,0.0133820042579452,0.268935363538339,0.321392820229484,5.78040390744906e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42272,0.125542327957871,0.00569611639379677,0.114377939826029,0.136706716089712,8.2106648225716e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,0.0970123316482886,0.0044016010369334,0.0883851936158991,0.105639469680678,8.50274884091243e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39736,0.106686088505097,0.00484207809707837,0.0971956154348238,0.116176561575371,2.42294954781107e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,42119,0.128433498840725,0.0058600258904913,0.116947848095362,0.139919149586088,1.17907250623815e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFH,Complement factor H,39418,0.0572460604559012,0.00260781207435024,0.0521347487901747,0.0623573721216277,1.56219739806e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,42184,0.0698348533679806,0.00318980622630578,0.0635828331644213,0.0760868735715399,1.91300184548215e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.145688577447082,0.00668205078752782,0.132591757903527,0.158785396990636,1.42712344767004e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFP,Properdin,39979,0.0574162100439912,0.00263591310966292,0.0522498203490519,0.0625825997389305,4.29023371118219e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0687185696823449,0.00315604236572376,0.0625327266455263,0.0749044127191634,5.24617614994202e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0768302573816932,0.00353975832485039,0.0698923310649865,0.0837681836984,9.99968828981044e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.256324225545963,0.0118920259173632,0.233015854747931,0.279632596343995,2.46428040863431e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.126216678972907,0.00586999305196873,0.114711492591048,0.137721865354765,7.28679536465077e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,42137,0.0557198414687932,0.00259634059263806,0.0506310139072226,0.0608086690303638,1.69297822994105e-100
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,42145,0.0637611115672373,0.0029717178172978,0.0579365446453336,0.069585678489141,1.87184202855873e-100
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,39736,0.0658287995431997,0.00307892832996421,0.0597941000164698,0.0718634990699295,1.99537100262258e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,42145,0.0836920296384484,0.00393387400390969,0.0759816365907854,0.0914024226861114,7.99716753079464e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42137,0.062740018558359,0.00295040481630169,0.0569572251184077,0.0685228119983103,9.81495740435597e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,42211,0.14429229057193,0.00680453324445308,0.130955405412801,0.157629175731058,3.28258885012068e-98
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,42123,-0.105528896986781,0.00498317524368867,-0.11529592046441,-0.0957618735091509,6.00841418859636e-98
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.103827435962702,0.00490475425417184,0.0942141176245255,0.113440754300879,7.53867701838562e-98
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0839188879767352,0.00397887138681866,-0.0917174758948998,-0.0761203000585707,3.50126075840303e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,42296,0.0612525135488641,0.00292233479417449,0.0555247373522821,0.0669802897454461,4.85139262689412e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,39958,0.108531774459728,0.00518181927653902,0.098375408677711,0.118688140241744,1.3279604848269e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.0965091555979186,0.00461550373460761,0.0874627682780877,0.105555542917749,1.42874613695566e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42296,0.0990688826355369,0.00475345727988193,0.0897521063669683,0.108385658904105,5.39903121623606e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,42073,0.0895465069324975,0.00430686090785339,0.0811050595531048,0.0979879543118901,1.56216725176277e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0859301513200945,0.00415723295877391,0.0777819747208976,0.0940783279192914,1.75999778163336e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.115215031336829,0.00558437572828125,0.104269654909398,0.126160407764261,7.67592981169312e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,42310,0.117740728186329,0.00572417149000865,0.106521352065912,0.128960104306746,1.29272086631985e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,0.256407696156496,0.0124696404358777,0.231967200902175,0.280848191410816,1.64424232465436e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.167580229944119,0.00816760883511124,0.151571716627301,0.183588743260937,3.86323393894711e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,41225,0.0950510136604066,0.00463126490787232,0.0859737344409769,0.104128292879836,4.17518134673789e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C9,Complement component C9,39990,-0.13218362720893,0.00643555533451133,-0.144797315664572,-0.119569938753288,4.39662967178875e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.165350336433647,0.0080746815065457,0.149523960680817,0.181176712186476,8.61500928546233e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,0.0845092228809205,0.00413043603910489,0.0764135682442749,0.0926048775175661,1.1998022578621e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,42070,0.150143486088675,0.00734578204173131,0.135745753286881,0.164541218890468,1.81090974934888e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.0556650159572848,0.00272599580747857,0.0503220641746268,0.0610079677399428,2.59268028570249e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0674133178389059,0.00331241829395406,0.0609209779827559,0.0739056576950559,9.77398543247773e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,42194,0.0700922635771891,0.00345920199597354,0.063312227665081,0.0768722994892973,5.83585911034577e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,42137,0.05630341359559,0.00277966404664069,0.0508552720641742,0.0617515551270057,6.79475700480081e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,42231,0.0848097739129395,0.00418980964216871,0.0765977470142888,0.0930218008115901,8.69387340162235e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.130381156814953,0.00645353560703933,0.117732227025156,0.143030086604751,1.9583204070037e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.180285377432067,0.0089268860155473,0.162788680841595,0.19778207402254,2.23272317952258e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0679414517691172,0.00336575736044756,0.06134456734264,0.0745383361955944,4.72894214875686e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,39958,0.151581507536343,0.0075169747485055,0.136848237029272,0.166314778043414,7.04426387593891e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEP,Leptin,42145,0.156339187554893,0.00776966911903636,0.141110636081581,0.171567739028204,9.38786593018406e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,39870,0.0732057879951472,0.00363494416552572,0.0660812974307168,0.0803302785595776,1.19656126054016e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,0.189901885037017,0.00947983658086233,0.171321405338527,0.208482364735507,5.48978822776699e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42239,0.0795601636450445,0.00397776230192192,0.0717637495332776,0.0873565777568115,9.68415836606792e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,39645,0.062089883719094,0.00310259801851569,0.0560087916028032,0.0681709758353847,1.51969183588397e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORT1,Sortilin,42129,0.0850431698626099,0.00425910887523578,0.0766953164671478,0.0933910232580721,1.91581421705717e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,0.193285341136248,0.0097007551167883,0.174271861107343,0.212298821165153,8.20223551475139e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,42070,0.194911261072303,0.00981565527547658,0.175672576732369,0.214149945412237,1.64301594788219e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0683093151465598,0.00344839185503304,-0.0750681631824245,-0.061550467110695,7.41731990110211e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42296,0.0729248555956061,0.00369209836271955,0.0656883428046758,0.0801613683865365,1.204179805912e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0431103686738872,0.00219294428941114,0.0388121978666413,0.047408539481133,7.2119059425204e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0454684681950178,0.00231293704001512,0.0409351115965882,0.0500018247934475,8.08981602959341e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.110491039222889,0.00562364205000656,0.0994687008048758,0.121513377640901,8.85209212877572e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOST,Sclerostin,42129,0.0850126330692749,0.0043285298721393,0.0765287145198818,0.0934965516186679,1.05901889891746e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFI,Complement factor I,39979,0.0426457317832934,0.00217001099304223,0.0383925102369306,0.0468989533296562,1.38455106871411e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EZR,Ezrin,42249,0.053175030587467,0.00271929949760414,0.0478452035721629,0.0585048576027712,5.28986818773676e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,39736,0.101000174108431,0.00518456377397968,0.0908384291114306,0.111161919105431,3.8253354327615e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42119,0.183794267059334,0.00946859935875808,0.165235812316168,0.2023527218025,8.32744802898707e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.118578803942146,0.00611577343230863,0.106591888014821,0.130565719869471,1.31106276577995e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,39806,0.0584707802621547,0.00301399502923466,0.0525633500048548,0.0643782105194546,1.73382968519895e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,39958,0.196636997932773,0.0101399195035143,0.176762755705885,0.216511240159661,1.91340448774086e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41843,0.167037015694237,0.00863234298601806,0.150117623441642,0.183956407946833,2.76937148147486e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0562046957664751,0.00290495336687214,0.0505109871674057,0.0618984043655445,2.77948833358274e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.0652811607973909,0.00337806043879473,0.0586601623373532,0.0719021592574286,4.20550713582904e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,41827,0.12793536889955,0.00662444500617735,0.114951456687443,0.140919281111658,5.63487878984592e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,39736,0.139476985742908,0.00722375567667988,0.125318424616615,0.153635546869201,9.87767132923457e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.148063286510342,0.00767042815265488,0.133029247331139,0.163097325689546,1.13280551853854e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,39638,0.115360724690152,0.00598192078273309,0.103636159955996,0.127085289424309,1.56611517640781e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.142255942215998,0.00738750618105662,0.127776430101127,0.156735454330869,2.45699917777865e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,42070,0.0644215374798125,0.00334979788597714,0.0578559336232973,0.0709871413363277,2.47540198987618e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0817283373502764,0.00425067568579087,0.0733970130061263,0.0900596616944265,2.66109797666387e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,41961,0.102927495995897,0.00535919816422841,0.0924234675940089,0.113431524397784,4.08989693657555e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.0746243455537722,0.00389066122034422,0.0669986495618975,0.0822500415456468,6.3649949149373e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,42137,0.0849291577700617,0.00445023456883169,0.0762066980151516,0.0936516175249718,3.8420601660924e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42119,0.0863514368923681,0.00452751313636764,0.0774775111450876,0.0952253626396487,4.78399061912677e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,39736,0.0663508928073025,0.00347563500637575,0.0595386481948061,0.073163137419799,5.71857094218769e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,42145,0.133942947104515,0.00702986199808979,0.120164417588259,0.147721476620771,6.80484263306979e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0412320509860864,0.0021653024561631,0.0369880581720068,0.0454760438001661,8.47995797985297e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.194877390008122,0.0102732859827058,0.174741749482019,0.215013030534226,3.38449587612058e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,42145,0.0739718663228228,0.00391729127085954,0.0662939754319381,0.0816497572137075,1.58784458413475e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.174146210671623,0.00923378623261783,0.156047989655692,0.192244431687553,2.59081380895592e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,42262,0.0711614915730142,0.00377636168181271,0.0637598226766613,0.0785631604693671,3.22509420985984e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,42249,0.0479726093169625,0.0025471988289801,0.0429800996121615,0.0529651190217635,3.91790607965234e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,41992,0.0681255538729803,0.00362081914053174,0.0610287483575381,0.0752223593884225,5.74951318915952e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,0.141898431172246,0.00754484948430004,0.127110526183018,0.156686336161474,6.5289139795749e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0420145698557026,0.00223989470915113,0.0376243762257664,0.0464047634856388,1.6289458875091e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,0.179668018103377,0.00958267850135887,0.160885968240713,0.19845006796604,1.94580914789402e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.22113102800301,0.0117964786889467,0.198009929772674,0.244252126233345,2.03435981648845e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41777,0.0692109349899175,0.00369290042489107,0.061972850157131,0.076449019822704,2.29015700935527e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.143260580249574,0.00764646692971339,0.128273505067336,0.158247655431813,2.53157580803878e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,42069,0.0928643826303504,0.00495758919511931,0.0831475078079165,0.102581257452784,2.61126953222913e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0561920712852256,0.00300074505973385,0.0503106109681473,0.062073531602304,2.87831125523304e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,0.0630948123536059,0.00336945926563498,0.0564906721929613,0.0696989525142504,4.54475732290534e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,42249,0.119510190016256,0.00641470721988585,0.10693736386528,0.132083016167233,1.607921018682e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,0.0691419598121839,0.00370633139007858,0.0618775502876299,0.076406369336738,1.64008281712822e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,0.26290491594774,0.0141141786887959,0.2352411257177,0.29056870617778,1.76802920957663e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42119,0.122424352168938,0.00658001559570218,0.109527521601362,0.135321182736515,2.59568765321002e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0656581419728732,0.00353092489164843,0.0587375291852423,0.0725787547605041,3.11879921760572e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.122437534627047,0.00658810074973368,0.109524857157569,0.135350212096525,3.79109804132488e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,41913,0.171970822322646,0.00925734140749461,0.153826433163957,0.190115211481336,4.5279585009826e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.107829280272483,0.00580999114660589,0.0964416976251351,0.11921686291983,6.01499912994018e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0451048020755157,0.00242993629026931,0.0403421269465879,0.0498674772044436,8.49504683312957e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,39958,0.058510319208301,0.00315540496302255,0.0523257254807768,0.0646949129358252,1.21113332657359e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0767450037747636,0.004141259242554,0.0686281356593577,0.0848618718901694,1.48882224139024e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42152,0.0644411256131579,0.0034832173463268,0.0576140196143574,0.0712682316119584,1.73615615507436e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.100363962181856,0.00544814515699546,0.0896855976741444,0.111042326689567,1.12841742991137e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,42195,0.0699634369224307,0.0038099422517216,0.0624959501090564,0.077430923735805,2.04340303126705e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0958851553168547,0.00523181989259203,0.0856307883273743,0.106139522306335,6.22585333381042e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,42119,0.0706885422928701,0.00386385790240708,0.0631153808041522,0.078261703781588,7.07204642925895e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,42080,0.0854474534899394,0.0046715564771724,0.0762912027946815,0.0946037041851973,7.6150283192201e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0680880638209017,0.00372590049982876,0.0607852988412373,0.075390828800566,1.01766643373583e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0794314923322063,0.00435005860624761,0.070905377463961,0.0879576072004516,1.2898380757748e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.148782196945765,0.00813810805414555,0.13283150515964,0.164732888731891,1.29894378362753e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,39657,0.171849503982356,0.00940703065460491,0.15341172389933,0.190287284065381,1.77662250543094e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.111719710185203,0.00613728097725101,0.0996906394697912,0.123748780900615,3.80335802921506e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,0.133762163709596,0.00736295819174827,0.119330765653769,0.148193561765422,6.93245224977365e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,39979,-0.05587094543432,0.00307229113038478,-0.0618926360498742,-0.0498492548187659,7.21322020739766e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,42247,0.104928690770329,0.00577705546898959,0.093605662051109,0.116251719489548,7.29491890919214e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,0.0534742328530388,0.00294185968915105,0.0477081878623028,0.0592402778437749,8.66264949257257e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.0928523426303832,0.00511471352116339,0.0828275041289029,0.102877181131863,8.97107331809929e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,42145,0.0784863172066238,0.00433613276167888,0.0699874969937332,0.0869851374195144,2.24442478241135e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,42070,0.108948290305215,0.00602103360672694,0.0971470644360305,0.1207495161744,2.51952930241475e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0553708115365885,0.00306416264454013,0.0493650527532898,0.0613765703198871,3.83571175623237e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42249,0.293232276230301,0.0162421473273559,0.261397667468684,0.325066884991919,5.06080512084476e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,39802,0.0473527172858175,0.00262074341895065,0.0422160601846742,0.0524893743869608,5.91090759343888e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0586713299808253,0.00324864893781582,0.0523039780627063,0.0650386818989443,6.92320003179262e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,42002,0.0732498538065353,0.00407020210168861,0.0652722576872256,0.081227449925845,1.43785713136256e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",39979,0.0336078282576539,0.00186669318588147,0.0299491096133262,0.0372665469019816,1.77301415564005e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0445808414179764,0.00247719634912874,0.039725536573684,0.0494361462622687,2.12153396815932e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.091224768169393,0.00507695126746803,0.0812739436851557,0.10117559265363,2.34019660468247e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.107263487208648,0.00598228094933352,0.0955382165479547,0.118988757869342,6.53153096315714e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,41992,0.100641492904597,0.0056571368128435,0.0895535047514234,0.11172948105777,5.36931543854447e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFM,Afamin,39979,0.0402211902554561,0.00226653680461361,0.0357787781184135,0.0446636023924988,1.60328767096204e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,42224,0.0966933946076063,0.00545663234130649,0.0859983952186456,0.107388393996567,1.75564580783019e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,39958,0.113608783566289,0.00642916641040491,0.101007617401895,0.126209949730683,5.86698515601971e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,39958,0.180764365051348,0.0102323357081928,0.16070898706329,0.200819743039405,6.3789147850585e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.160861864976955,0.00913204178560716,0.142963063077165,0.178760666876745,1.08252611931e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.157076663712998,0.00893795492114623,0.139558272067552,0.174595055358445,3.12133268032554e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,42137,0.109662164904759,0.00625160465102796,0.0974090197887445,0.121915310020774,3.91501131588096e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,0.117384783816647,0.00669730171194019,0.104258072461244,0.13051149517205,5.04644106584959e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0736991838972612,0.00420818636534304,0.0654511386211889,0.0819472291733336,9.14917504371963e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,39709,0.101189210293617,0.00578376915851842,0.0898530227429213,0.112525397844314,1.24882889077719e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MME,Neprilysin,42070,0.152074146234909,0.00872241753363513,0.134978207868984,0.169170084600834,2.45755476015815e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,0.0568187473323579,0.00325961555657898,0.0504299008414631,0.0632075938232527,2.60192712298203e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,0.178481569089023,0.0102600999759766,0.158371773136108,0.198591365041937,4.73442916313701e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.274752898911886,0.0157888665237755,0.243806720525286,0.305699077298486,5.92641840784666e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,0.058024220846349,0.0033394780346281,0.0514788438984779,0.0645695977942201,6.70904331749805e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.112183718378229,0.00645828891537427,0.0995254721040959,0.124841964652363,1.06001931687633e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,42137,0.0551173099636897,0.00317995329041354,0.0488846015144791,0.0613500184129002,1.39161534914723e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MLN,Promotilin,42119,0.173359099982464,0.0100129269526359,0.153733763155297,0.19298443680963,1.93347014349262e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,42119,0.108252670446319,0.00626523709894325,0.0959728057323902,0.120532535160248,3.51610785598511e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,39966,0.054575075576881,0.00315543911549822,0.0483904149105045,0.0607597362432575,3.56167018607753e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,42239,0.0390268096827327,0.00226099460839264,0.0345952602502831,0.0434583591151823,4.65629811306863e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,41843,0.145508094053909,0.00843662101058237,0.128972316873168,0.162043871234651,6.15827012163875e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,0.0626894122969299,0.00363038804977054,0.0555738517193797,0.0698049728744802,6.17875277619258e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OCLN,Occludin,39934,0.0857471541109883,0.00497879806434258,0.0759887099048769,0.0955055983170998,1.22924619864949e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42218,0.128625634659148,0.00747738447742135,0.113969961083402,0.143281308234894,1.26554019480724e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.167736096941154,0.00974470111182517,0.148636482761977,0.186835711120332,1.44586587385704e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,42119,0.114374053883337,0.00665240855701162,0.101335333111594,0.12741277465508,1.49224353451844e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42162,0.062084968193052,0.00361494834912521,0.0549996694287666,0.0691702669573374,2.02428847281254e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.119560566769602,0.00696205716724503,0.105914934721802,0.133206198817403,2.81800109834174e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0847486068683745,0.00496413938974132,0.0750188936644815,0.0944783200722675,1.14375688194692e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,42181,0.102852365480504,0.00603254922842601,0.0910285689927889,0.114676161968219,1.64939849118285e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0997609409032059,0.00585125199341567,0.0882924869961112,0.111229394810301,1.65399854067161e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,41880,0.0696232866055651,0.0040859456383724,0.0616148331543552,0.077631740056775,2.01394140808119e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,0.0817601401471214,0.00480302988272406,0.0723462015769823,0.0911740787172606,2.6076097357276e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.0805806988789624,0.00474101570272658,0.0712883081016183,0.0898730896563065,3.97729877426764e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.162165545324374,0.00953187835262091,0.143483063753237,0.180848026895511,4.30399376347609e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,39713,0.0749388554357428,0.00440765339699894,0.0662998547776249,0.0835778560938608,5.10273769607743e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,0.0441397633456453,0.00259894204412747,0.0390458369391555,0.0492336897521351,6.88389304711522e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.135697995994663,0.00799623991455801,0.120025365762129,0.151370626227197,8.36737897148145e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0632859801380907,0.00373686162881581,0.0559617313456117,0.0706102289305697,1.11376047418878e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,42119,0.0749717948655769,0.00442888387284676,0.0662911824747972,0.0836524072563565,1.26519513530993e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,0.101155323689665,0.00597815692277256,0.0894381361210306,0.112872511258299,1.42094685592619e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,0.0545477624607784,0.00322540133767095,0.0482259758389433,0.0608695490826135,1.66643365443622e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42119,0.100544746450317,0.00594898122803225,0.0888847432433734,0.11220474965726,1.97358753987574e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PXN,Paxillin,41839,0.0972985907051269,0.00575917516640249,0.086010607378978,0.108586574031276,2.27328495570036e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,42199,0.0484209021213615,0.00287584526404051,0.0427842454038421,0.0540575588388809,5.66026112418356e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,42204,0.12981545567822,0.00771663015958256,0.114690860565438,0.144940050791002,7.16559305391964e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,42119,0.0848880836251582,0.0050760532756368,0.0749390192049101,0.0948371480454063,3.73451026815514e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.105880736283068,0.00633740481593509,0.0934594228438349,0.118302049722301,6.38479851140447e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,0.113998073381659,0.00683356525883868,0.100604285474335,0.127391861288983,1.01563331492716e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_E,,42119,0.0547374490929676,0.00329219283261054,0.048284751141051,0.0611901470448843,1.82640038265707e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.16792721073277,0.010107976720489,0.148115576360612,0.187738845104929,2.29252552792742e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0735957658676678,0.00443167709137717,0.0649096787685686,0.0822818529667671,3.41952478682497e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,42249,0.109726843045648,0.00661972947743253,0.0967521732698803,0.122701512821416,4.12607477178108e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0516475093487437,0.00311806232651727,0.0455361071887698,0.0577589115087175,5.04960211468267e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FN1,Fibronectin,39979,0.050552376628297,0.00306000611601601,0.0445547646409056,0.0565499886156884,1.32670212756558e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,42296,0.0628266002119627,0.00380889900778575,0.0553611581567026,0.0702920422672227,1.53520582401687e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.113478566602746,0.00688849339742308,0.0999771195437971,0.126980013661696,2.26057560000446e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41843,0.0515920766762588,0.00313756974958283,0.0454424399670765,0.0577417133854412,3.69124649996985e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,42116,0.07469567139165,0.004545503995638,0.0657864835601995,0.0836048592231005,4.25347673244172e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.106308646278876,0.00647669328421253,0.093614327441819,0.119002965115932,5.7116145063518e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MENT,Protein MENT,39736,-0.0439604938116478,0.00267570345516344,-0.0492048725837682,-0.0387161150395275,5.95299911441398e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,0.0739210208188544,0.00450388188384449,0.0650934123265192,0.0827486293111896,7.7976011185287e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,42137,-0.0497886576559334,0.00303938092336625,-0.0557458442657312,-0.0438314710461355,9.77877253729174e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,39736,0.107982367537579,0.00659376225906196,0.0950585935098176,0.12090614156534,1.39704619908811e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,39638,0.116099827456233,0.00708961013917605,0.102204191583448,0.129995463329018,1.42562026029415e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,42016,0.122740795038599,0.0075051353311063,0.108030729789631,0.137450860287568,1.52707308469065e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.0631204006429874,0.00386322717572429,0.0555484753785678,0.0706923259074071,1.94824507110869e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,42115,0.169203142122797,0.0103957252317923,0.148827520668484,0.18957876357711,5.29480554877064e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,41831,0.072548451386038,0.00445985685635087,0.0638071319475903,0.0812897708244857,6.30852412963388e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0686399621991032,0.00422031159935452,0.0603681514643684,0.0769117729338381,6.44730761079172e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,39638,0.115058737914436,0.00707610880024853,0.101189564665948,0.128927911162923,9.09672253597908e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,42138,0.0745438896625083,0.00459001924759387,0.0655474519372244,0.0835403273877923,9.36970384695472e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.0616957601638109,0.00380903461840255,0.0542300523117419,0.0691614680158799,1.88958735705462e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,-0.201605968318655,0.0124524723798175,-0.226012814183097,-0.177199122454212,2.92043908501251e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.0629254050889431,0.00389508091525313,0.055291046495047,0.0705597636828392,3.61804118782075e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,41839,0.0956588810969381,0.0059221296276648,0.0840515070267151,0.107266255167161,3.89869155310664e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,0.0417804298996189,0.00259054199794472,0.0367029675836473,0.0468578922155906,5.68942640971103e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,42070,0.138871170925642,0.00864042358368342,0.121935940701622,0.155806401149661,1.36905068896289e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,0.0729248577203829,0.00453792167196895,0.0640305312433237,0.081819184197442,1.38690119654792e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,0.085419661620503,0.0053153862731923,0.075001504525046,0.0958378187159599,1.39072362123116e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.110261728056171,0.00686255730964034,0.096811115729276,0.123712340383066,1.48451469138247e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,39934,0.0762000165216478,0.00474591838431571,0.066898016488389,0.0855020165549066,2.22739264987144e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,0.137947991668718,0.00859261870604171,0.121106459004876,0.15478952433256,2.3454936774269e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42262,0.222125175759376,0.0138925622981489,0.194895753655004,0.249354597863748,5.03096710451954e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0527806281995979,0.00330090714404165,0.0463108501972763,0.0592504062019195,5.14589568276562e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GH1,Somatotropin,42129,-0.318657523908545,0.0199478032248053,-0.357755218229163,-0.279559829587926,6.36638425571293e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.116015651778871,0.00727842957499685,0.101749929811877,0.130281373745865,1.09191644267018e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,0.065688319847886,0.00412488033912159,0.0576035543832077,0.0737730853125643,1.39669156475013e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42247,0.0510949104718068,0.00320917791581533,0.0448049217568087,0.0573848991868048,1.45116782099579e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.123040991095244,0.00773227197287342,0.107885738028412,0.138196244162075,1.66671433381451e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,42070,0.0573182992922539,0.00360334455235303,0.0502557439696419,0.0643808546148658,1.8502730224702e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,42166,0.0583589355952239,0.00367235033733163,0.0511611289340539,0.0655567422563939,2.34066692620124e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,0.143965012169743,0.0090509079749109,0.126225232538917,0.161704791800568,2.41717614217789e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0570772691415457,0.00359085029372384,0.050039202565847,0.0641153357172444,2.87435771734168e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,0.227585756479642,0.0143398018348935,0.199479744883251,0.255691768076034,3.22238467959318e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42249,0.111925230161616,0.00706653021539241,0.0980748309394466,0.125775629383785,5.29595443485544e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,42232,0.0742373030166559,0.00469828375233478,0.0650286668620798,0.0834459391712321,9.56907064106978e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,39638,0.105902940520972,0.00669546173536161,0.0927798355196634,0.119026045522281,9.68885527220947e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,39929,0.0691380302518528,0.00437264816942252,0.0605676398397846,0.0777084206639209,1.02065090946015e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42296,0.134308083871733,0.0085157440545876,0.117617225524742,0.150998942218725,1.49969663236739e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,42181,0.0960968212348707,0.00609313788130001,0.0841542709875227,0.108039371482219,1.52377222994425e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COCH,Cochlin,39958,0.0814252101123786,0.0051663373160954,0.0712991889728316,0.0915512312519256,2.23477019628306e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0862871131313567,0.00548357745489797,0.0755393013197567,0.0970349249429568,2.73216657843495e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,0.0632999929755643,0.0040254687078243,0.0554100743082286,0.0711899116428999,3.10161694657036e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,0.149701215036318,0.00952686814243767,0.13102855347714,0.168373876595496,3.76787188702358e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0975671486435471,0.00621087391872188,0.0853938357628522,0.109740461524242,3.96614918300708e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,39966,0.201025083476759,0.0127854870763415,0.175965528807129,0.226084638146388,4.00702668013609e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,42262,0.0963095181259757,0.00613374618714212,0.0842873755991772,0.108331660652774,4.46709797527167e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,42296,0.0752480561797523,0.00479245667152319,0.0658548411035668,0.0846412712559377,4.47076011699069e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,39736,0.0541427340691527,0.00344475165087761,0.0473910208334325,0.0608944473048728,4.47931083898197e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,0.119972566892876,0.00765074860881159,0.104977099619606,0.134968034166147,6.13440160117453e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,0.0962054278489246,0.0061397921028702,0.084171435327299,0.10823942037055,7.59695162894911e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,39657,0.168170405682423,0.0107270077037492,0.147145470583075,0.189195340781772,8.40061364574447e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,39358,0.0426378240613145,0.00272071352773509,0.0373052255469537,0.0479704225756752,9.52211791885355e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,0.0868468344468298,0.00555040426441513,0.0759680420885762,0.0977256268050835,1.05162482782299e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,0.0602293973600513,0.00385353877198856,0.0526764613669537,0.0677823333531489,1.68785642407935e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42070,0.200123376860323,0.0128150604076481,0.175005858461332,0.225240895259313,1.69410361021022e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,39757,0.227123114568745,0.0145319347859287,0.198640522388325,0.255605706749166,1.73787354010463e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0935459219501219,0.00599242946087548,0.081800760206806,0.105291083693438,1.88077755413063e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0697203290126559,0.00446713888033911,0.0609647368071912,0.0784759212181206,1.90596138869139e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,39929,0.115850655674165,0.00742115094855528,0.101305199814997,0.130396111533334,2.25863014916755e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0683475268128424,0.00438591354042406,0.0597511362736112,0.0769439173520735,2.78259617355388e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.0553738077873766,0.00355452451060672,0.0484069397465874,0.0623406758281657,3.03005349874478e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,42070,0.0543359114980596,0.00349740318396012,0.0474810012574977,0.0611908217386214,5.80749365787025e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0592427993104188,0.00382395289563399,0.0517478516349762,0.0667377469858614,1.12074678170312e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0443896507167966,0.00286513098410774,0.0387739939879454,0.0500053074456478,1.36379173936287e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0417373332644855,0.00270021684586285,0.0364449082465943,0.0470297582823767,1.93441704483693e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,42103,-0.10879389455349,0.00704137417750285,-0.122594987941395,-0.0949928011655843,2.13725074257344e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,0.215033451688535,0.0139101283088362,0.187769600203216,0.242297303173854,2.3789137646695e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,0.0434852263815667,0.00281863441068891,0.0379607029366165,0.049009749826517,3.01147499729691e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,39911,0.100388840436514,0.00651073833647021,0.0876277932970322,0.113149887575995,4.22769125816087e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,42123,0.047339873530413,0.00307439934916528,0.0413140508060491,0.053365696254777,4.75026941554518e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,42144,0.0512262222537611,0.00332920660347791,0.0447009773109444,0.0577514671965778,5.62003972300006e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.214145667811429,0.0139265992166736,0.186849533346749,0.241441802276109,6.56648351077116e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0986218806283844,0.00640891371103884,0.0860604097547483,0.111183351502021,6.94820622143345e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,0.126076464308848,0.00821191631022667,0.109981108340804,0.142171820276892,9.59636327094005e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELP,P-selectin,42217,0.0961242708975359,0.00626178550265207,0.0838511713123379,0.108397370482734,9.6474478419496e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,42107,0.157519498680968,0.0102697105873358,0.13739086592979,0.177648131432147,1.17852886063578e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.168537274753052,0.0109889741352073,0.146998885448046,0.190075664058058,1.18563528742091e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,42199,0.0315078115973744,0.00205802176702771,0.0274740889340001,0.0355415342607487,1.80153207999177e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.0593912977489205,0.00388338933241404,0.051779854657389,0.067002740840452,2.31040149222403e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,42262,0.190684200101054,0.0124695168463843,0.166243947082141,0.215124453119967,2.3440121386534e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42249,0.0876871029255054,0.00573650051887311,0.0764435619085141,0.0989306439424967,2.57678990088549e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,39911,0.111370769233706,0.00729465561951654,0.0970732442194537,0.125668294247959,4.16209411318927e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,0.0486025507667888,0.00318853351431504,0.0423530250787313,0.0548520764548463,4.91994249422175e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,41830,0.0848519408547843,0.00556662417775454,0.0739413574663854,0.0957625242431832,5.06864875725764e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,0.0855909185651135,0.00561574611672541,0.0745840561763317,0.0965977809538953,5.08602134642459e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,42081,0.0721099517693898,0.004736792007806,0.0628258394340901,0.0813940641046896,6.68073773157831e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,0.0829115663185501,0.00544449750130716,0.072240351215988,0.0935827814211121,7.45175927694145e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.166220075295424,0.0109177681845988,0.144821249653611,0.187618900937238,8.13126414965568e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0877431218921735,0.00576388878082952,0.0764458998817477,0.0990403439025994,8.3903825287666e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0840426007536015,0.00552201848152882,0.0732194445298051,0.094865756977398,8.51839465529968e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.0678939848899526,0.00446645136274389,0.0591397402189746,0.0766482295609306,9.22349598652199e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42284,0.0889709949119251,0.00585682075208047,0.0774916262378474,0.100450363586003,1.07056880680553e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANG,Angiogenin,42152,0.0558821048365581,0.0036785415927104,0.0486721633148458,0.0630920463582705,1.07464510491499e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.124439278101203,0.00820235504342133,0.108362662216097,0.140515893986309,1.44756628038418e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0508692675563434,0.00335061326794613,0.044302065551169,0.0574364695615178,1.48847732829978e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.142611720239561,0.00940276768062522,0.124182295585536,0.161041144893587,1.55786358482634e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.052879900830736,0.00348606765950198,0.0460472082181121,0.0597125934433599,1.81690381913452e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.153659787398556,0.0101336359370172,0.133797860962002,0.173521713835109,1.97484036693598e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.134264721465343,0.0088554096399405,0.11690811857106,0.151621324359626,2.02228272564654e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,39915,0.187089410942079,0.0123898302262527,0.162805343698624,0.211373478185534,5.06251209223834e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0843830761614274,0.0055888779622613,0.0734288753553953,0.0953372769674596,5.48478000284454e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,39930,0.18513571260854,0.0122727858707488,0.161081052301873,0.209190372915208,6.33403031037391e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42249,0.0517184258671829,0.00343354198948939,0.0449886835677837,0.0584481681665821,7.29885504800935e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,42119,0.0950371016984736,0.00631479869779545,0.0826600962507945,0.107414107146153,8.90899601219079e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,42145,0.106657044103907,0.00709175606457348,0.0927572022173425,0.120556885990471,1.03672244815076e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,39966,0.0439831182719494,0.00292297367616783,0.0382540898666604,0.0497121466772384,1.10372754490435e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,42249,0.0594925062853799,0.00396520031952903,0.0517207136591031,0.0672642989116568,1.75446117363952e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.0684620281281756,0.00457565215984207,0.0594937498948852,0.0774303063614661,3.29047704910481e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,42181,0.0941605235365549,0.00629918232990399,0.0818141261699431,0.106506920903167,4.01297473858003e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.142322039268972,0.00952038112241694,0.123662092269035,0.160981986268909,4.72202754672888e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,42310,0.0730549367059722,0.00489421060027044,0.0634622839294422,0.0826475894825023,5.44495595198538e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.0882607830907384,0.00591375391712482,0.0766698254131738,0.0998517407683031,5.73103233922722e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.106990216199693,0.00717071740121358,0.0929356100933142,0.121044822306071,6.17279706415967e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,42296,0.145079343124495,0.00973218938621333,0.126004251927517,0.164154434321473,7.28062517975993e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42119,0.0609798081480021,0.00409149752318557,0.0529604730025584,0.0689991432934458,7.71380469343552e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42296,0.0461075498423062,0.00309568582946203,0.0400400056165606,0.0521750940680517,8.82133960671888e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.183344155410757,0.0123011778712023,0.1592338467832,0.207454464038313,9.10141872948538e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,42217,0.168637687436994,0.0113262386740312,0.146438259635893,0.190837115238095,9.54601430416225e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,39903,0.122427836720475,0.00822087189985685,0.106314927796755,0.138540745644194,1.09263798123499e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0720018773894402,0.00484072881001638,0.0625140489218081,0.0814897058570723,1.20504569308276e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0631082289388439,0.00424277475678484,0.0547923904155456,0.0714240674621422,1.21167029836502e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,42250,0.0845880220529934,0.00568750857417993,0.0734405052476007,0.0957355388583861,1.21454536003189e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,0.0588020698400297,0.00395976227090062,0.0510409357890645,0.066563203890995,1.73490163379856e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,42119,0.110451830753297,0.00744511046825189,0.0958594142355236,0.125044247271071,2.11229997121202e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.128846686264917,0.00868302493813423,0.111827957386174,0.145865415143661,2.37641222377245e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0557939061352849,0.00376436814161572,-0.0631720676928517,-0.0484157445777181,2.55799912454429e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,42081,0.0522192443715916,0.00352571820236244,0.0453088366949613,0.059129652048222,3.03350013125254e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0638215257621821,0.00431137260387561,0.0553712354585859,0.0722718160657783,3.45990182861354e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBIN,Erbin,42070,0.170413593196441,0.0115147670808939,0.147844649717889,0.192982536674993,3.58592898726591e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,39736,0.090092470767423,0.00608696957095377,0.0781620104083537,0.102022931126492,4.22869420159675e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,42145,0.0673115829524382,0.00455321027677118,0.0583872908099667,0.0762358750949098,4.5253278100901e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,42296,0.0484634921240024,0.00327846545101544,0.0420376998400122,0.0548892844079927,4.5449654198212e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,0.0616599211042116,0.00417810217228091,0.053470840846541,0.0698490013618821,6.62914872210663e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0719216862349346,0.00487351640463305,0.0623695940818538,0.0814737783880153,7.80077613293503e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,39958,0.0539425730456206,0.0036560343039023,0.0467767458099721,0.0611084002812691,8.15099949978216e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.106677536557318,0.0072307474962612,0.0925052714646455,0.120849801649989,8.30107791184525e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0687756649472997,0.00466236801168752,0.0596374236443921,0.0779139062502072,8.55723968696912e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,39990,-0.043025274504835,0.00291874818868566,-0.0487460209546589,-0.0373045280550111,9.87436434291306e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,42119,0.140936440562826,0.00957042159343893,0.122178414239686,0.159694466885967,1.04215558691689e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BSG,Basigin,42284,0.0345466574494736,0.00234980875671727,0.0299410322863077,0.0391522826126394,1.46998853383043e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0402445064868102,0.0027390173232263,0.0348760325332866,0.0456129804403337,1.69443780157833e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.120883661711747,0.00822138901505633,0.104769739242237,0.136997584181258,1.75594709215671e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.0641085224776176,0.00436675986117231,0.0555496731497199,0.0726673718055153,1.98936135567504e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,39930,0.0561772903934202,0.00382464988245477,0.0486809766238089,0.0636736041630316,2.13483178826001e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,39948,0.0731547840585049,0.00498075264936781,0.063392508865744,0.0829170592512658,2.15380798494347e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,39979,0.0502974268006483,0.00342562323001811,0.0435832052698128,0.0570116483314838,2.30205722124926e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,0.10945226081926,0.00746887646181288,0.0948132629541066,0.124091258684413,2.92287530285869e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,41839,0.0788720398632813,0.00538192117200334,0.0683234743661548,0.0894206053604079,2.98672363724547e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41832,0.0641391867985305,0.00438089392752309,0.0555526347005852,0.0727257388964757,3.67744165849647e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,42070,0.116815040052913,0.0079859034779165,0.101162669236197,0.132467410869629,4.37232905508561e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.109487277562357,0.00748448893623781,0.0948176792473314,0.124156875877384,4.37931244067638e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42181,0.0910996234083181,0.00622989981010906,0.0788890197805044,0.103310227036132,4.64705215185703e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,41960,0.0663810644686908,0.00454179544924687,0.057479145388167,0.0752829835492147,5.24095300614966e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.16470175579907,0.0112671515583197,0.142618138744764,0.186785372853377,5.89641535431822e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.0992987760808336,0.00679866743087883,-0.112624164245356,-0.0859733879163111,5.9333321419433e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,42089,0.169013480595164,0.0115733934782727,0.14632962937775,0.191697331812579,6.18097133805136e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,42146,0.0925916648557482,0.00634688213423949,0.0801517758726388,0.105031553838858,7.65919732533813e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,0.0980947910835916,0.00672926371469051,0.0849054342027982,0.111284147964385,9.01482944250889e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.0865811358638515,0.00594087616237721,0.0749370185855921,0.0982252531421108,9.65441269196496e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.112849345724578,0.00774013445807213,0.097678682186757,0.1280200092624,1.04772340014096e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,0.0508451607136484,0.00349163464994925,0.0440015567997479,0.0576887646275489,1.12346078256274e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42296,0.0897385611573686,0.00616652301207482,0.0776521760537019,0.101824946261035,1.27514533119074e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0757106326339962,0.00520071353144926,0.0655172341123557,0.0859040311556367,1.42453989545591e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.0919454402167642,0.00632192321217398,0.0795544707209032,0.104336409712625,1.46844336738686e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PYY,Peptide YY,39575,0.163963212271474,0.0112833446584952,0.141847856740823,0.186078567802124,2.10803334975027e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42016,0.0551450513112465,0.00379987191388222,0.0476973023600373,0.0625928002624556,2.31106156703329e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.154864473748655,0.0106781027076091,0.133935392441741,0.175793555055569,2.61685663964789e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,42262,0.10426238365124,0.00719274440793663,0.0901646046116839,0.118360162690795,2.90030996142149e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.102330229556284,0.00705466470050419,0.0885030867432957,0.116157372369272,2.96218711129804e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,0.129104084290702,0.00890771362055,0.111644965594424,0.14656320298698,3.06089868789016e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42249,0.127249177896397,0.00878961743241606,0.110021527728862,0.144476828063933,3.77198837699027e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,39966,0.0663673943580201,0.00458555943434898,0.0573796978666961,0.0753550908493441,4.690297786097e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,42296,0.154180802755073,0.0106628284425338,0.133281659007707,0.175079946502439,4.83709393493914e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.15447302297413,0.0106823701741229,0.133535577432849,0.175410468515411,4.85427551729203e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,42147,0.07560716809425,0.0052293014177418,0.0653577373154761,0.0858565988730239,4.96977666122294e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,41997,0.130528125920775,0.0090308267811041,0.112827705429811,0.148228546411739,5.36683955559118e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,42070,0.0902117694679327,0.00624303832675463,0.0779754143474936,0.102448124588372,5.62894899827229e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39657,0.0726723845048821,0.00502659407377253,0.0628202601202879,0.0825245088894763,6.01260659480772e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.179840377777524,0.0124479548025629,0.155442386364501,0.204238369190547,6.80598488306494e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,39959,0.0474497489409824,0.00328537266111556,0.0410104185251959,0.0538890793567689,7.24057916445635e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42253,0.0919209934700466,0.00637007822831379,0.0794356401425516,0.104406346797542,7.39629087327769e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,41839,0.102684189701055,0.0071196462435295,0.0887296830637371,0.116638696338373,8.43248579981342e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0537382814807644,0.00372777829703139,0.0464318360185828,0.0610447269429459,9.11745753875364e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0800510772792525,0.00555544770672341,0.0691623997740746,0.0909397547844304,1.01736693454583e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,0.045462326538107,0.00315303173405802,0.0392823843393533,0.0516422687368608,1.02087250117119e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42217,0.0508125877113733,0.00352725328361943,0.0438991712754792,0.0577260041472674,1.04998161544254e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,39990,-0.0802541615411792,0.00556869816358492,-0.0911688099418057,-0.0693395131405528,1.12401131926719e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,42016,0.142715453158333,0.00991114075583288,0.123289617276901,0.162141289039765,1.16069226596378e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42247,0.0903497063742855,0.00627691115274986,0.0780469605148957,0.102652452233675,1.23898269047676e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,0.103580962565018,0.00719725029332123,0.0894743519901084,0.117687573139928,1.28955849820021e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,0.0975543546471692,0.00677600677347478,0.0842733813711587,0.11083532792318,1.3901735462217e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,42296,0.0769774752609575,0.0053576826110433,0.0664764173433126,0.0874785331786024,1.79643284597016e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.049287303960971,0.00343524330731675,0.0425542270786301,0.0560203808433118,2.40045479974681e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0678725491382057,0.00473856976350503,0.0585849524017359,0.0771601458746756,3.44502286049414e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,39937,0.0521161321439729,0.00363843117384442,0.0449848070432378,0.059247457244708,3.9237163497906e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.168328049684419,0.0117559648696443,0.145286358539916,0.191369740828921,4.22951203156659e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,0.201535847204868,0.0140970895490556,0.173905551688719,0.229166142721017,4.97847189161824e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42145,0.0735985363090302,0.00515579722795755,0.0634931737422334,0.083703898875827,6.74973194415228e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0744708656750799,0.00521413234161016,0.0642511662855239,0.0846905650646358,7.19106200407385e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,41839,0.0544489032771517,0.00382220530141488,0.0469573808863785,0.0619404256679249,1.04152282295176e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0410396434857359,0.00288577314701286,0.0353835281175907,0.0466957588538811,1.70160937832379e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,42296,0.0488685900624781,0.00344372317837708,0.042118892632859,0.0556182874920972,2.19551673660004e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39575,0.108205926335558,0.0076244441207948,0.0932620158587998,0.123149836812315,2.58276597766509e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,42185,0.0610482645173168,0.00430570998174694,0.0526090729530928,0.0694874560815408,2.62095876819884e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,0.123463530434979,0.00871396934855772,0.106384150511806,0.140542910358152,3.48880560867657e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.105916762950003,0.00748049471099455,0.0912549933164534,0.120578532583552,3.50589333850494e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,0.109109478160332,0.00770473555532127,0.0940081964719022,0.124210759848762,3.85377520480079e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,41843,0.0627060935291704,0.0044310462000758,0.0540212429770219,0.071390944081319,3.89585301177314e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,41839,0.106437896271924,0.00752249984821496,0.0916937965694226,0.121181995974425,4.02209633574446e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42016,0.0891761012011695,0.00630757972660389,0.0768132449370259,0.101538957465313,4.66832990421843e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0588868773533371,0.00416638520390665,0.0507207623536801,0.0670529923529942,4.91100676215879e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,39958,0.158543457345474,0.0112198020296902,0.136552645367281,0.180534269323667,5.90193883395949e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,0.055841911131304,0.00395906755052156,0.0480821387322818,0.0636016835303263,7.36606434668563e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,0.0550503708087845,0.00391172120615889,0.0473833972447131,0.0627173443728559,1.31383758072259e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0647019987338854,0.00459803275528027,0.0556898545335361,0.0737141429342348,1.3454115155402e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,42185,0.0749797304093234,0.00533897976909555,0.0645153300618962,0.0854441307567507,1.72004709732658e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,0.0426403469185568,0.00303750919916184,0.0366868288881996,0.048593864948914,1.86714251289014e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,0.0528138085905226,0.00376324917953529,0.0454378401986335,0.0601897769824118,1.97618455546307e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,42217,0.0901198255904452,0.00642469157525065,0.0775274301029539,0.102712221077936,2.16680613193803e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0816473003353876,0.00581600684311929,0.0702479269228738,0.0930466737479014,2.18101699292619e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.0605440003461973,0.00431699900886365,0.0520826822888246,0.0690053184035701,2.23717365341069e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.12052052426687,0.00859090934293253,0.103682341954722,0.137358706579018,2.4326935582397e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,39919,0.0580127202491358,0.00413793232136537,0.0499023728992597,0.0661230675990119,2.76785676059896e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,42262,0.0743468496782615,0.00530962133661483,0.0639399918584964,0.0847537074980265,3.05119636179769e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0729832702264818,0.00521404134733661,0.062763749185702,0.0832027912672615,3.28417082439015e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0366019401713247,0.00261668001112634,0.0314732473495171,0.0417306329931323,4.2829346621089e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42137,0.0542345585174737,0.00388348222517454,0.0466229333561316,0.0618461836788158,5.11622209666079e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.130880161706308,0.00936674979525654,0.112521332107605,0.149238991305011,5.36612099007246e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,0.0359207898951996,0.00257757349940678,0.0308687458363623,0.0409728339540369,7.63079914632811e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,0.0424540805169938,0.00304592492184809,0.0364840676701715,0.048424093363816,8.53047272391079e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,39958,0.0429264226508228,0.00308216442902798,0.0368853803699279,0.0489674649317176,9.8806911120346e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,0.133967211355709,0.00964011848851627,0.115072579118217,0.152861843593201,1.31577541390676e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,39930,0.175143264121359,0.0126097426876209,0.150428168453622,0.199858359789096,1.66558651447528e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,42199,0.0501865008836293,0.00361597796934539,0.0430991840637124,0.0572738177035463,1.67868396921596e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0810637789820342,0.00584706403502077,0.0696035334733935,0.0925240244906749,2.05681531808138e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,42310,0.039611074014387,0.00285779963957652,0.034009786720817,0.045212361307957,2.15022436020536e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.148699094308052,0.0107299425611053,0.127668406888285,0.169729781727818,2.26718222928247e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.0427605713331806,0.00308597195260323,0.0367120663060782,0.0488090763602829,2.29411428025757e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0870746200926602,0.00628402933104328,0.0747579226038153,0.099391317581505,2.29726453552332e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,39736,0.170472133805157,0.0122960503513024,0.146371875116604,0.19457239249371,2.39778580290568e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,0.213481003658764,0.0154203670603202,0.183257084220536,0.243704923096992,2.73272995155265e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,42148,0.0968811848440464,0.0069986445012466,0.0831638416216031,0.11059852806649,2.76896410683114e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,39958,0.117049337595951,0.00845165386053083,0.100484096029311,0.133614579162591,2.8857177961054e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,0.098911248325305,0.00714535153053587,0.0849063593254547,0.112916137325155,3.16132805037184e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.043801175175904,0.00316789893464901,0.037592093263992,0.0500102570878161,3.47498057644417e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.178438651720978,0.0128979142134401,0.153158739862636,0.203718563579321,3.57432378128869e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,39736,0.0849260439085473,0.00614033294695328,0.0728909913325189,0.0969610964845757,3.77257803252546e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,39929,0.145489410341045,0.0105392409174735,0.124832498142797,0.166146322539293,5.32972239102095e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,42310,0.0895633038117617,0.00651059699774399,0.0768025336961835,0.10232407392734,8.9471602504812e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41932,0.0637805303958676,0.00464083862375278,0.0546844866933122,0.0728765740984231,1.09124809399359e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0610308953272943,0.00444307616776736,0.0523224660384703,0.0697393246161183,1.18794372655412e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0398222744917158,0.0029017148873026,0.0341349133126027,0.0455096356708289,1.42106493522316e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,0.0663392412644381,0.00483511184133561,0.0568624220554203,0.0758160604734559,1.48641974659212e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39638,0.0486643442099275,0.00354668725120818,0.0417128371975595,0.0556158512222956,1.69373480314968e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,42145,0.0398716043245824,0.00290960750973811,0.0341687736054957,0.0455744350436691,1.85825007027295e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTR,Transthyretin,39862,0.0383718386297651,0.00279968101333471,0.0328844638436291,0.0438592134159011,2.05103915636099e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,39919,0.155616886754587,0.011360195989956,0.133350902614274,0.177882870894901,2.25718922354268e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42137,-0.0574962679609814,0.00420488252735283,-0.0657378377145929,-0.0492546982073698,2.78335986915125e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,0.118488216715259,0.00866918736804374,0.101496609473893,0.135479823956625,3.05173193203013e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,42129,0.0475338769322151,0.0034823966495987,0.0407083794990017,0.0543593743654286,3.85069863062179e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,42230,-0.0419185424171975,0.00307237895280555,-0.0479404051646964,-0.0358966796696987,4.16150063876527e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,41913,0.0725353241695588,0.00531837584513586,0.0621113075130925,0.0829593408260251,4.52324632140167e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,42146,0.0839533293425622,0.00616012579297141,0.0718794827883382,0.0960271758967862,5.12889373769857e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42185,0.163813228256247,0.0120242784373713,0.140245642518999,0.187380813993494,5.47524298749622e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,42020,0.107528614914927,0.00789271186733464,0.0920588996549512,0.122998330174903,5.49941965941336e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0773632027475943,0.00568407748097878,0.0662224108848759,0.0885039946103127,6.54546650604686e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0477961783288813,0.00351490816014368,0.0409069583349997,0.0546853983227629,7.7355818886752e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,42070,0.136203732108466,0.0100170586783451,0.116570297098909,0.155837167118022,7.85706954039752e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.133082580128927,0.00979716135665963,0.113880143869874,0.15228501638798,9.4109089754177e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,0.117386482073585,0.0086429684843072,0.100446263844343,0.134326700302827,9.64189556978648e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42101,0.171858743916491,0.0126704160998086,0.147024728360866,0.196692759472116,1.23026107471974e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.0366894281289262,0.00270643584822674,0.0313848138664018,0.0419940423914506,1.36980234418841e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0958554911532749,0.00707539411022642,0.0819877186972311,0.109723263609319,1.752484863669e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,42070,0.0438059575966683,0.00323676560083584,0.03746189701903,0.0501500181743065,1.8416239761174e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,39958,0.0463946314018389,0.00343057056478076,0.0396707130948686,0.0531185497088092,2.3610138065824e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0565895441173067,0.00419410216521511,0.0483691038734851,0.0648099843611283,3.23379724072282e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.0302569672834616,0.00224307958833335,0.0258605312903283,0.034653403276595,3.35889491292899e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.119200051064566,0.00884108658935409,-0.1365285807797,-0.101871521349432,3.64919612134811e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0544820746452631,0.00403879210554671,0.0465660421183916,0.0623981071721347,3.78250916732998e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,42129,0.0461229532939775,0.00342303810963241,0.039413798599098,0.052832107988857,4.08088622577669e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,42262,0.0397383541874659,0.00294934406010581,0.0339576398296585,0.0455190685452733,4.09230469366107e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,39934,0.162621265049016,0.0120692178273157,0.138965598107477,0.186276931990555,4.60085019061981e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,42137,0.0575917266027155,0.00427935364769016,0.0492041934532428,0.0659792597521882,5.06730423301087e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0585747500807854,0.00435551272948227,0.0500379451310002,0.0671115550305707,5.76213146282315e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,42137,0.1151961849294,0.00856621224750995,0.0984064089242803,0.131985960934519,5.81448714014498e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,41997,0.0953722846761564,0.00709952992387349,0.0814572060253644,0.109287363326948,7.06448881682476e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0726112354218202,0.005406935628473,0.0620136415900132,0.0832088292536273,8.35252740095724e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,42249,0.0454414263506397,0.00339045818037276,0.0387961283171091,0.0520867243841703,1.05377045666012e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,39930,0.0900157055728644,0.0067159123077162,0.0768525174497407,0.103178893695988,1.17856580367358e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,42016,0.0915446356337836,0.0068346510864785,0.0781487195042857,0.104940551763281,1.19266217520254e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,42272,0.0430307240508234,0.00321466703097871,0.0367299766701052,0.0493314714315417,1.31950240834563e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,41797,0.106161670706557,0.00793428870503178,0.0906104648446943,0.121712876568419,1.45220074865381e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C3,Complement C3,39445,0.0693227559976031,0.00518259821045532,0.0591648635051107,0.0794806484900955,1.74577617869967e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,0.11039063726091,0.00825803224518319,0.0942048940603512,0.126576380461469,1.89040752452295e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,39930,0.114943856684716,0.00860455825379007,0.0980789225072875,0.131808790862145,2.13513894983009e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,41959,0.0651271682311848,0.00487937562338978,0.0555635920093408,0.0746907444530288,2.22337563970513e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.116181181139344,0.00871567780539959,0.099098452640761,0.133263909637927,2.81000271705109e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0503204534353599,0.00377968155301515,0.0429122775914502,0.0577286292792696,3.44255089033541e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.18593928338055,0.0139649845995092,0.158567913565512,0.213310653195588,3.46496201581612e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,0.0878870141496032,0.0065995045536234,0.0749519852245014,0.100822043074705,3.68124264667835e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELE,E-selectin,42310,0.0756406933177143,0.00568382124056411,0.0645004036862087,0.08678098294922,3.68688485618664e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,0.127587450811559,0.0095898849274981,0.108791276353662,0.146383625269455,3.95019078562366e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,39657,0.0655804564994567,0.00493334304530834,0.0559111041306524,0.0752498088682611,5.13075266559496e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,0.129592752263042,0.00975696569333745,0.110469099504101,0.148716405021984,5.84867058278756e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0847262400948915,0.00638414582145477,0.0722133142848402,0.0972391659049429,6.02998733622807e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,0.029888968611558,0.00225220893858593,0.0254746390919296,0.0343032981311865,6.06902526204015e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,0.0794996276353506,0.00599855962787778,0.0677424507647101,0.091256804505991,8.77932097488169e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,41638,0.0352024904292442,0.00265824277964029,0.0299923345811492,0.0404126462773392,8.97317770337334e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42249,0.0436330619378133,0.00329547103845546,0.0371739387024406,0.050092185173186,9.02764879329387e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,39929,0.0413356757882267,0.00312185494516073,0.0352168400957117,0.0474545114807417,1.00650333315394e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39736,0.103035995752084,0.00778232873747693,0.0877826314266294,0.118289360077539,1.03177994189213e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,39979,0.0314916380344592,0.0023790358229994,0.0268287278213804,0.036154548247538,1.05202175613092e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,0.0950689262984701,0.00718205226242408,0.0809921038641189,0.109145748732821,1.05660671725034e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,0.0590419550158102,0.00446463897362021,0.0502912626275145,0.0677926474041058,1.11916532033026e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,42144,0.035667716937739,0.00269713788966667,0.0303813266739924,0.0409541072014857,1.1191840847276e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,42296,0.0556220307001004,0.00421031814749459,0.047369807131011,0.0638742542691897,1.32607470091162e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.104490278850224,0.00790991886696487,0.0889868378709724,0.119993719829475,1.34835399576484e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,39850,0.147169317170005,0.0111430375002863,0.125328963669444,0.169009670670566,1.56717563674873e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,39929,0.0451958706753118,0.00342310466621035,0.0384865855295395,0.0519051558210841,1.64597038341194e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0546563016061465,0.00414255571128072,0.0465368924120363,0.0627757108002567,1.67306644467192e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,42262,0.0581671632735157,0.00441013485314425,0.049523298961353,0.0668110275856785,1.75916555008065e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39638,0.115357612948452,0.00874916328019936,0.0982092529192613,0.132505972977643,2.12442902559164e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,0.0421930987169583,0.00320311114683311,0.0359150008691654,0.0484711965647512,2.21446796191174e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.0403774564187844,0.00306557367250137,0.0343689320206817,0.0463859808168871,2.23851786560415e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,0.14140755090201,0.0107644912092787,0.120309148131824,0.162505953672196,3.51660071061541e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0726765226718741,0.00553016263212485,0.0618374039129094,0.0835156414308389,3.72797919557482e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0288597121037359,0.00220172283217476,-0.0331750888547984,-0.0245443353526733,5.14818375083689e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0505996290849644,0.00386110386175424,0.0430318655159261,0.0581673926540027,5.33302603145979e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,42145,0.0361100062853728,0.00275716734441358,0.0307059582903222,0.0415140542804234,5.92324533323838e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDK,Midkine,42129,0.0754958042232818,0.00576745441022615,0.0641915935792386,0.0868000148673251,6.47563328844422e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0696754403546497,0.00532917305541857,0.0592302611660293,0.0801206195432701,8.01568304880995e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,0.0628653075759812,0.00480913790581523,0.0534393972805833,0.072291217871379,8.17028505886817e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.107080137245833,0.00819456646728152,0.0910187869699612,0.123141487521705,8.70646416525648e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0597511337123155,0.00457335938453624,0.0507873493186244,0.0687149181060065,8.90499553676701e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,42107,0.0421149405922976,0.00322355841001982,0.0357967661086587,0.0484331150759364,8.99501792969323e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0554275076665123,0.00424276446383263,0.0471116893174003,0.0637433260156242,9.15170845883799e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0674501993980574,0.00516479697333687,0.0573271973303171,0.0775732014657977,1.06706198692142e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,42193,0.0485498878426616,0.00372112664033564,0.0412564796276037,0.0558432960577194,1.12693145472892e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0699328057933554,0.00535937423321041,0.059428432296263,0.0804371792904478,1.22713801885343e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.215492780967236,0.0165306202948468,0.183092765189336,0.247892796745136,1.44617061065663e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.125358946852671,0.00961616446949206,0.106511264492466,0.144206629212875,1.46484276554571e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.115272337339962,0.00885112291580328,0.0979241364249877,0.132620538254937,1.6992370949547e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0904656917677366,0.00694841148403228,0.0768468052590333,0.10408457827644,1.78338063494254e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0480233477958593,0.00369124033306176,0.0407885167430583,0.0552581788486604,1.82812915056654e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,0.12929364763156,0.00993700283955302,0.109817122066036,0.148770173197084,2.01873606267581e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.101336830428087,0.00779499021187951,0.0860586496128028,0.116615011243371,2.07575881891292e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39649,0.0716620713938155,0.00550879215081664,0.0608648387782149,0.0824593040094161,2.09012423504779e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,39919,0.0655362486103014,0.0050435226362478,0.0556509442432557,0.0754215529773471,2.48213258318608e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.185271480121573,0.0142815395574777,-0.213263297654229,-0.157279662588917,2.93365723105613e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0783547584785064,0.00604153042433764,0.0665133588468046,0.0901961581102081,3.09212360901228e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,39929,0.0687971653596224,0.00530232629737529,0.0584046058167668,0.0791897249024779,3.17771891683949e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,41881,0.0758761753609655,0.00585207933233306,0.0644060998695927,0.0873462508523383,3.26634264494614e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0406302083485797,0.00313401126570635,0.0344875462677953,0.0467728704293642,3.29471614505747e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,0.0740629554068735,0.00571512856428754,0.0628613034208699,0.0852646073928771,3.95260788570909e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,42249,0.0409331089034947,0.00316170680918528,0.0347361635574916,0.0471300542494978,4.1206052464562e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,0.0949613001269415,0.00734093108747039,0.0805730751954995,0.109349525058383,4.8003814899858e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0652474647330376,0.00504444878157543,0.0553603451211498,0.0751345843449254,4.88485337125857e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.109312074079035,0.00845000211228748,0.0927500699389516,0.125874078219119,5.3184481370052e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0648984622204344,0.00501773455621081,0.0550637024902612,0.0747332219506076,5.38550938424384e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,42239,0.0882238682046911,0.00683056894352743,0.0748359530753774,0.101611783334005,6.09912798509117e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.104916478485607,0.00812953718476573,0.0889825856034665,0.120850371367748,7.06074619870491e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,0.140687641764995,0.0109195876403175,0.119285249989973,0.162090033540017,1.01915895873485e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.0844931029330138,0.00656325420332093,-0.0973570811715228,-0.0716291246945048,1.05859385374774e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.149657103082295,0.011617511860137,0.126886779836427,0.172427426328164,1.06156871869035e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.163864403096994,0.0127317375879804,0.138910197424552,0.188818608769436,1.09735650935982e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,42168,0.0467557236331078,0.00363307224391819,0.0396349020350282,0.0538765452311875,1.1104859071983e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42262,0.0871180668783173,0.00677306984234014,0.0738428499873306,0.100393283769304,1.21109561153128e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.0625142242907591,0.004863195934129,0.0529823602598662,0.0720460883216519,1.34134589466766e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0552495394506101,0.00430091329233474,0.046819749397634,0.0636793295035862,1.50033549296767e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39860,0.039950783121147,0.00311377798514448,0.0338477782702638,0.0460537879720301,2.02696400778056e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.0402698589445204,0.00314091375369195,0.0341136679872842,0.0464260499017567,2.05894810382808e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,39930,0.053228844004007,0.00415038084469598,0.0450940975484029,0.0613635904596111,2.15963272065747e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,0.0527099324813359,0.00411000432381838,0.0446543240066518,0.0607655409560199,2.1664126556359e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0781847120017931,0.00610756959034303,0.0662138756047208,0.0901555483988655,2.94787692821772e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,42189,0.0518227479033715,0.00405482782910395,0.0438752853583277,0.0597702104484152,3.44923638741512e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0903445113170195,0.00707090649874835,0.0764855345794728,0.104203488054566,3.61501110665792e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,41900,0.0717763447267646,0.00561959637202219,0.0607619358376011,0.0827907536159281,3.8586322015413e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,0.126892736682875,0.00993089149247837,0.107428189357617,0.146357284008132,3.94865647342589e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.104274726625992,0.00816165836389422,0.0882778762327588,0.120271577019224,4.05771606322716e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.111363963108158,0.00873372527834639,0.0942458615625996,0.128482064653717,5.03566100669818e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,0.131651324552065,0.0103194370936443,0.111425227848523,0.151877421255608,5.07360272329069e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,42113,0.0423507667473366,0.00332169783587747,0.0358402389890167,0.0488612945056564,5.1108315556246e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42181,0.11934380156237,0.00936411985909508,0.100990126638544,0.137697476486196,5.42766291369173e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42185,0.0490817234541974,0.00385313454074606,0.0415295797543351,0.0566338671540597,5.90518875250077e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,0.133440452513609,0.0104755072023666,0.112908458396971,0.153972446630248,5.95150315988649e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0828987414135821,0.00650976787665774,0.0701395963753329,0.0956578864518313,6.21928370029948e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41843,0.0818963086663948,0.00643688675963496,0.0692800106175103,0.0945126067152793,7.24361311290456e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42181,0.0393675913775412,0.00309794796293353,0.0332956133701915,0.045439569384891,8.68600466464485e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,39979,0.100093816143187,0.00787692585841489,0.0846550414606943,0.115532590825681,9.57731336386443e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.100456004139378,0.00790893169149958,0.0849544980240389,0.115957510254717,1.03072282254357e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0639824331826222,0.0050443110351824,-0.0738692828115797,-0.0540955835536647,1.28468286653707e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAX,Protein max,41839,0.151759715619903,0.0119780035528214,0.128282828656373,0.175236602583433,1.41602346762212e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,42249,0.0868738893753461,0.00686330691352565,0.0734218078248358,0.100325970925856,1.62601863607712e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0697725086521193,0.00551653102355677,0.0589601078459481,0.0805849094582906,1.84851484769995e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,42258,0.0381819649590002,0.00302020036064567,0.0322623722521346,0.0441015576658657,1.97636585284914e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.0382470743317346,0.00302599821990619,0.0323161178207185,0.0441780308427508,2.05794633377882e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42076,0.0626265654746345,0.00496130873933221,0.0529024003455434,0.0723507306037257,2.53142686016148e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,42255,0.0347739790412623,0.0027559097536785,0.0293723959240525,0.0401755621584722,2.67972068554739e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0472472099984283,0.00374530420899219,0.0399064137488036,0.054588006248053,2.77794388908435e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,39492,0.100385394372612,0.00796071768580544,0.0847823877084334,0.115988401036791,3.32463830764705e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,0.0353086858043094,0.00280225468146654,0.029816266628635,0.0408011049799838,3.36079681469838e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,0.0376340928599084,0.00298591849885935,0.0317816926021441,0.0434864931176728,3.50488505108736e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41886,0.0569240760688081,0.0045199735011779,0.0480649280064994,0.0657832241311168,3.67032182848603e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.04017187058368,0.00319025341554444,0.0339189738892129,0.0464247672781471,3.7091216397499e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,39934,0.0785899224873452,0.0062390083289604,0.0663614661625828,0.0908183788121076,3.85114163491913e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,42084,0.0464095755420541,0.00368673651351571,0.0391835719755633,0.0536355791085449,3.91181474400277e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,0.0940335180875191,0.00747259539017549,0.0793872311227752,0.108679805052263,4.56121390697812e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0754803711647568,0.0060035968072306,0.0637133214225849,0.0872474209069288,4.75403601609668e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,39586,0.0578581151130454,0.00460063088909318,0.0488408785704227,0.066875351655668,5.05673052641898e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0881956297743685,0.00701795451604954,0.0744404389229114,0.101950820625826,5.06368515076922e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41955,0.049962186955857,0.00397761558746542,0.0421660604044248,0.0577583135072892,5.53624176737078e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.138215385222478,0.0110057059035975,0.116644201651427,0.159786568793529,5.67632200846119e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42296,0.0667772807855422,0.00531837355921587,0.0563532686094791,0.0772012929616053,5.81654477995328e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,42070,0.106278297583798,0.00846457409140551,0.0896877323646436,0.122868862802953,5.88294096157351e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,39468,-0.0602034889541022,0.00479653601849136,-0.0696046995503453,-0.0508022783578592,6.9194977026024e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.154218710941499,0.0123108237851508,0.130089496322604,0.178347925560395,8.37002010706702e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0915147662885249,0.00730625912105897,0.0771944984112493,0.1058350341658,8.51553634387063e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.0591569643067288,0.00472038244727164,0.0499050147100764,0.0684089139033812,8.58827463292992e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0742473939440748,0.00592748607460451,0.06262952123785,0.0858652666502996,9.37432808154836e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,42275,0.0960144917133603,0.00767672907689274,0.0809681027226505,0.11106088070407,1.06879769061213e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,0.0672819962269756,0.0053798480830795,0.0567374939841398,0.0778264984698114,1.08728367764267e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FST,Follistatin,42166,0.0685090883432425,0.00548905398311695,0.0577505425363333,0.0792676341501517,1.48511883445299e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42137,0.0346003548457032,0.00277473310086,0.0291618779680176,0.0400388317233888,1.70912531136645e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,42137,0.0712019553216004,0.00571155187191274,0.0600073136526514,0.0823965969905494,1.78472849452006e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.0888258410709655,0.00712800287066106,0.0748549554444699,0.102796726697461,1.91233419734954e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,39649,0.0609150836780653,0.00489173197890658,0.0513272889994084,0.0705028783567222,2.33498491687464e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.127574120556388,0.0102465870142419,0.107490810008474,0.147657431104302,2.36914312547561e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.0226224785702658,0.001818448445983,0.0190583196161391,0.0261866375243924,2.44238527304037e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41843,0.0733051159963961,0.00589510878230026,0.0617507027830876,0.0848595292097047,2.65926509572718e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,39929,0.0546161713088408,0.00439135261780779,0.0460091201779375,0.063223222439744,2.78863942941722e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0724768714507659,0.00582779737718713,0.0610543885914791,0.0838993543100526,2.81620161850358e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.0500533964707126,0.00402886255918849,0.0421568258547032,0.057949967086722,3.05426589387332e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPSE,Heparanase,39866,0.133993223196884,0.0107894202946359,0.112845959419398,0.15514048697437,3.50375301854232e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,0.0536349292741814,0.00432148444688225,0.0451648197582922,0.0621050387900706,3.53358423711863e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,0.0516979645478002,0.00416688666002647,0.0435308666941483,0.0598650624014521,3.72450569125663e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,39906,0.0457108266247107,0.00369070787902237,0.0384770391818269,0.0529446140675946,5.28719251407018e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41913,0.129485801174024,0.010467675691454,0.108969156818774,0.150002445529274,5.90503563213765e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2,Complement C2,42199,0.0314530527053863,0.00254398315162418,0.0264668457282029,0.0364392596825697,6.32713621201942e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,41900,0.0653057864750114,0.00528280663411891,0.0549514854721384,0.0756600874778845,6.52775767109733e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.101118301401093,0.00819075091635006,0.0850644296050471,0.117172173197139,7.94169668408867e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.0481354369991316,0.00389927311621998,0.0404928616913404,0.0557780123069227,8.02323508856867e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,41900,0.0744403356211077,0.00604227555279754,0.0625974755376245,0.0862831957045909,1.09378035177186e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.0421963689315368,0.00342558711000826,0.0354822181959206,0.048910519667153,1.10840233328395e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,39657,0.0582612094670289,0.00472710707503961,0.0489960795999512,0.0675263393341065,1.1229795087413e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.117526677038693,0.00954775146005414,0.0988130841769865,0.136240269900399,1.23443982606861e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,41900,0.117465048220802,0.00954360250564914,0.0987595873097295,0.136170509131874,1.26189520406873e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.101554898763991,0.00826236700182847,0.0853606594404069,0.117749138087575,1.55649293227155e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,0.131642984782061,0.0107119658783494,0.110647531660496,0.152638437903625,1.57936488053977e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0777997951935578,0.00633157468352249,0.0653899088138537,0.0902096815732618,1.60726697965089e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,39979,0.0352172479160234,0.00286634173175306,0.0295992181217874,0.0408352777102594,1.77029630447377e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,0.0186004798209142,0.00151472505538819,0.0156316187123534,0.0215693409294751,1.93780137052534e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,41900,0.0781450599051919,0.00637789772167424,0.0656443803707104,0.0906457394396734,2.49491818591878e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.0327552834196494,0.00267370354304583,0.0275148244752796,0.0379957423640192,2.51598815724575e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,39990,-0.0648782152049726,0.00529475198245956,-0.0752559290905933,-0.0545005013193519,2.65122706679485e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPL,Periplakin,39657,0.0446894449199046,0.00364763151050477,0.0375400871593152,0.051838802680494,2.74616181484602e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,0.0557531713130649,0.0045554791875764,0.0468244321054152,0.0646819105207147,2.94024459041865e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,0.0534736251142048,0.00437535882888395,0.0448979218095922,0.0620493284188173,3.64336946407182e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0735032038904089,0.00602175693392515,0.0617005602999156,0.0853058474809022,4.38708168198568e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.148496782616773,0.0121688173150066,0.12464590067936,0.172347664554186,4.88842146085203e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,42119,0.119000539898186,0.00976643322640212,0.0998583307744377,0.138142749021934,5.6552580402352e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42295,0.0320088112086726,0.0026281121925924,0.0268577113111915,0.0371599111061537,5.9959887123631e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.0957836684165417,0.00788546394065181,0.0803281590928642,0.111239177740219,8.99350651269502e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,0.0315060846782282,0.00259370377421003,0.0264224252807765,0.0365897440756799,9.61908202778206e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,0.120551427453408,0.00992522841381814,0.101097979762324,0.140004875144491,9.88931203441725e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.122117677121692,0.0100567222096383,0.102406501590801,0.141828852652583,1.01334888545101e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0808511865518097,0.00666264428125881,0.0677924037605424,0.093909969343077,1.04087270671303e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,39934,0.105271747327529,0.00867300564524002,0.0882726562628585,0.122270838392199,1.07654609347825e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,42119,0.131940422983672,0.0108790167424347,0.1106175501685,0.153263295798844,1.12304633149992e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0837734664183796,0.00690923896152065,0.0702313580537991,0.0973155747829601,1.16625260081239e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.124519899361965,0.0102652125956868,0.104400082674419,0.144639716049511,1.19376403636148e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.152880454130789,0.0126119550029604,0.128161022324987,0.177599885936591,1.21336410289074e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,0.0415650753670916,0.00343058297475787,0.0348411327365662,0.0482890179976171,1.30324928319231e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,39929,0.0744606627097805,0.0061438711232765,0.0624186753081585,0.0865026501114024,1.34348208715021e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,42145,0.167588515857865,0.0138515315208706,0.140439514076958,0.194737517638771,1.5933352882002e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KAZN,Kazrin,39930,0.143832941605336,0.0118849096126236,0.120538518764594,0.167127364446079,1.65550460648006e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,39990,0.0337936384513819,0.00279388593836492,0.0283176220121866,0.0392696548905771,1.78738413872013e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,42137,0.0368551815447012,0.00304860707544341,0.0308799116768321,0.0428304514125702,1.79185436795896e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.108433494581251,0.00897810652308827,0.090836405795998,0.126030583366504,2.07976113123014e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,42232,0.0570416737049553,0.00473087584694514,0.0477691570449428,0.0663141903649678,2.6215783086483e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,41992,0.0627439571087943,0.00520558769940268,0.052541005217965,0.0729469089996235,2.77384810803378e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0769342643663058,0.00638948479778693,0.0644108741626434,0.0894576545699681,3.23431188449723e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.0486026089612254,0.00403853357427838,0.0406870831556398,0.056518134766811,3.44763413498855e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,41976,0.0758471658552452,0.00630794458145623,0.063483594475591,0.0882107372348995,3.93504372196251e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42249,0.0844571064467737,0.00702739422054132,0.0706834137745128,0.0982307991190347,4.18537868526833e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42181,0.0464281630831833,0.00386363020610836,0.0388554478792109,0.0540008782871557,4.27181864077604e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0806021434855715,0.00670880987196785,0.0674528761365145,0.0937514108346285,4.42758762726055e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,0.0642559785113557,0.00534869875962695,0.0537725289424869,0.0747394280802245,4.48949409657036e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42129,0.129010635003162,0.0107417584421222,0.107956788456603,0.150064481549722,4.62549442250491e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,39575,0.0795064853151833,0.00661854941661249,0.0665341284586228,0.0924788421717438,4.91009813583579e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,42070,0.0475955335184519,0.00396531100582753,0.03982352394703,0.0553675430898739,5.05123655837576e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,39929,0.0844398127494988,0.00703523592879851,0.0706507503290537,0.0982288751699439,5.46859536244491e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,0.0986449066075224,0.00822151867280515,0.0825307300088243,0.114759083206221,5.73152989724625e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39638,0.123843082451805,0.0103273018266337,0.103601570871603,0.144084594032007,6.28047829209323e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.100676265048033,0.00839560483061832,0.0842208795800209,0.117131650516045,6.3007175762092e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,42296,0.0789999924538835,0.00659308920230254,0.0660775376173706,0.0919224472903965,6.43038694056776e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,39736,0.0901738667206242,0.00752112524628717,0.0754324612379014,0.104915272203347,6.43641350673292e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0439268912862778,0.00366910052056676,0.036735454265967,0.0511183283065887,7.25378495594732e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,0.119886070254206,0.0100147233626564,0.1002572124634,0.139514928045013,7.95359634880495e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,39638,0.0528455462576522,0.00441730029496196,0.0441876376795268,0.0615034548357777,8.81764563721426e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,39925,0.0345920703121181,0.00289272506573158,0.0289223291832842,0.040261811440952,9.25043079534195e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.058056047456639,0.00485511457330442,0.0485400228929623,0.0675720720203156,9.3869287650655e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,0.0565015140711788,0.00473383546960403,0.0472231965507549,0.0657798315916027,1.14844412509947e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0610177918956408,0.00512093644573295,0.0509807564620042,0.0710548273292774,1.43512242689017e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,42016,0.0715129284460406,0.00600400082426785,0.0597450868304756,0.0832807700616056,1.51543209610447e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,39966,0.0529911454796772,0.00445115543293743,0.0442668808311199,0.0617154101282346,1.73761571440272e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.116211654624388,0.00976558987613653,0.0970710984671607,0.135352210781616,1.84508758741125e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,39919,0.113089440434383,0.00950328264285365,0.0944630064543895,0.131715874414376,1.84676026258173e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,42070,0.0790841662810736,0.00664917702468787,0.0660517793126854,0.0921165532494618,1.85231283415696e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,0.153999837226388,0.0129427496856402,0.128632047842533,0.179367626610242,1.87870825844497e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0342319098975693,0.00287886153454099,0.028589341289869,0.0398744785052697,1.90870783481092e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0576938192462902,0.00485433963922265,0.0481793135534138,0.0672083249391666,2.06558174462652e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42185,0.0869790284903752,0.00732531832813729,0.0726214045672261,0.101336652413524,2.34207191227072e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.0970800834511158,0.00817695527465424,0.0810532511127935,0.113106915789438,2.56044054618916e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,42119,0.10761068584199,0.00907055428209037,0.0898323994490926,0.125388972234887,2.64135012747488e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,-0.0363721354575414,0.00306464802549246,-0.0423788455875066,-0.0303654253275762,2.68039157628264e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,39929,0.0821099225376433,0.00692037513926246,0.0685459872646888,0.0956738578105977,2.79465760049319e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.11884090719408,0.0100170115671272,0.0992075645225106,0.138474249865649,2.82919831544279e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,0.0814871955196577,0.0068768931633354,0.0680084849195203,0.0949659061197951,3.1521726889506e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,0.0755651580030611,0.00638206037144209,0.0630563196750346,0.0880739963310876,3.51270289315759e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,39736,0.0513433933901322,0.00433835775230392,0.0428402121956165,0.0598465745846479,4.019482049433e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,39958,0.072269918481941,0.00611017705128808,0.0602939714614164,0.0842458655024657,4.32523425353948e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0767387119175344,0.00651598842515453,0.0639673746042315,0.0895100492308373,7.92059536887048e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,42025,0.0958866994319806,0.008146868053235,0.07991883804764,0.111854560816321,8.00993197665869e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,0.0478341343980827,0.00407261927682297,0.0398518006155096,0.0558164681806557,1.06383316581324e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0659717173060018,0.00561910349064859,0.0549582744643305,0.076985160147673,1.13276197733183e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,42310,0.0821215719127178,0.00699607599066314,0.068409262971018,0.0958338808544175,1.15047449576674e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,39701,0.0864880239750782,0.00736755516560412,0.0720476158504941,0.100928432099662,1.236244810176e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.0885380321675085,0.0075454463738163,0.0737489572748285,0.103327107060188,1.30021066066354e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,39930,0.0872826945738076,0.00744028940335686,0.0726997273432282,0.101865661804387,1.34487132654375e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,39958,0.0876781133598765,0.00747793318298721,0.0730213643212216,0.102334862398531,1.44390066551113e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,0.104239977312538,0.00889022893229781,0.0868151286052346,0.121664826019842,1.45492220733924e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.111211087758891,0.00949585569685353,0.0925992105930585,0.129822964924724,1.68999160887501e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,42087,0.087415025995568,0.00747082419010659,0.0727722105829591,0.102057841408177,1.7908022831593e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,39930,0.104392267789086,0.00891781460449382,0.086913351164278,0.121871184413894,1.80116579934034e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,39959,0.0297239849937133,0.00253944602918384,0.024746670776513,0.0347012992109137,1.8230607871879e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42070,0.112150399952551,0.00959712513090076,0.0933400346959857,0.130960765209117,2.13452324299479e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,39929,0.110343510225378,0.00945313427754779,0.0918153670413842,0.128871653409372,2.65489115114727e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,42016,0.0518505244298088,0.00444433778186124,0.0431396223773608,0.0605614264822568,2.67244710120629e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,42185,0.102127216062711,0.00875843241431222,0.0849606885306589,0.119293743594763,2.86008045490489e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39638,0.0699301828025964,0.00599481676278359,0.0581803419475406,0.0816800236576522,2.93065076638083e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,0.0731266012186234,0.00627675396381622,0.0608241634495436,0.0854290389877032,3.4406278502999e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,0.041559961256523,0.00356882483177679,0.0345650645862405,0.0485548579268055,3.44127905000208e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,41997,0.091301626340038,0.00784099083495884,0.0759332843035187,0.106669968376557,3.47303417219882e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0366825005009301,0.00315372590608527,0.030501197725003,0.0428638032768573,3.99303294367014e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.0353932605155778,0.00304579223692354,0.0294235077312077,0.041363013299948,4.55558140227999e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.103075137496765,0.00886775914737782,0.0856943295679048,0.120455945425626,4.69064020658474e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGN,Mimecan,42137,0.0567340270623233,0.00488361556146516,0.0471621405618515,0.066305913562795,4.72942417509758e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0697477867180711,0.00600558434114442,0.057976841409428,0.0815187320267141,5.25200352110495e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,0.048400485346044,0.00417091012690555,0.0402255014973092,0.0565754691947789,5.48672731253744e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0365048006830207,0.00314599233051182,0.0303386557152175,0.0426709456508239,5.51647899667972e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,42085,0.101915406111444,0.00878398912143761,0.0846987874334266,0.119132024789462,5.62158561004329e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,42249,0.0357878771059896,0.00308468502277364,0.0297418944613533,0.041833859750626,5.63874943360627e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0539467262568906,0.00464736166333868,0.0448378973967467,0.0630555551170344,5.65473559094179e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,39929,0.0999249749339905,0.00861216340435585,0.0830451346614531,0.116804815206528,5.96748555338547e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NBN,Nibrin,41913,0.0710923147748759,0.00613078929817724,0.0590759677504486,0.0831086617993033,6.08396930686724e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,0.0453745187940121,0.00391727512441479,0.0376966595501591,0.0530523780378651,7.01050690827163e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42224,0.0766164415119425,0.00661550394821555,0.0636500537734401,0.089582829250445,7.14697718633383e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.0919799939798909,0.0079509806587334,0.0763960718887734,0.107563916071008,8.96183768096622e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.124798404229583,0.0107999511163271,0.103630500041582,0.145966308417584,9.65973966736334e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0512957807401858,0.00443726171797808,0.0425987477729487,0.0599928137074228,9.73843243596949e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,0.113193020282263,0.00979822374962483,0.0939885017329986,0.132397538831528,9.99993374606289e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,0.0805495479452838,0.00697971396965445,0.0668693085647611,0.0942297873258065,1.14735017414467e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,42119,0.120094738974553,0.0104131568641297,0.0996849515208586,0.140504526428247,1.2513883057631e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,42119,0.0520606801491765,0.00451515725100262,0.0432109719372114,0.0609103883611417,1.29202241232019e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0856322302763581,0.00742292659937852,0.0710832941415762,0.10018116641114,1.30130575906891e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0441755537310684,0.00382985155957649,0.0366690446742985,0.0516820627878383,1.3095671835763e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRELP,Prolargin,42123,0.03041401770146,0.00263916679468657,0.0252412507838743,0.0355867846190457,1.38585095040017e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0555497788287975,0.00482584728088654,0.0460911181582599,0.0650084394993351,1.60943204797464e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,42185,0.0539670481177242,0.00468909289800106,0.0447764260376421,0.0631576701978062,1.64480476873825e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,0.104563827465422,0.00908729294368179,0.0867527332958054,0.122374921635038,1.6935631776756e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,0.0995501763715765,0.00865715348135302,0.0825821555481246,0.116518197195028,1.96395412123842e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,42296,0.0628080179407367,0.00546707280237198,0.0520925552480877,0.0735234806333858,2.07888073383098e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42016,0.10419828301896,0.00907822823187234,0.0864049556844905,0.12199161035343,2.36287169361707e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.038354516834218,0.00335061180585073,0.0317873176947506,0.0449217159736854,3.36391575767138e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,0.0346068264838778,0.00302362493144681,0.028680521618242,0.0405331313495135,3.62085193510788e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,0.0376243849692375,0.00329114245932944,0.0311737457489518,0.0440750241895232,3.97717655583081e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.105077973084424,0.00918875639512922,0.0870680105499711,0.123087935618878,4.06457477244245e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0597084666123224,0.00523024864623363,0.0494571792657045,0.0699597539589403,4.76198179037617e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,41843,0.0573114764854403,0.00502186316259419,0.0474686246867557,0.0671543282841249,5.00875736517053e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,39638,0.0573506287187519,0.00502609125190486,0.0474994898650184,0.0672017675724854,5.45095308070202e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,0.0995496513427955,0.00872476926218155,0.0824491035889196,0.116650199096671,5.46840681795531e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0781671400409238,0.00686358516305943,0.0647145131213273,0.0916197669605203,6.50822138738875e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0456499279198261,0.00400944084695121,0.0377914238598018,0.0535084319798505,7.16930028786932e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.132437233707555,0.0116415611692391,0.109619773815846,0.155254693599263,7.96963920735759e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.106008197359566,0.00932675432066433,0.0877277588910644,0.124288635828069,8.42828576547253e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0344852617381937,0.00303295997268475,0.0285406601917316,0.0404298632846558,8.52989638656583e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39657,0.0379519108658047,0.00333936171885151,0.0314067618968557,0.0444970598347536,9.13281385970223e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,0.0610689076235586,0.0053764552729852,0.0505310552885077,0.0716067599586096,9.72735492312038e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,42166,0.0393409986463507,0.00346695208225521,0.0325457725651305,0.0461362247275709,1.03956825221038e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0620576042041667,0.00546925706198436,0.0513378603626773,0.072777348045656,1.11339922293745e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,42016,0.123706603454525,0.0109102486885962,0.102322516024876,0.145090690884173,1.15322385427377e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0834305926461537,0.00736481164106703,0.0689955618296623,0.0978656234626451,1.30089412135041e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,41839,0.0870956660434193,0.00768974069310457,0.0720237742849343,0.102167557801904,1.33161200727821e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,42249,0.14431289509761,0.0127513704772955,0.119320208962111,0.169305581233109,1.4567419601521e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,0.0851947189478925,0.00753786735143901,0.070420498939072,0.0999689389567129,1.72792359784473e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39638,0.0780393753083306,0.00690694284051447,0.0645017673409223,0.091576983275739,1.93223659564486e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGRN,Neugrin,39929,0.0287117663165101,0.0025424730765134,0.0237285190865438,0.0336950135464764,2.04394669494117e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,0.0866641297403888,0.00767952242974435,0.0716122657780898,0.101715993702688,2.24418368530405e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,0.0580910498916071,0.00515285867909577,0.0479914468805794,0.0681906529026348,2.38709577835725e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,0.0297485637103182,0.00264137920315756,0.0245714604721293,0.034925666948507,2.71638886548512e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,0.027222202441067,0.00241769717741729,0.0224835159733291,0.0319608889088049,2.80809077837347e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39736,0.107219110226516,0.00951827592931074,0.0885632894050666,0.125874931047965,2.82669896393692e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,42310,0.0249990995924542,0.00222057320439189,0.0206467761118461,0.0293514230730623,2.84442254122634e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,39736,0.0666202501054234,0.00591476566923989,0.0550273093937132,0.0782131908171336,2.86413117457242e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,42296,0.0450013826654772,0.00400758933189499,0.037146507574963,0.0528562577559913,3.93624837309651e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.0309305518100824,0.00275463549034356,0.0255314662490091,0.0363296373711558,3.9748915411264e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41843,0.0737251189087625,0.00657062074065257,0.0608467022570835,0.0866035355604415,4.37889573957917e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.028950591232071,0.00258054173042253,0.0238927294404428,0.0340084530236991,4.42778017658366e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.134523572739991,0.0119977600085092,0.111007963123313,0.158039182356669,4.76161246311232e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0676961026974012,0.00603566090038108,0.0558662073326543,0.0795259980621481,4.88339922364769e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0912913891998528,0.00814462682363858,0.0753279206255212,0.107254857774184,4.98841774908048e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,42099,0.0607615552459833,0.00542584008657963,0.0501269086762872,0.0713962018156793,5.56145437160628e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.0423834005282102,0.00378499623136798,0.034964807914729,0.0498019931416915,5.59273550748707e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,39966,-0.0727518117921968,0.00649662695108379,-0.0854852006163211,-0.0600184229680726,5.88482143277094e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,0.0776114422796263,0.00693340009625571,0.0640219780909651,0.0912009064682875,6.19120432316895e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,0.0906582806116606,0.00810501991196472,0.0747724415842098,0.106544119639111,6.40986889702357e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,39657,0.0573187771958737,0.00512212854300222,0.0472794052515894,0.0673581491401581,6.49500799916631e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,39876,0.0598195960337716,0.00535209169372054,0.0493294963140793,0.0703096957534638,7.50290411050618e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,42119,0.0602646334706688,0.00539680194331919,0.0496869016617631,0.0708423652795744,7.93112326539781e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGMN,Legumain,42185,0.0457383300020309,0.00409613669854457,0.0377099020728836,0.0537667579311783,7.96596683936179e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,41839,0.0898153535655808,0.00805585527568925,0.0740258772252298,0.105604829905932,9.71410395220037e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,0.0910127934706132,0.00816844162996616,0.0750026478758795,0.107022939065347,1.04574399771483e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEXN,Nexilin,39990,0.0879335688439437,0.00789331404014029,0.0724626733252687,0.103404464362619,1.12350743868761e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,42310,0.0388147614032621,0.00348669819869359,0.0319808329338227,0.0456486898727015,1.15986408396151e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,42143,0.132222746445806,0.0118927671293449,0.10891292287229,0.155532570019322,1.36475609378467e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,42070,0.0534053871108216,0.0048038050397611,0.0439899292328898,0.0628208449887533,1.37603851424344e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.105190533775743,0.00947402480892023,0.0866214451502597,0.123759622401227,1.62252578388073e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.0787639854028083,0.00709828468767222,0.0648513474149707,0.0926766233906458,1.8543312814823e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39657,0.0406070742239615,0.00366585428639099,0.0334219998226351,0.0477921486252878,2.28403195685206e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,0.0620748651601797,0.00560558746942006,0.0510879137201164,0.073061816600243,2.35105436169946e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.112195153200919,0.0101337403343822,0.0923330221455302,0.132057284256308,2.40963225649603e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRN,Progranulin,42077,0.0313890387455943,0.00283801477890415,0.0258265297789422,0.0369515477122464,2.58965115512181e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,39929,0.0359299001626489,0.00325220125336434,0.0295555857060548,0.042304214619243,3.12782242066332e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,42015,0.0733824934914785,0.00665007292799151,0.0603483505526152,0.0864166364303419,3.43079672143456e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,41843,0.0800993330961115,0.00726361880965312,0.0658626402291914,0.0943360259630316,3.73452221464493e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.0956758163467286,0.00867673400761795,0.0786694176917974,0.11268221500166,3.74309603369844e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.112848614291123,0.0102290334249061,0.0927997087783066,0.132897519803939,3.74747044474593e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,39886,0.0356340363450707,0.00323059567368402,0.02930206882465,0.0419660038654914,3.80536113659744e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,42224,0.0863889653938042,0.00784743291645168,0.0710079968775589,0.101769933910049,4.5627010507416e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0454785652135701,0.00413532386214815,0.0373733304437597,0.0535837999833804,5.16978951140895e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0837579004932864,0.0076161572978914,0.0688302321894192,0.0986855687971535,5.47866859139696e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,42185,0.114759782655355,0.0104556584457042,0.0942666921017746,0.135252873208935,6.54024346119879e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.0889593418158013,0.00811037930159119,0.0730629983846825,0.10485568524692,7.08383900973213e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,42310,0.0566187029011212,0.00516494349232899,0.0464954136561564,0.066741992146086,7.58480502944938e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.0677251557956579,0.00617569512732666,0.0556207933460977,0.0798295182452182,7.65046451057102e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,39919,0.0410672948238366,0.00375011333111929,0.0337170726948428,0.0484175169528304,9.06147456126702e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,39649,0.163413477575465,0.0149291574259509,0.134152329020601,0.192674626130328,9.64682830423659e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,39966,0.105499014496172,0.00963893642946023,0.0866066990944301,0.124391329897914,9.64761188188659e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,42181,0.0526110073929604,0.00482116109047875,0.043161531655622,0.0620604831302987,1.30762820450412e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0750153903809603,0.00688217299639771,0.0615263313080208,0.0885044494538998,1.50131150267955e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWC2,Brorin,41973,0.0503817069525082,0.00462435167834224,0.0413179776629574,0.059445436242059,1.59140049765045e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,41839,0.075576299691007,0.00693688320014532,0.0619800086187222,0.0891725907632919,1.59600965707253e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0610578137174801,0.0056098651505928,0.0500624780223182,0.072053149412642,1.78452574828335e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,42070,0.0683389308804674,0.00627964983855217,0.0560308171969052,0.0806470445640297,1.81523440454994e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42310,0.0521483554927456,0.00479388914647168,0.0427523327656611,0.0615443782198301,1.89784077970802e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,39736,0.0914043261201432,0.00840261595710078,0.0749351988442257,0.107873453396061,2.01390852071018e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42105,0.082248079187955,0.00756589468034811,0.0674189256144727,0.0970772327614373,2.06013057498993e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,39934,0.0593207048307109,0.00545523939058116,0.0486284356251718,0.0700129740362499,2.09172620035149e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,39859,0.0376827387858798,0.00346842228313183,0.0308846311109415,0.0444808464608182,2.32505150635321e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,0.0972986455612232,0.00896317737973,0.0797308178969524,0.114866473225494,2.44260739629269e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,42181,0.0376088337071075,0.00346511611590006,0.0308172061199434,0.0444004612942716,2.48340458218129e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.0338060436250397,0.00311622598828349,0.027698240688004,0.0399138465620753,2.62628133200774e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,0.155301910724073,0.014311105344903,0.127252144248063,0.183351677200083,2.67638288135239e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0659785926949896,0.00608293357945749,0.0540560428792529,0.0779011425107263,2.82017455201337e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,41839,-0.0915630907243722,0.00844757927432519,-0.10812034610205,-0.0750058353466948,2.92808585271839e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,42119,0.0986564897142566,0.00910735689241135,0.0808060702051303,0.116506909223383,3.1199153864901e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41809,0.0923949131230073,0.00853286697229619,0.0756704938573068,0.109119332388708,3.29518854204623e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.126941626627582,0.0117305887215394,0.103949672733365,0.1499335805218,3.51746699413172e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,42119,-0.0413358473454404,0.00382094138554179,-0.0488248924611023,-0.0338468022297785,3.64521680455014e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.065881471296513,0.00609239321987803,0.0539403805855521,0.0778225620074739,3.82712161158592e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41614,0.0394558219122683,0.00365032888269557,0.032301177302185,0.0466104665223516,4.07488989003758e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,39930,0.0832752190177046,0.00770941307818414,0.0681647693844637,0.0983856686509455,4.57385226366556e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,39979,0.0201824493039018,0.00186861522190486,0.0165199634689683,0.0238449351388353,4.61777280710198e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.0498337061070622,0.00461857577929054,0.0407812975796528,0.0588861146344717,5.19232343411601e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.0966373112811251,0.00895692516580065,0.0790817379561558,0.114192884606094,5.28473490602151e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.0360994770597905,0.0033496082882792,0.0295342448147632,0.0426647093048177,5.6815445826237e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,39736,0.0621347859120614,0.00576356669526042,0.050838195189351,0.0734313766347718,5.77379777956249e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.106117052310962,0.00985618610354161,0.0867989275480201,0.125435177073903,6.71690778844238e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,39736,0.0479818823942109,0.00445850135847117,0.0392432197316074,0.0567205450568144,7.06155187687716e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0783662069392544,0.00728323280731731,0.0640910706369125,0.0926413432415963,7.1834615454891e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,42310,0.0785017790658945,0.00730134155331234,0.0641911496214023,0.0928124085103867,7.4448368114081e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.0390394485253021,0.00363163893722528,0.0319214362083405,0.0461574608422636,7.60932275955388e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,0.0891591331434878,0.00829595914603304,0.072899053217263,0.105419213069713,8.20357881694153e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,39934,0.0945904694058089,0.00880899735818644,0.0773248345837634,0.111856104227854,9.08286993313484e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0360639579913547,0.00336205997326103,0.0294743204437631,0.0426535955389463,1.02339766227045e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",42262,0.0879766924025059,0.00821245645949389,0.0718802777418978,0.104073107063114,1.13368866514374e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42117,0.112305609250229,0.0104893251650924,0.0917465319266482,0.13286468657381,1.21123204578514e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.066150290628352,0.00618589341605839,0.0540259395328775,0.0782746417238264,1.39609317308111e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,39934,0.0932769807742787,0.00871993107203069,0.0761859158730986,0.110368045675459,1.40779445709798e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFD,Complement factor D,39979,0.0244643076426498,0.00228865244102103,0.0199785488582486,0.028950066427051,1.52492317661652e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0631385808378874,0.00590992182811788,0.0515551340547764,0.0747220276209985,1.62659456474772e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,39733,0.0465871180412409,0.00436351314658168,0.0380346322739408,0.055139603808541,1.76060681829109e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39657,0.066910794176308,0.00626869842543297,0.0546241452624594,0.0791974430901567,1.81608623954056e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41843,0.0523908558997665,0.00491053157508252,0.0427662140126048,0.0620154977869283,1.81903369489968e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,39929,0.131280214002411,0.0123106635684226,0.107151313408303,0.15540911459652,2.00282838903987e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0913795571051433,0.00856980439499762,0.074582740490948,0.108176373719339,2.02366117671004e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,42145,0.0999093810841831,0.00937877697354202,0.0815269782160407,0.118291783952325,2.15415182642478e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,41820,0.0573362625900964,0.00538660704044811,0.0467785127908181,0.0678940123893747,2.37171905937854e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,39979,0.0375781472926315,0.00353031212942184,0.0306587355189647,0.0444975590662983,2.46197589082456e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,41843,0.046456913549241,0.00436769343682172,0.0378962344130704,0.0550175926854116,2.57422719089675e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,42119,-0.053339339605762,0.00501653127241941,-0.0631717408997041,-0.04350693831182,2.66639165855482e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.114324986753565,0.0107519110455348,0.0932512411043171,0.135398732402814,2.6689307007476e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,42261,0.0415492826585387,0.00390796793977046,0.0338896654965886,0.0492088998204888,2.68176471452134e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,0.0516681208376461,0.00486018725674777,0.0421421538144205,0.0611940878608717,2.72588705585127e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,0.0349760610063927,0.00329118778469237,0.0285253329483956,0.0414267890643897,2.96123185867813e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0804905423090829,0.00758170783929118,0.0656303949440722,0.0953506896740936,3.16932316435525e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.0946892064414841,0.00892151606617495,0.0772030349517812,0.112175377931187,3.27360368473465e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,42262,0.0336886086559693,0.00317551254926553,0.0274646040594089,0.0399126132525297,3.42656314306746e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42119,0.0896723658849624,0.00846379386121467,0.0730833299169816,0.106261401852943,3.98717524508022e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41973,0.0295671774142817,0.00279075577002193,0.0240972961050387,0.0350370587235247,4.00310171236015e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,39736,0.0837209828915769,0.00790392184915762,0.068229296067228,0.0992126697159259,4.30383082099068e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.111946454080725,0.0105743600834515,0.0912207083171596,0.13267219984429,4.35808277841438e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,42112,0.0790729929539546,0.00747449237161593,0.0644229879055874,0.0937229980023219,4.71279403268823e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,0.0689143329212603,0.00651869804290807,0.0561376847571605,0.0816909810853601,5.08572543219729e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,41843,0.0571606454890792,0.00540697493822175,0.0465629746101646,0.0677583163679938,5.120516172071e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALB2,Calretinin,41839,0.0351409808768912,0.00332624039517181,0.0286215497023544,0.0416604120514279,5.50693891763426e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPARC,SPARC,42181,0.0833511787790025,0.00789135070165816,0.0678841314037525,0.0988182261542525,5.61653239332521e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.13668437586446,0.0129458381415095,0.111310533107101,0.162058218621818,6.14604529252774e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.114131117384418,0.0108196371649541,0.0929246285411083,0.135337606227728,6.50276103692646e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0432430188462297,0.00409818613177567,0.0352105740279494,0.05127546366451,6.622576140687e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,41843,0.114453206067475,0.0108561840488293,0.0931750853317693,0.13573132680318,6.95375721460105e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0529225769149975,0.00502424535734025,0.0430750560146106,0.0627700978153844,8.02737938975322e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,39759,0.0292158299449613,0.0027737683986703,0.0237792438835675,0.0346524160063551,8.05219468975586e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.0634781290239311,0.00602940121114681,0.0516605026500834,0.0752957553977788,8.10335097344659e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,39958,0.0332542318746749,0.00315851973649341,0.0270635331911478,0.039444930558202,8.39983421217254e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,42249,0.043748169260987,0.00416245287390692,0.0355897616281294,0.0519065768938445,9.72298218638076e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0571136288695221,0.00543273682721233,0.0464654646881859,0.0677617930508582,9.89791028386546e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,42249,0.0443664326022326,0.00422534790881529,0.0360847507009547,0.0526481145035106,1.08149293898899e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NADK,NAD kinase,42145,0.0648091749274131,0.00617248308633839,0.0527111080781899,0.0769072417766363,1.08761767829466e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.0840334689302542,0.00800400165245855,0.0683456256914354,0.099721312169073,1.10066806964326e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.110308872183354,0.0105069418163207,0.0897152662233659,0.130902478143343,1.14887939804931e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0789640620423301,0.00752232611220909,0.0642203028624002,0.0937078212222599,1.17584982043187e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,0.0536185395302298,0.00511240306761379,0.0435982295177067,0.0636388495427528,1.23691585100754e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,0.142353090290683,0.0135759889783178,0.11574415189318,0.168962028688185,1.32312189861367e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.109254592889568,0.0104248259990199,0.0888219339314889,0.129687251847647,1.40378670228021e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,39929,0.053872188040176,0.00514386855019217,0.0437902056817993,0.0639541703985526,1.50216622697922e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0670013784114643,0.00640923841735664,0.0544392711134453,0.0795634857094833,1.76058896958356e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0669242366491755,0.00640234804362005,0.0543756344836802,0.0794728388146708,1.78215982147206e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,39900,0.0538602160812765,0.00515358897764881,0.0437591816850848,0.0639612504774681,1.89344734004686e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.0443755068203053,0.00425573156480564,0.0360342729532863,0.0527167406873244,2.33236081312345e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,39970,0.0418726577753493,0.00401606895693961,0.0340011626197477,0.0497441529309509,2.44680844650981e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42145,0.0775477353814133,0.00744142194508504,0.0629625483690466,0.09213292239378,2.4766992093225e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,41843,0.115859092137127,0.0111362956553879,0.094031952652567,0.137686231621688,2.98255561039455e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,42137,0.143245825451784,0.0137709992988154,0.116254666826106,0.170236984077462,3.02258859206199e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,0.0648644361071636,0.00623553597201513,0.0526427856020139,0.0770860866123132,3.02509517610899e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,42119,0.105387719809747,0.0101356938188216,0.0855217599248563,0.125253679694637,3.16222898659409e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0467907638373568,0.00450097616896067,-0.0556126771285197,-0.0379688505461939,3.22745463337004e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,0.0689865134752725,0.00663753728179415,0.0559769404029559,0.081996086547589,3.32191233851304e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39657,0.0407565714665447,0.00392016970337341,0.0330730388479328,0.0484401040851566,3.35550081493096e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,39919,0.0261344533064139,0.00251448888536218,0.0212060550911041,0.0310628515217238,3.44372549861598e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,39638,0.1030879617971,0.00992181432840082,0.0836412057134344,0.122534717880766,3.595343489753e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,42119,0.0582031318273188,0.00561229419494096,0.0472030352052345,0.0692032284494031,4.18835715780623e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.117046635742668,0.0112911130741511,0.0949160541173317,0.139177217368004,4.38349551355121e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,42181,0.0258914236090747,0.00249995459227391,0.0209915126082179,0.0307913346099316,4.83298866718094e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTD,Biotinidase,39979,0.0240371980366936,0.00232021738832375,0.0194895719555791,0.0285848241178082,4.87583725952201e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,39919,0.0475138497608399,0.00458972478794149,0.0385179891764746,0.0565097103452052,5.28584136826048e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,39930,0.0409438111046792,0.00396035819390054,0.0331815090446342,0.0487061131647243,6.09594301196523e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42119,0.0980211647815835,0.00949724837913243,0.0794065579584839,0.116635771604683,7.00438612447241e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,42217,0.0543071026578631,0.005262914820639,0.0439917896094106,0.0646224157063155,7.15312878052558e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,42216,0.068242758086621,0.00661603599099842,0.0552753275442641,0.0812101886289779,7.46088959656389e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41839,0.072421863539784,0.00702951013030802,0.0586440236843803,0.0861997033951877,8.51290086094266e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.066657729944154,0.00647071131486121,0.053975135767026,0.079340324121282,8.96057757424123e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.12083696290066,0.0117456299071582,0.0978155282826304,0.14385839751869,9.86454634288212e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,41913,0.055955538372096,0.00544148147578972,0.0452902346795481,0.0666208420646438,1.03850592134295e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0732289540413085,0.00712000104048231,0.0592737520019632,0.0871841560806538,1.05904188815177e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,42152,0.0467766043792796,0.00455837895269629,0.0378421816319948,0.0557110271265643,1.29035690920134e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.117879968339761,0.0114890651515193,0.095361400642783,0.140398536036739,1.31088970023535e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.069243726815826,0.00675101725095225,0.0560117330039595,0.0824757206276924,1.41878014216313e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,0.0690197850934638,0.00673309789595399,0.055822913217394,0.0822166569695336,1.44016272051095e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,42181,0.0709026931979374,0.00692204136787254,0.0573354921169072,0.0844698942789676,1.56192004993786e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,39958,0.114614140264416,0.0111886818513208,0.0926843238358276,0.136543956693005,1.61357486333216e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,39934,0.0645867114362318,0.00631102406458482,0.0522171042696455,0.076956318602818,1.78493796603488e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,41839,0.0835184012565201,0.00816644334831333,0.067512172293826,0.0995246302192142,1.85019465944579e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,41913,0.039365594159561,0.00384990243536586,0.0318197853862439,0.0469114029328781,1.88502124439958e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPART,Spartin,39736,0.0902028454629855,0.00882026640233101,0.0729151233144167,0.107490567611554,1.92931689002932e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42229,0.0577581153166854,0.0056517538383552,0.0466806777935092,0.0688355528398616,1.98642343993931e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,39929,0.0836818783153968,0.00818927651165207,0.0676308963525587,0.0997328602782348,2.09138327674478e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,0.0227820818126036,0.0022301721454627,0.0184109444074967,0.0271532192177105,2.15689149237127e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41997,0.086086479066875,0.00843620926148373,0.0695515089143669,0.102621449219383,2.32630305555898e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,0.0472496109098971,0.0046322499305988,0.0381704010459234,0.0563288207738707,2.42629533289444e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,39925,0.0553684481022078,0.00542926152221042,0.0447270955186754,0.0660098006857403,2.57370037082599e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.125146984741924,0.0122912714904504,0.101056092620641,0.149237876863206,3.04096014238587e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,39914,0.112272818488026,0.0110343297923925,0.0906455320949364,0.133900104881115,3.2637694543397e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42070,0.103395000269834,0.0101655710593567,0.0834704809934951,0.123319519546173,3.26443259863086e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,42249,0.0260142044529097,0.00255837790996477,0.0209997837493788,0.0310286251564407,3.35195256860094e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,42296,0.0728921703106644,0.00717145864898956,0.0588361113586449,0.0869482292626839,3.49030202351977e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,39990,0.0550607782626868,0.0054169191615642,0.0444436167060209,0.0656779398193526,3.61756128310681e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,41900,0.0620495989790335,0.00610710085268523,0.0500796813077705,0.0740195166502966,3.65543484691828e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,0.0959732347017608,0.00944611543768722,0.0774588484438938,0.114487620959628,3.66114603882047e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0874083703125898,0.00860352032667366,0.0705454704723094,0.10427127015287,3.81047770922862e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.119380638426219,0.0117724728647164,0.0963065916113749,0.142454685241063,4.4461951137329e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.0976258393258707,0.00962979107816113,0.0787514488126749,0.116500229839067,4.59151639349774e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0833934987354129,0.00822394733164132,0.0672745619653959,0.0995124355054299,4.63183448273297e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,42027,0.0529614475605777,0.00522479337982001,0.0427208525361305,0.0632020425850249,4.64137501276419e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0353096051467901,0.00348225950479514,0.0284843765173916,0.0421348337761886,4.70161773755115e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0605478170792878,0.00597851292495383,0.0488299317463783,0.0722657024121973,5.30698074626282e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,42145,0.0428221173391549,0.00423185040952262,0.0345276905364906,0.0511165441418193,5.53700683748978e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,42145,0.0337808048222871,0.0033386866155503,0.0272369790558086,0.0403246305887657,5.59418771086438e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0704879563526162,0.00696839639470789,0.0568298994189887,0.0841460132862437,5.76402852727946e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,39657,0.0532608513104389,0.0052718948402785,0.0429279374234931,0.0635937651973848,6.81655527871983e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,39919,0.0461572451279455,0.00457129752226371,0.0371975019843087,0.0551169882715824,7.17424603482891e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0659748092521924,0.00655410796849054,0.0531287576339509,0.0788208608704339,9.4648949360074e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,42070,0.0937962538138383,0.00931839274880669,0.0755322040261772,0.112060303601499,9.5020518795727e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,39934,0.0754324475302592,0.00749196152125341,0.0607482029486025,0.0901166921119158,9.58428724708008e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,0.0326569931415457,0.00324515121082049,0.0262964967683375,0.0390174895147538,9.72375208402515e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,39930,0.0816015491182599,0.00810759720166122,0.0657106586030039,0.0974924396335159,9.94163387550544e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.132680809747935,0.0131879860263413,0.106832357136306,0.158529262359564,9.99128795104943e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0483325541496415,0.00480300817572187,0.0389186581252266,0.0577464501740564,1.01898332840498e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,39919,0.0818349333794907,0.00813365919770722,0.0658929613519846,0.0977769054069969,1.03064088872499e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.0857950198128486,0.0085374117713753,0.069061692740953,0.102528346884744,1.12149049791846e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0728226027552777,0.00724584501679251,0.0586207465223644,0.0870244589881911,1.15573145024607e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,0.0589052192103735,0.00586381134338454,0.0474121489773398,0.0703982894434072,1.16710354033227e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,39990,0.03233070170485,0.00321806746216898,0.0260232894789988,0.0386381139307012,1.19262691077949e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0228014562024035,0.00227077443844186,0.0183507383030574,0.0272521741017495,1.26024507527273e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0689250775872036,0.00686878402156996,0.0554622609049264,0.0823878942694807,1.30494545588153e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,41740,0.0946247452333468,0.00943768018556191,0.0761268920696454,0.113122598397048,1.42015755353325e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,42299,0.0384515651267432,0.00383583137088558,0.0309333356398075,0.045969794613679,1.43699329243052e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,39934,0.0886451897625506,0.0088501852709649,0.0712988266314594,0.105991552893642,1.62049769756622e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,0.05803102120634,0.00579733446973469,0.04666824564566,0.06939379676702,1.66299909020882e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,42145,0.0516569722335708,0.00516337334278682,0.0415367604817087,0.061777183985433,1.7568479456754e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.0751125888248127,0.00750970763415522,0.0603935618618685,0.0898316157877569,1.86693578913452e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,42103,0.0749499415530814,0.00749705311834622,0.0602557174411228,0.08964416566504,1.89033059449213e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0688677992919003,0.00689293803032849,0.0553576407524564,0.0823779578313441,2.09931652947914e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,0.109721818229077,0.0109852588844857,0.0881907108154848,0.131252925642669,2.15892558242285e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,39958,0.0932943011356139,0.00934465321374901,0.0749787808366659,0.111609821434562,2.24217978585776e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41997,0.0369721516237507,0.00370506267938745,0.0297102287721513,0.0442340744753501,2.27683527177612e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,42096,0.0494048659843785,0.00495176014040774,0.0396994161091794,0.0591103158595777,2.31007875063543e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,39930,0.0790565574255111,0.00792350823634256,0.0635264812822797,0.0945866335687426,2.38772413822829e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0781130509447982,0.00784139065343289,0.0627439252640697,0.0934821766255267,2.81174211389391e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42145,0.145140506597005,0.0145807153016454,0.11656230460578,0.17371870858823,2.90358371788026e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,39966,0.0948792393164448,0.00953672317024161,0.0761872619027713,0.113571216730118,3.17497176968975e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0459092564982314,0.00461693251407172,0.0368600687706509,0.054958444225812,3.23510750031323e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0613000242843365,0.00616655438069315,0.0492135776981779,0.073386470870495,3.45978069625508e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0631898431944909,0.00636204613989002,0.0507202327603065,0.0756594536286753,3.75397346094368e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39657,0.0464952264287525,0.00468199462010148,0.0373185169733536,0.0556719358841514,3.82785216440272e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42181,0.0428142310568207,0.00431503422421958,0.0343567639773503,0.051271698136291,3.99896017543791e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.0387190294548591,0.00390399409628028,0.0310672010261498,0.0463708578835685,4.18573195757906e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42016,0.112091178736398,0.0113075434627667,0.0899283935493749,0.13425396392342,4.38963350352342e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,39908,0.0961811157300274,0.0097022192567875,0.0771647659867239,0.115197465473331,4.52485063129142e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,39649,0.0515302411435651,0.00520303974535849,0.0413322832426625,0.0617281990444678,4.9940995723005e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.0850368350469344,0.00860453277039405,0.0681719508169621,0.101901719276907,5.9353159890509e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.134628822153255,0.013625758661414,0.107922335176883,0.161335309129626,6.26316018548104e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,39636,0.0500834372175984,0.00506945672941511,0.0401473020279447,0.060019572407252,6.36225399429987e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,39919,0.0697985702942867,0.00706723622533085,0.0559467872926382,0.0836503532959351,6.5240203972163e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.113934327589299,0.0115463862914377,0.0913034104580815,0.136565244720517,6.88861854567534e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.049740716695423,0.00504503916543597,0.0398524399311685,0.0596289934596775,7.75822601489985e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,42166,0.0637298259165639,0.00646934500384432,0.0510499097090291,0.0764097421240988,8.09087808053021e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,0.0888632237246331,0.00901904884954692,0.0711858879795212,0.106540559469745,8.27304446865717e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,42016,0.0479305683346056,0.00487342253770057,0.0383786601607125,0.0574824765084987,9.48948091231591e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,42085,0.0927336124877955,0.00943215028339497,0.0742465979323413,0.11122062704325,9.80835273915134e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42097,0.0922737444718567,0.00938737662352597,0.0738744862897458,0.110673002653968,1.00115288893787e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0555387588230538,0.00565688456685735,0.0444512650720134,0.0666262525740942,1.16462863442103e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,42137,0.0500420585596884,0.00510137395713839,0.0400433656036972,0.0600407515156797,1.21886373892929e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,39657,0.0473296310541164,0.00482391790820542,0.0378747519540338,0.0567845101541991,1.24327678186819e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.07427862530502,0.00757555538434511,0.0594305367517036,0.0891267138583364,1.32157615536687e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNLY,Granulysin,42137,0.0597878418443597,0.00610125794236596,0.0478293762773224,0.071746307411397,1.34828031112337e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0731427985844186,0.00746278715838326,0.0585157357539874,0.0877698614148498,1.37054217247778e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,0.0273088229907293,0.0027877056438841,0.0218449199287164,0.0327727260527421,1.44244995403065e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,39958,0.0719329496327027,0.00734661630673966,0.0575335816714929,0.0863323175939124,1.50675098116157e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,39575,0.0542116134135505,0.00553671987928271,0.0433596424501564,0.0650635843769446,1.5177698365705e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.0956701019666372,0.00977143547107358,0.076518088443333,0.114822115489941,1.52114457206114e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSPN,Persephin,42119,0.0955413294611265,0.00976216844568312,0.0764074793075876,0.114675179614665,1.52281555945065e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,41832,0.120223166795947,0.0122919275831123,0.096130988733047,0.144315344858847,1.62494788143284e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,39638,0.0325590547917714,0.0033291053140038,0.0260340083763239,0.0390841012072188,1.69124743989261e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.0350256398430271,0.00358465875675988,0.0279997086797777,0.0420515710062765,1.84955023386999e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,42035,0.0749158338735928,0.00767259878229797,0.0598775402602888,0.0899541274868969,1.90677463311233e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0593894469534376,0.00608423398558004,0.0474643483417008,0.0713145455651745,2.0243969945445e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.0837177125382944,0.00857786912506836,0.0669050890531604,0.100530336023428,2.06469176734075e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0366619429322817,0.0037594229607208,0.0292934739292689,0.0440304119352944,2.13969235764086e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0644688190003927,0.00661043171021469,0.0515123728483719,0.0774252651524135,2.21321459031142e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,0.067686959269047,0.00694953696787098,0.0540658668120199,0.0813080517260741,2.41506687409151e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0540884541713424,0.00555191886873976,0.0432066931886124,0.0649702151540723,2.43549677859163e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41900,0.0536065580966178,0.0055061170740117,0.0428145686315549,0.0643985475616808,2.51812654513115e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0417499728390271,0.00429301046424151,0.0333356723291137,0.0501642733489404,2.8796667110644e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.037978009578619,0.00390707292601515,0.0303201466436293,0.0456358725136087,2.91659984730554e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,39978,0.061399755698133,0.00631527686329065,0.0490218130460833,0.0737776983501827,2.95351279938862e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.0301663555094277,0.00310423153061899,0.0240820617094144,0.0362506493094409,2.98650094069703e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,41714,0.02890293338364,0.00297481727783671,0.02307229151908,0.0347335752481999,3.06662383673295e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,39586,0.0602058964319027,0.00619866119437216,0.0480565204909333,0.0723552723728722,3.26875912617987e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.0322595737642916,0.00332328820715542,0.025745928878267,0.0387732186503162,3.32204576224038e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.10835055914916,0.0111592251971062,0.0864784777628314,0.130222640535488,3.35029824604928e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0710051128285639,0.00731453943260106,0.0566686155406658,0.085341610116462,3.42151804992645e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,42051,0.0756137463590874,0.00779815162470257,0.0603293691746704,0.0908981235435045,3.69206517748386e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.0919348117206848,0.00948615832911063,0.0733419413956279,0.110527682045742,3.99435200737927e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.10882192960668,0.011239047792507,0.0867933959333666,0.130850463279994,4.35830045795678e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42119,0.0998369617463876,0.0103204051828826,0.0796089675879376,0.120064955904838,4.59616178743566e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,0.0978948481819696,0.0101244669376495,0.0780508929841767,0.117738803379763,4.80791443330841e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0903391022296987,0.00934651287081286,0.0720199370029055,0.108658267456492,4.97699861732388e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,42145,0.0742024303085652,0.0076781435689625,0.0591532689133987,0.0892515917037317,5.04493153711559e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,42119,0.0604083094230807,0.00625164099821777,0.0481550930665739,0.0726615257795875,5.11144803796555e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,39486,0.0911995711103006,0.00943603335790976,0.0727049457287974,0.109694196491804,5.20287249844544e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.0899870877858308,0.0093193322785092,0.0717211965199527,0.108252979051709,5.45981945304514e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39575,0.0467940047238498,0.00484700155993784,0.0372938816663716,0.0562941277813279,5.76757975333036e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,42137,0.063644613371603,0.00660546338007849,0.0506979051466491,0.0765913215965568,6.6790577191725e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,42057,0.0605186682927889,0.00628255573888672,0.0482048590445709,0.0728324775410068,6.83824451377192e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41933,0.0369243651659054,0.00383745276641309,0.0294029577437358,0.0444457725880751,7.5950246252689e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0664679397540544,0.0069306032544671,0.0528839573752988,0.0800519221328099,1.0650054126447e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42181,0.0768990860559782,0.00802844664081911,0.0611633306399727,0.0926348414719837,1.15465157937102e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.0240076102230303,0.00250852612552632,0.0190908990169987,0.0289243214290619,1.24680007342167e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0474464045728667,0.00495791286790871,0.0377288953517656,0.0571639137939677,1.29850927468342e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0725981606488829,0.00759571985990479,0.0577105497234695,0.0874857715742963,1.41228449189964e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,0.0288791589154174,0.00302171005637548,0.0229566072049214,0.0348017106259133,1.41574517612444e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,41913,0.0862467398895227,0.00903446401590814,0.0685391904183428,0.103954289360703,1.57345899642579e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,42119,0.0695720473733659,0.0072939422803322,0.0552759205039148,0.083868174242817,1.69604590202629e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.120780510503795,0.0126659532592554,0.0959552421156547,0.145605778891936,1.74143898483419e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,42016,0.0606311159772747,0.00636996949788017,0.0481459757614296,0.0731162561931199,2.05726014973254e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.0956100689349488,0.0100450200924298,0.0759218295537865,0.115298308316111,2.11816483424581e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.113778593284096,0.0119782874045151,0.0903011499712466,0.137256036596946,2.55740137746034e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,0.0264497497318053,0.00278888253842267,0.0209835399564968,0.0319159595071137,2.84416203450867e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,39813,0.118530675042415,0.0125020409222363,0.0940266748348313,0.143034675249998,3.02754697874008e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0526331473883902,0.00556160390109366,0.0417324037422467,0.0635338910345338,3.57549038634829e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.0395646073417121,0.00418256569896546,0.0313667785717398,0.0477624361116844,3.70422141498453e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,42016,0.0364402192214744,0.00385466481641906,0.028885076181293,0.0439953622616557,3.81142299814507e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,42002,0.0502963540669574,0.00532115702615915,0.0398668862956855,0.0607258218382293,3.86271414607143e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,42196,0.031601347991769,0.00334412742721571,0.0250468582344262,0.0381558377491118,3.94106721176547e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,39649,0.0533437258981553,0.00565793064337932,0.0422541818371319,0.0644332699591788,5.00686131342435e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.0911124270547917,0.00967229268898523,0.0721547333843807,0.110070120725203,5.38550670941704e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,42070,0.0416374228981314,0.00442290836973427,0.0329685224934523,0.0503063233028106,5.53817071074391e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,42158,0.0328558980217826,0.00349125169600158,0.0260130446976195,0.0396987513459457,5.6982233843861e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.0285980530995107,0.00304019975949974,0.0226392615708912,0.0345568446281301,6.13498852312186e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,0.0330063941913643,0.0035120144113103,0.0261228459451961,0.0398899424375325,6.41933224575478e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.101031298559266,0.0107508250158107,0.0799596815282769,0.122102915590255,6.65517203853747e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.0359966536126621,0.00383183953012081,0.0284862481336254,0.0435070590916989,6.68090556561153e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.113561636325572,0.0120918228301597,0.0898616635784588,0.137261609072685,7.0363154483714e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,42119,0.0410205007285069,0.00437044661597438,0.0324544253611971,0.0495865760958167,7.22081287465092e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,0.0501376396057601,0.00534589275320852,0.0396596898094714,0.0606155894020488,7.73019594032071e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,39736,0.0563577112691694,0.00602036938696828,0.0445577872707116,0.0681576352676273,9.39757979882175e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.0320762316824548,0.00342787233912101,0.0253576018977776,0.038794861467132,9.74157713726863e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,39958,0.0886630142774416,0.00947657521070405,0.0700889268644617,0.107237101690422,9.82993044594755e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,39990,0.030713078862641,0.00328521865813046,0.0242740502927053,0.0371521074325767,1.05071003801296e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.074142467527207,0.00794692065625891,0.0585665030409395,0.0897184320134744,1.26221310160155e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0766204753132073,0.00822591835292147,0.0604976753414812,0.0927432752849334,1.41320759190961e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,39897,0.0928515562273993,0.00996568034103947,0.0733188227589619,0.112384289695837,1.41637668357248e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41843,0.0507799652430509,0.00545692788959803,0.0400843865794388,0.0614755439066631,1.53908767141281e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,0.0541536918194936,0.0058222930824076,0.0427419973779747,0.0655653862610125,1.60425781199871e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,41890,0.0591463192525893,0.00636580230659164,0.0466693467316696,0.0716232917735089,1.75879052345539e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,39713,0.109430500225408,0.0117785918234594,0.0863444602514276,0.132516540199388,1.81912398971435e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,42145,0.0496303173953395,0.00535086231933739,0.0391426272494382,0.0601180075412408,2.03759522754924e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0502110261289414,0.00541221340380839,0.0396030878574769,0.0608189644004058,2.05179659160716e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0516910405451383,0.00557648121978119,0.0407611373543672,0.0626209437359095,2.14929399047235e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,39638,0.0543377292554251,0.00586339091769141,0.04284548305675,0.0658299754541003,2.26332865696272e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0421712346210949,0.00455314351509681,0.0332470733315051,0.0510953959106846,2.366005302866e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.101818837705055,0.0109979413893744,0.0802628725818809,0.123374802828229,2.39542686104383e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,42107,0.0420186422054094,0.0045393295872568,0.033121556214386,0.0509157281964327,2.42444894709816e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,42262,0.0231733196079377,0.00250366238675572,0.0182661413298965,0.0280804978859789,2.43887599059888e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,41881,0.059503635198717,0.00642991082867259,0.0469010099745187,0.0721062604229153,2.48457358614388e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.05455826345558,0.00589639389535445,-0.0661151954904747,-0.0430013314206853,2.50987517244563e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.118791788816841,0.0128407238838794,0.093623970004437,0.143959607629244,2.5468507566196e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.0381637298004351,0.00413115450856609,0.0300666669636456,0.0462607926372247,2.96905039034705e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,0.0608268202605976,0.0065876749690149,0.0479149773213284,0.0737386631998668,3.0860613025054e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.0410110745684241,0.00444413078708299,0.0323005782257414,0.0497215709111067,3.15847394000491e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,0.124407905877249,0.0134778500592441,0.0979913197611308,0.150824491993368,3.16943157453127e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,0.0451454773701745,0.00489252607965414,0.0355561262540524,0.0547348284862966,3.17783682537605e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,39990,0.0765513902287456,0.00829534781965359,0.0602925085022245,0.0928102719552666,3.23553501562761e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41839,0.0385325254964183,0.00417717501380079,0.0303452624693688,0.0467197885234679,3.27351816738869e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,39930,0.108322454790277,0.0117412505231492,0.0853096037649042,0.131335305815649,3.31199995995177e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41948,0.0290796928037155,0.00315301601995974,0.0228997814045944,0.0352596042028366,3.32248552132259e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,0.0422974067989888,0.00458980779717643,0.033301383516523,0.0512934300814546,3.55375854947094e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,0.0652620936876196,0.00708489325009154,0.0513757029174402,0.079148484457799,3.78251397709775e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,0.0238468022777056,0.00259005989047736,0.0187702848923699,0.0289233196630412,3.93973530656426e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RETN,Resistin,42105,0.0445539277587064,0.00484615284126157,0.0350554681898337,0.0540523873275791,4.34454338641996e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0731550530041484,0.00797106327147894,0.0575317689920497,0.0887783370162471,5.17251126177193e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,0.0865547869021251,0.00943370719311007,0.0680647208036293,0.105044853000621,5.30735650390714e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,41913,0.0495726044432521,0.00542574342528556,0.0389381473296924,0.0602070615568118,7.36755641186879e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,39934,0.0313015410792859,0.00342685920823179,0.0245848970311516,0.0380181851274203,7.70663844908542e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0548188477553264,0.00600831161172236,0.0430425569963506,0.0665951385143023,8.26730164189859e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0768805475455613,0.00843238663672366,0.0603530697375829,0.0934080253535396,9.01853341870077e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,41839,0.0532857552981168,0.00584674954549378,0.041826126188949,0.0647453844072846,9.08975116455917e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNST,Consortin,42145,0.112130067961102,0.0123068569831456,0.0880086282741368,0.136251507648067,9.27718920577749e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41900,0.0380489667820326,0.00417909142819785,0.0298579475827648,0.0462399859813004,9.8772368481984e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0301504253714176,0.00331116725787767,0.0236605375459774,0.0366403131968578,1.00152764845061e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0273112725705151,0.00300185540964567,0.0214276359676096,0.0331949091734207,1.04436749715561e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.0387815326463211,0.00426443570528538,0.0304232386639618,0.0471398266286805,1.11703838691498e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0505480621252065,0.00556999079044893,0.0396308801759266,0.0614652440744864,1.3232414877851e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.102169486279641,0.0112614793843246,0.0800969866863644,0.124241985872917,1.36137949066456e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0710938443800313,0.00784058335067417,0.05572630101271,0.0864613877473527,1.42578242813175e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0370039747933003,0.00408189007452835,0.0290034702472247,0.0450044793393759,1.45219321962973e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,0.0432694768558644,0.00477684508228987,0.0339068604945762,0.0526320932171525,1.50596094909586e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,0.0400388900647602,0.00442145555600385,0.0313728371749926,0.0487049429545277,1.54755730490954e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.0473669034906384,0.00523169614450335,0.0371127790474118,0.0576210279338649,1.57104021719477e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42041,0.0406498661548077,0.00449119611027991,0.031847121778659,0.0494526105309563,1.60887032651011e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0689938989968467,0.00762043320205545,0.054057849920818,0.0839299480728754,1.6121715853193e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,41949,0.0716224711692702,0.00792004455307945,0.0560991838452344,0.0871457584933059,1.72904516109059e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,0.109999908021816,0.0121710467100763,0.0861446564700668,0.133855159573566,1.85686699831017e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.0930050273790503,0.010298226643673,0.0728205031574512,0.113189551600649,1.98044391771198e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,0.0856225177945888,0.00948508591696088,0.0670317493973455,0.104213286191832,2.04743023944617e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42119,0.0707216541148758,0.00783838191588416,0.0553584255597428,0.0860848826700087,2.08367884591492e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.117569935399458,0.0130272667714961,0.0920364925273252,0.14310337827159,2.08786268448863e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,42137,0.0458356603105995,0.0050893144835605,0.0358606039228209,0.0558107166983781,2.4136024024468e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,39929,0.101950043890487,0.0113268739548693,0.0797493709389435,0.124150716842031,2.59925185248996e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,0.0922205638185467,0.0102552616307369,0.0721202510223024,0.112320876614791,2.74083851637973e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,42166,0.0836062640815287,0.00930311462013525,0.0653721594260636,0.101840368736994,2.87465852493764e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,42144,0.0331013622105315,0.00368533035243461,0.0258781147197596,0.0403246097013033,3.00777183743544e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAT,Catalase,39827,0.0532858533100663,0.0059326259766367,0.0416579063958584,0.0649138002242742,3.08706817537518e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,39638,0.120303583668863,0.0133956296828197,0.0940481494905363,0.14655901784719,3.12358854321192e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0306734253974843,0.00341996132272882,0.0239703012049358,0.0373765495900327,3.38222423981976e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,39919,0.0406690412325025,0.00453331355424412,0.031783746666184,0.049554335798821,3.39527149457556e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,39929,0.0641841550909798,0.00715756451653159,0.0501553286385779,0.0782129815433817,3.51419574912796e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,39958,0.0730847655866282,0.00816139939987078,0.0570884227628814,0.0890811084103749,3.92750273944328e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,39575,0.0399044183944415,0.00445891484097191,0.0311649453061366,0.0486438914827465,4.15021648811166e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAYN,Layilin,41997,0.0362228841465476,0.00404897365811227,0.0282868957766476,0.0441588725164476,4.15719540870346e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0750873013655661,0.00839600448211038,0.0586311325806297,0.0915434701505024,4.27587796849684e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.0439261379359698,0.0049137898910276,0.0342951097495557,0.0535571661223839,4.51735295671789e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,0.0410823451505279,0.00460045950986477,0.0320654445111929,0.0500992457898628,4.80459853396497e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41934,-0.0545087200995356,0.00610705312395411,-0.0664785442224856,-0.0425388959765855,5.00839926975683e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.0943861944755729,0.0105943653011324,0.0736212384853533,0.115151150465792,5.79757642302163e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,39934,0.067135326283467,0.00753603646108056,0.0523646948197491,0.0819059577471849,5.95663590304073e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0583940128882343,0.00656204782362069,0.0455323991539377,0.0712556266225308,6.37364769057673e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,0.0489802998708674,0.00550468851090048,0.0381911103895024,0.0597694893522323,6.40511849886567e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,39657,0.0358914159843741,0.00403555194688754,0.0279817341684745,0.0438010978002736,6.82199140005328e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,41910,0.0737338378953743,0.00829459402913686,0.0574764335982661,0.0899912421924826,6.92665124992688e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,0.0450341671644042,0.00507945300221505,0.0350784392800627,0.0549898950487457,8.5151126613815e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,0.109683168072794,0.0123750307158684,0.0854281078696917,0.133938228275896,8.73205590467001e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,0.0247826930614295,0.00279657167664534,0.0193014125752046,0.0302639735476544,8.84030823275808e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,39929,0.0572830828690644,0.00646748487658048,0.0446068125109666,0.0699593532271621,9.43427397652813e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.0298111941700527,0.00336878115615158,0.0232083831039956,0.0364140052361098,9.91666098315872e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,39638,0.0742489728088358,0.00840021434884797,0.0577845526850938,0.0907133929325778,1.11276797010827e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39560,0.0502591889069212,0.00569021469353415,0.0391063681075943,0.0614120097062482,1.17876023341117e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,41843,0.0797660746948731,0.00903497871176305,0.0620575164198175,0.0974746329699286,1.19185002603305e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBN1,Drebrin,39657,0.0510783944420845,0.00578471111652025,0.0397403606537048,0.0624164282304642,1.20553745077332e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,0.0865075244025412,0.00980688547871181,0.067286028864266,0.105729019940816,1.27075775417263e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,39930,0.0433335338639386,0.00491282207762159,0.0337044025918003,0.0529626651360769,1.3059969496218e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.119735093137128,0.0136039571536678,0.0930713371159388,0.146398849158317,1.5113939394311e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.0431426988985892,0.00490193307035088,0.0335349100807014,0.0527504877164769,1.51930084833313e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,42224,0.060786023724258,0.0069118482834377,0.0472388010887201,0.0743332463597959,1.60788804027887e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.09993757079685,0.0113694921194862,0.077653366242657,0.122221775351043,1.71119600230879e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0503650047256985,0.00573434672343001,0.0391256851477757,0.0616043243036213,1.81944061117209e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0254345118436869,0.0029019411731569,0.0197467071442994,0.0311223165430744,2.09412766211521e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,42081,0.102978884854605,0.0117593061460091,0.0799306448084273,0.126027124900783,2.23714985633628e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.0970355365674769,0.0110857712976913,0.0753074248240019,0.118763648310952,2.31803769426942e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0260431536072755,0.00297690389902883,-0.031877885249372,-0.0202084219651789,2.47498974371588e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,0.0458311462875792,0.0052419643438842,0.0355568961735662,0.0561053964015922,2.53446470961644e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,39929,0.0840237650868694,0.00960886380534684,0.0651903920283896,0.102857138145349,2.55783100474655e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.0866028320283205,0.00992838571989268,0.0671431960173309,0.10606246803931,3.10073795697795e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFB,Complement factor B,39794,0.0322798079995622,0.00370446333063219,0.0250190598715231,0.0395405561276013,3.35281028962054e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42144,0.0501237411329035,0.00576250432993271,0.0388292326462354,0.0614182496195716,3.75473294774891e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,0.0284596442025784,0.00327254933899528,0.0220454474981477,0.0348738409070092,3.81254981278706e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,0.0412079229402253,0.00473965984543176,0.0319181896431791,0.0504976562372716,3.88469198400571e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42185,0.0212527666346497,0.00244453464953612,0.0164614787215589,0.0260440545477405,3.89635198406155e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0568028848355611,0.00653675273663622,0.0439908494717541,0.0696149201993681,4.04485610979122e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,39966,0.0251418340602175,0.00289341712154493,0.0194707365019895,0.0308129316184456,4.14450674050296e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0509417838013126,0.00586695843008988,0.0394425452783364,0.0624410223242887,4.30818861261981e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0820790048670772,0.00945773474184598,0.063541844773059,0.100616164961095,4.46193493210095e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.106693259498117,0.0122936383092733,0.0825977284119409,0.130788790584292,4.57512415498424e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,42181,0.026979883467353,0.00311192331164851,0.0208805137765219,0.0330792531581841,4.81283902447239e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,0.0360311087333374,0.00415881284091712,0.0278798355651398,0.0441823819015349,5.070516623458e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0346595261236426,0.00400068054783697,0.0268181922498821,0.042500859997403,5.09514673915235e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.0602388894850475,0.0069594015453084,0.0465984624562431,0.073879316513852,5.57514576674224e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0422823692931533,0.00489851099261336,0.0326812877476311,0.0518834508386755,6.71389775052301e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,42081,0.106257251948597,0.012312121466232,0.0821254938747819,0.130389010022411,6.79843956252717e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0496020802415567,0.00574787344337509,0.0383362482925415,0.0608679121905719,6.82849061806724e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41913,0.0642651777087293,0.00745427966171535,0.0496547895717672,0.0788755658456914,7.36444119828974e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0552974689286303,0.00641390210402801,-0.0678687170525252,-0.0427262208047354,7.50986491547603e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39579,0.0544428108236738,0.00631806437213694,0.0420594046542854,0.0668262169930622,7.81371455563481e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,42124,-0.0560725897208957,0.00651006511649335,-0.0688323173492226,-0.0433128620925687,7.88327750835903e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0541314819450633,0.00628410340246359,0.0418146392762346,0.0664483246138919,8.01057289685881e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,42062,0.0313773098798138,0.00364507201646691,0.0242329687275387,0.0385216510320889,8.24168355017195e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,0.0597850980211732,0.00694899761916262,0.0461650626876145,0.073405133354732,8.75631855924012e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39882,0.0475819490436939,0.00554695231740314,0.0367099225015838,0.0584539755858041,1.09105487548991e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,39736,-0.0944454568402772,0.0110112365752912,-0.116027480527848,-0.0728634331527063,1.10081203039413e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,42296,0.07676563019898,0.00896085808163022,0.0592023483589847,0.0943289120389752,1.17691956489953e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0470299241428344,0.00549584078005766,0.0362580762139214,0.0578017720717474,1.30345388052799e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,39649,0.0799215720282248,0.00934124499679361,0.0616127318345093,0.0982304122219402,1.32536836284632e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0487736709489286,0.00570531315258973,0.0375912571698527,0.0599560847280044,1.402890649127e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,41843,0.0520807939360661,0.006095560318485,0.0401334957118355,0.0640280921602967,1.43648870733278e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0687841026109824,0.00805259785295004,0.0530010108192003,0.0845671944027645,1.48906947317151e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,0.0554919819672432,0.00649962177806414,0.0427527232822375,0.0682312406522489,1.54820590042845e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,0.0294717876112264,0.00345258998684408,0.022704711237012,0.0362388639854407,1.56450599156448e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39638,0.0421218810856291,0.00493610786527361,0.0324471096696928,0.0517966525015654,1.60654928900047e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,42165,0.051594560361332,0.00605605978302404,0.0397246831866049,0.0634644375360591,1.77000124944862e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.045376886694908,0.0053250143272311,0.034939858613535,0.0558139147762809,1.77465235492181e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,39979,0.0181332053750385,0.00212958173620999,0.0139592251720669,0.0223071855780101,1.87624114137996e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.0705471458728953,0.00829056662082804,0.0542976352960724,0.0867966564497183,1.97518738134793e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,39638,0.0302694952857658,0.00356109843220921,0.0232897423586358,0.0372492482128959,2.13886180862053e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0596120070104842,0.00702036189637056,0.0458520976935979,0.0733719163273705,2.30497087219327e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,39919,0.0432832888012561,0.00510417969070019,0.0332790966074837,0.0532874809950285,2.5317967904942e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.0369554847106909,0.00436213936535938,-0.0455052778667953,-0.0284056915545866,2.66040207127354e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.050377480636886,0.00595506236586456,0.0387055583997915,0.0620494028739805,3.01093344854743e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,42185,-0.0636394720250276,0.00752635444093612,-0.0783911267292624,-0.0488878173207928,3.05867836734541e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,0.0401503522989941,0.00474843697900263,0.030843415820149,0.0494572887778393,3.12556720383879e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.116135738669416,0.0137435444441568,0.0891983915588684,0.143073085779963,3.20282054981712e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39757,0.0329809683318238,0.00390402000510686,0.0253290891218143,0.0406328475418332,3.33194913037186e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0631538802266931,0.00747584104171031,0.0485012317849409,0.0778065286684453,3.33217649976062e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0448628529060926,0.00532093418581247,0.0344338219019002,0.0552918839102851,3.76723146060712e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39575,0.0636126589620894,0.00754444687409756,0.0488255430888582,0.0783997748353207,3.8322508671007e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0549346801266549,0.00652044405470924,0.0421546097794248,0.067714750473885,3.97698536534449e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,41992,0.0492779988951086,0.00586960747169843,0.0377735682505796,0.0607824295396375,5.10376675237907e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0744752828828516,0.00888889506631887,0.0570530485528666,0.0918975172128366,5.89863776029981e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,41825,0.053431843763432,0.00637823660982064,0.0409305000081835,0.0659331875186805,5.96208488893091e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,0.0290222491455761,0.00346914843076975,0.0222227182212674,0.0358217800698848,6.66905124314655e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0440784482163061,0.00527071980307878,0.0337478374022717,0.0544090590303405,6.72747479998866e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0615562527165895,0.00736150346604583,0.0471277059231396,0.0759847995100393,6.77975102204165e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39736,0.0909425285980699,0.0108784342666487,0.0696207974354384,0.112264259760701,7.02370549336593e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,42264,0.0194385076770715,0.00233096410031672,0.0148698180404507,0.0240071973136923,8.18573789595542e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.084519319027581,0.0101328799654836,0.0646588742952332,0.104379763759929,8.22720045589631e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.0357316529269714,0.00428692957120693,0.0273292709674058,0.044134034886537,8.66642902483481e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,41913,0.0274463170446322,0.00329577696731152,0.0209865941887016,0.0339060399005628,9.04067510119675e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0392613323950258,0.00471964242789464,0.0300108332363524,0.0485118315536993,9.94194003387637e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,42016,0.0399962405441317,0.00481361289590097,0.0305615592681658,0.0494309218200976,1.05726245658775e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0641843444397809,0.00773147341601092,0.0490306565443995,0.0793380323351623,1.12521294977914e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,0.0375122465753979,0.00451829480838401,0.0286563887509652,0.0463681043998305,1.13689541827056e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0351574762823238,0.00423710114099539,0.0268527580459728,0.0434621945186747,1.18636102360389e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.104745827201462,0.0126284279329902,0.0799941084528016,0.129497545950123,1.19561557569896e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,39735,0.029170532678964,0.00351714919526699,0.0222769202562407,0.0360641451016873,1.22301017936405e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,39930,0.0588027447684167,0.00709900231993517,0.0448887002213438,0.0727167893154897,1.33332536508772e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,41900,0.0737150680822842,0.00891370923526329,0.0562441979811681,0.0911859381834002,1.46779256228208e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0225432637779663,0.00272607019667611,0.0172001661924811,0.0278863613634515,1.4696943847951e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.0353533519727018,0.00427815383384383,0.0269681704583679,0.0437385334870357,1.54294180652745e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,39919,0.0451647962254457,0.00546484282609613,0.0344537042862973,0.0558758881645941,1.55764591806541e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,0.0508866581328262,0.00616474936513057,0.0388037493771703,0.0629695668884821,1.69445980602314e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0425259704655213,0.0051601565072998,0.0324120637112137,0.0526398772198289,1.8928256737283e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,39657,0.0458119664904473,0.005564956424717,0.034904651898002,0.0567192810828926,2.04411857769384e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PI3,Elafin,41966,0.0523481662747803,0.00636314225477364,0.039876407455424,0.0648199250941367,2.09983385263452e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,39930,0.0892197672729248,0.010845199795718,0.0679631756733176,0.110476358872532,2.13524812092561e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,41839,0.0416354240379963,0.00506471455891971,0.0317085835025137,0.0515622645734789,2.21062649883642e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,42145,0.0632440372491278,0.00770089876104858,0.0481502756774726,0.078337798820783,2.3601639948737e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42181,0.0637574824117457,0.00777842423844021,0.0485117709044029,0.0790031939190885,2.69048060465692e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.0878920516234016,0.0107270724436864,0.0668669896337762,0.108917113613027,2.81018419311077e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,41976,0.0603351964252021,0.00737717983567406,0.0458759239472809,0.0747944689031232,3.12826501347807e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,41693,0.0832075205835915,0.0101748948974794,0.063264726584532,0.103150314582651,3.15738422354395e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,39575,0.0613132430624424,0.0074971399626446,0.046618848735659,0.0760076373892258,3.19807061901679e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0314996967901038,0.00385454626340626,0.0239447861138275,0.0390546074663801,3.29879048166823e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.0449709757709386,0.00550747750181722,0.0341763198673768,0.0557656316745003,3.48946918491098e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,39638,0.0643299391676874,0.00787938048667545,0.0488863534138035,0.0797735249215712,3.58340552324811e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.118425633862049,0.0145233159423792,0.089959934614986,0.146891333109113,3.88568409784662e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,39586,0.0596175246404564,0.00731538804692825,0.045279364068477,0.0739556852124358,4.04714036413934e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.081860048233018,0.0100518509823409,0.0621584203076297,0.101561676158406,4.24281885925156e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,42296,0.0452040283829053,0.00555559467575159,0.0343150628184322,0.0560929939473785,4.4109101022272e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0518115611482939,0.00636740342818409,0.0393314504290531,0.0642916718675347,4.47957545502873e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,42166,0.0801465180876406,0.00986041441920418,0.0608201058260004,0.0994729303492808,4.73581355488586e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.034437584916674,0.00423903123052041,0.026129083704854,0.042746086128494,4.98967714311197e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,42145,0.0700862169727662,0.00862948640914905,0.053172423610834,0.0870000103346983,4.99155860921249e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,0.0522181112707567,0.00643126171307733,0.0396128383131251,0.0648233842283883,5.16909345185717e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0372756848629801,0.00459540378239039,0.0282686934494949,0.0462826762764652,5.52749363372649e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,42137,0.0668178091648211,0.0082532725997466,0.0506413948693178,0.0829942234603245,6.16594828990849e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.0369959126845282,0.00457630483403662,0.0280263552098165,0.04596547015924,6.89222733932107e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,39657,0.0157026034344425,0.00194321004683765,0.0118939117426408,0.0195112951262443,7.10624040042859e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0438864256867727,0.00543418373465468,0.0332354255668495,0.0545374258066959,7.37007037042528e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.0959450630397038,0.0119001029438146,0.0726208612698273,0.11926926480958,8.23682159681402e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0613805565157969,0.00763144614750595,0.0464229220666852,0.0763381909649085,9.6593243840483e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0624776734572409,0.00778114745933502,0.0472266244369442,0.0777287224775375,1.07811782630248e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0949099450469744,0.0118261385918038,0.0717307134070389,0.11808917668691,1.1113526637444e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.0765268378946308,0.00953776231090981,0.0578328237652476,0.095220852024014,1.11320388447366e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,39979,0.0166800001567279,0.00207969035859319,0.0126038070538853,0.0207561932595706,1.1569348738302e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0366134580812232,0.00456900141052517,0.0276582153165938,0.0455687008458525,1.22461771492335e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0574322065315177,0.00717517953442852,0.0433688546440378,0.0714955584189976,1.30123075088582e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,41697,0.0363006822562286,0.00453969129032174,0.027402887327198,0.0451984771852592,1.38933640569163e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,39919,0.0566426347207091,0.00708463530215738,0.0427567495284806,0.0705285199129375,1.42001687582553e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.0529513499307408,0.00662541723742616,0.0399655321453856,0.0659371677160961,1.4337913227512e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0693881546018736,0.00868584505819212,0.052363898287817,0.0864124109159301,1.49986319753191e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,41843,0.0515426836762721,0.00645946061730705,0.0388821408663503,0.0642032264861939,1.5906862881742e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,42123,0.0508240328376183,0.00637526137699989,0.0383285205386985,0.0633195451365381,1.68487916085444e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,39638,0.0663916564579152,0.00833361314469669,0.0500577746943097,0.0827255382215207,1.78937038870196e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39736,0.102130162837412,0.0128277577953193,0.0769877575585866,0.127272568116238,1.86240483827229e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0391385167501566,0.00492179214090821,0.0294918041539765,0.0487852293463367,1.98197145136637e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0522143443794849,0.00657444091174495,0.0393284401924648,0.065100248566505,2.14949779434321e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0345480231074332,0.00435461009897187,0.0260129873134484,0.0430830589014181,2.32815472078999e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0668890393748068,0.00843637795558308,0.050353738581864,0.0834243401677497,2.42660200256958e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,0.0778657374007218,0.00982973364774648,0.0585994594511387,0.0971320153503049,2.56679296705521e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,42145,-0.0281441326073125,0.00355565648572823,-0.0351132193193398,-0.0211750458952852,2.65713160468242e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42125,0.0686133271806243,0.00866906445017836,0.0516219608582747,0.0856046935029738,2.66978320210857e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0354184314784927,0.00448144463768481,0.0266347999886305,0.0442020629683549,2.96629966438956e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0533653709238943,0.00675286147973729,0.0401297624236092,0.0666009794241793,2.98329312489499e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0479399583266936,0.00606997494405779,0.0360428074363404,0.0598371092170469,3.05235266554215e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,39649,0.0615777597056437,0.00779593646811568,0.046297724228137,0.0768577951831504,3.08535124323485e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0437668250237267,0.00555149515373162,0.0328858945224127,0.0546477555250406,3.47490869777397e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0475471986881037,0.00603748744363745,0.0357137232985743,0.0593806740776331,3.6575072416866e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.0272226974612111,0.00346009939956726,0.0204409026380593,0.0340044922843629,3.88584147573116e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39657,0.0573823717288524,0.00729841523525875,0.0430774778677453,0.0716872655899596,4.12165375027728e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0569797437063967,0.00724807672817985,0.0427735133191642,0.0711859740936292,4.1533401586232e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.027981876215073,0.00356776999121365,0.0209890470322942,0.0349747053978517,4.73466635997539e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,0.0782992519069338,0.00999881752947348,0.0587015695491657,0.0978969342647018,5.2775621194851e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,39966,0.0285277550259068,0.00364426262945597,0.0213850002721732,0.0356705097796405,5.39102436804138e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.0930711268840725,0.0119006239970614,0.0697459038498321,0.116396349918313,5.64415013576206e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0600282168885028,0.00767923564788961,0.0449769150186392,0.0750795187583664,5.81119252531975e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.071632680546434,0.00916924157116642,0.0536609670669478,0.0896043940259202,6.12458770107582e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,42224,0.0632582851124835,0.0081039686861389,0.0473745064876512,0.0791420637373157,6.34008930445539e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,39979,0.0363423393529856,0.00467504429616883,0.0271792525324947,0.0455054261734765,8.27952465167783e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELL,L-selectin,39979,0.0205055441137675,0.00263906792925385,0.0153329709724299,0.025678117255105,8.52327858125504e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.0232664840667526,0.00299445174195015,0.0173973586525303,0.0291356094809749,8.53133333546033e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,-0.0281021400364262,0.00361779397491648,-0.0351930162272625,-0.0210112638455899,8.55820294551853e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,42119,0.060011861413347,0.00772655890539478,0.0448678059587733,0.0751559168679208,8.61627605174393e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,0.0256937176953409,0.00330926346695083,0.0192075613001173,0.0321798740905645,8.92425440594928e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,0.0649062736810696,0.00837135154695719,0.0484984246490335,0.0813141227131057,9.72559643241675e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,42110,0.0258783699944128,0.00333850120618546,0.0193349076302893,0.0324218323585363,9.72875593822639e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,39560,0.0490646482907944,0.00633666224506433,0.0366447902904683,0.0614845062911205,1.05665606745611e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,0.0238129682066442,0.00307851992765693,0.0177790691484367,0.0298468672648518,1.10473089942369e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,41843,0.0331599877081178,0.00428735859015149,0.0247567648714208,0.0415632105448147,1.114114249844e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,42143,0.0315262995522531,0.00407785876557129,0.0235336963717334,0.0395189027327729,1.14124153295485e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.035949434296421,0.0046597355111753,0.0268163526945174,0.0450825158983246,1.29523110760687e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39757,0.0651010722672845,0.00843703738470791,0.048564478993257,0.081637665541312,1.3015991170482e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DMD,Dystrophin,39638,0.0450530184509635,0.00584007843429082,0.0336064647197535,0.0564995721821735,1.31962923965239e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.030230806635465,0.00392601880754433,0.0225358097726781,0.0379258034982519,1.45510442316912e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,41843,0.0570243448530955,0.0074262707938276,0.0424688540971934,0.0715798356089976,1.71914750709687e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,0.062318506822038,0.00814209575673513,0.0463599991388372,0.0782770145052389,2.11106349788717e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0324511748341052,0.00423999304715559,0.0241407884616802,0.0407615612065301,2.11294010023242e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,0.0297570127971273,0.00388908538254938,0.0221344054473305,0.0373796201469241,2.12128415563329e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,0.0419150656742821,0.00548260807315106,0.0311691538509061,0.0526609774976582,2.26200520887433e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,0.028417753948343,0.00372302123446871,0.0211206323287843,0.0357148755679016,2.48297321741229e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0462737550288288,0.00606381164898504,0.0343886841968181,0.0581588258608395,2.48301930089521e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,39958,0.0461910303772298,0.0060518175091329,0.0343294680593293,0.0580525926951303,2.48500021570367e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0374074154314365,0.00490277421467158,0.0277979779706802,0.0470168528921928,2.5437864155773e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,39575,0.0338703311812069,0.00445294898165535,0.0251425511771625,0.0425981111852514,3.05186124706291e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39657,0.0476764947715179,0.00628285189350212,0.0353621050602538,0.0599908844827821,3.50033183562192e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,0.0631869934063842,0.00832936450276725,0.0468614389809604,0.079512547831808,3.5102210580806e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0617613718194155,0.00814020794912038,0.0458065642391395,0.0777161793996914,3.52519123965191e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,42181,0.0287706859579964,0.00380354939830174,0.021315729137325,0.0362256427786678,4.15398535995732e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,39586,0.0360010897283299,0.00476847146174368,0.0266548856633123,0.0453472937933475,4.70401793568408e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0318824627058608,0.00422405638029506,0.0236033122004825,0.0401616132112391,4.76528684262024e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0264854081002583,0.00351175928264164,0.0196023599062807,0.0333684562942359,4.98399251639065e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,39929,0.117761019530172,0.0156143682487695,0.0871568577625837,0.14836518129776,4.98809268825758e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39864,0.0356842050120806,0.00473223393617307,0.0264090264971814,0.0449593835269798,5.0349191445552e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.033895785094235,0.00449619280893415,0.0250832471887241,0.0427083229997459,5.11178361287072e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,41742,-0.0782085422121067,0.0103786386735138,-0.0985506740121937,-0.0578664104120197,5.18138065654644e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.0234598979075641,0.00311260587472747,0.0173591903930983,0.02956060542203,5.18241650289808e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.0872229365009379,0.0115892923790267,0.0645079234380457,0.10993794956383,5.55287883010262e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,42113,0.0204519186410528,0.0027176118430421,0.0151253994286903,0.0257784378534154,5.57530895579006e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,39966,0.0717045257910019,0.00952755413030072,0.0530305196956125,0.0903785318863913,5.62621480843271e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,0.0494578509359869,0.00657440138840234,0.0365720242147183,0.0623436776572555,5.70117203380491e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0265479226021053,0.00353028434034883,0.0196285652950216,0.033467279909189,5.89948660758565e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0561578708613327,0.00747184017386592,0.0415130641205555,0.0708026776021099,6.00071837128183e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,39966,0.0407730856981155,0.0054338201758457,0.030122798153458,0.0514233732427731,6.67324096671192e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.05356451478344,0.00714903605842732,0.0395524041089225,0.0675766254579576,7.2556955763664e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,39854,0.0365337352838761,0.00487989956256738,0.026969132141244,0.0460983384265081,7.59731748953178e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0239244050699265,0.00319799330652859,0.0176563381891304,0.0301924719507225,7.93540683625114e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,0.0182938408392391,0.00244588046632959,0.0134999151252331,0.023087766553245,8.0147647675876e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,0.0236572785812098,0.00316450280604735,0.017454853081357,0.0298597040810626,8.13885738651393e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,39575,0.0656401136985651,0.00878196741076157,0.0484274575734724,0.0828527698236577,8.34488223453426e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42181,0.0241460324917733,0.00323257394962868,0.0178101875505011,0.0304818774330455,8.53436548789643e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,0.0526368053736397,0.00704997058417473,0.0388188630286573,0.0664547477186222,8.85738958784747e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,41900,0.0377280841143694,0.0050581035563796,0.0278142011438654,0.0476419670848734,9.2624254019528e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,39657,0.0485589099672595,0.00652449007434341,0.0357709094215464,0.0613469105129726,1.06084665445214e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0736805636916172,0.00990479775161134,0.0542671600984589,0.0930939672847754,1.09000269113489e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,0.0710335171168151,0.00955533102582395,0.0523050683062002,0.0897619659274301,1.13272956106692e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.100856338081164,0.0135783713875926,0.0742427301614826,0.127469946000846,1.17101576973583e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41913,0.0450042488066221,0.00605892126230389,0.0331287631325065,0.0568797344807377,1.17166047899821e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,0.0252226117261159,0.00339897883197606,0.0185606132154428,0.0318846102367889,1.2504031180691e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42016,0.0443473359992071,0.0059782163749294,0.0326300319043455,0.0560646400940687,1.25893390795612e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0406480806064859,0.0054820825094105,0.0299031988880414,0.0513929623249305,1.29301837209842e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0420310930329338,0.00567171695355086,0.0309145278039741,0.0531476582618935,1.33300517780675e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,42296,0.0512511332812852,0.0069176915536244,0.0376924578361813,0.064809808726389,1.34997172261827e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,42249,0.0546145660101371,0.00737166982822695,0.0401660931468123,0.0690630388734619,1.35017775266119e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,42262,0.0266173848538767,0.00359407530690039,0.019572997252352,0.0336617724554015,1.37882754056788e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0342425605095865,0.00462426646362108,0.0251789982408892,0.0433061227782839,1.39117262032756e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,41839,0.0578147865833653,0.00780927842882562,0.042508600862867,0.0731209723038635,1.40812932399982e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,0.0558724323646586,0.00754872200561927,0.0410769372336449,0.0706679274956724,1.44102785199106e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,0.0292981737065023,0.00395876913206418,0.0215389862076565,0.0370573612053481,1.45234063878581e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,0.0637490597566006,0.00861703736208977,0.0468596665269046,0.0806384529862965,1.48307022020329e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,0.0736723807100634,0.00997498349580143,0.0541214130582926,0.0932233483618342,1.60466960212442e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0440098732985065,0.00595911797987139,0.0323300020579586,0.0556897445390544,1.6307453141552e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,42274,-0.0449227292487062,0.00608547540604917,-0.0568502610445626,-0.0329951974528499,1.64981140680302e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,0.0249023213935161,0.00337360670950454,0.0182900522428872,0.031514590544145,1.67459144955669e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,39934,0.0580512203014898,0.00787309278504385,0.0426199584428039,0.0734824821601758,1.77961800163206e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,0.0264196191622642,0.00358416848459788,0.0193946489324524,0.0334445893920761,1.78898988779154e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0270593666892783,0.00367401279624509,0.0198583016086379,0.0342604317699186,1.89306447447385e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,39736,0.0306029014407849,0.00415697895794341,0.0224552226832158,0.038750580198354,1.94221626550345e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0322329228348158,0.0043784014445249,0.023651256003547,0.0408145896660846,1.9443161941689e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0391767556610086,0.00532486988399382,0.0287400106883807,0.0496135006336365,1.98686807369637e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C5,Complement C5,39979,0.0125212357222094,0.00170312645168634,0.00918310787690415,0.0158593635675146,2.0879199263317e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BGN,Biglycan,41820,-0.0981994629371299,0.0133622290422147,-0.124389431859871,-0.0720094940143892,2.11363160026591e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41913,0.0328174203917721,0.00446815786923216,0.024059830968077,0.0415750098154671,2.18157693261003e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0273858915073496,0.00373640864031888,0.0200625305723246,0.0347092524423746,2.44227334490899e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,39934,0.0496081835511074,0.00676870109050987,0.036341529413708,0.0628748376885067,2.47541984001704e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0610751342184519,0.00833941371129602,0.0447298833443117,0.0774203850925921,2.55219084226099e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,42119,0.0571725150678144,0.00781509947217471,0.0418549201023519,0.0724901100332768,2.70567599411206e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.0846287235143369,0.011570821632932,0.0619499131137901,0.107307533914884,2.7732189649627e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,0.0560493593050965,0.00767106196365676,0.0410140778563293,0.0710846407538638,2.89374900203028e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,42070,0.061672874494277,0.00844621394749025,0.0451182951571961,0.0782274538313579,2.99789734145987e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0574862301423542,0.00788103638937633,0.0420393988191766,0.0729330614655318,3.21040360378429e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,39726,0.0173338136012741,0.00237907964518641,0.0126708174967088,0.0219968097058395,3.41070774049426e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0608323471749933,0.00834951793851155,0.0444672920155106,0.0771974023344759,3.4175456643012e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.033592940714247,0.00461213463029791,0.0245531568388631,0.0426327245896309,3.42756000140425e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,0.0308450572073083,0.0042361389801674,0.0225422248061802,0.0391478896084364,3.48608961209134e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,0.0550031091446956,0.00756134941290641,0.040182864295399,0.0698233539939922,3.6798203464054e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,42137,0.0524321966794469,0.00721627534404421,0.0382882970051202,0.0665760963537736,3.91052394894268e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,42310,0.0722751515401634,0.00995656948789449,0.0527602753438902,0.0917900277364366,4.10816918672423e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,0.0297036362780893,0.00409236804432155,0.0216825949112191,0.0377246776449596,4.1761221720146e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39638,0.0416303201058538,0.00574858019804225,0.030363102917691,0.0528975372940166,4.72090826233469e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,41913,0.0935446268102558,0.012922100744897,0.0682173093502576,0.118871944270254,4.76372087670019e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,41967,0.0860169484007644,0.0119075722353846,0.0626781068194106,0.109355789982118,5.33237172376341e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,42262,0.0331811209613729,0.00460689121447161,0.0241516141810085,0.0422106277417372,6.22129388606806e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42119,0.0635165825626473,0.00882069669674237,0.0462280170370322,0.0808051480882623,6.29966153619038e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,0.0421472224028099,0.00585468131637484,0.0306720470227152,0.0536223977829046,6.46484063585495e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.0808228955453016,0.0112345355297979,0.0588032059068977,0.102842585183706,6.61613467296527e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,39958,0.043594122953873,0.00606590712937908,0.03170494498029,0.055483300927456,7.05133377116936e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,42119,0.0258874164888591,0.00360438397232404,0.018822823903104,0.0329520090746142,7.21841419198677e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,42084,0.0654403405182638,0.00911410652558352,0.0475766917281201,0.0833039893084075,7.33000279908754e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,41900,0.0317116442085966,0.00441769864265333,0.0230529548689961,0.0403703335481972,7.43189176742728e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0477244874306666,0.00664865278707681,0.0346931279679961,0.0607558468933372,7.52361409634623e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,42189,0.0368219934511234,0.0051358752035197,0.0267556780522248,0.046888308850022,7.91220648353443e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,41900,0.0591677602230753,0.0082550720107033,0.0429878190820968,0.0753477013640538,8.04408465943872e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F2,Prothrombin,39979,0.012083173643782,0.00168570377300152,0.00877919424869903,0.015387153038865,8.07948845134618e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,0.0806490432130517,0.0112560145800273,0.0585872546361983,0.102710831789905,8.2630818713114e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,0.02878647101755,0.00401849588638776,0.02091021908023,0.03666272295487,8.36014744332221e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42145,0.0707469392582782,0.00988989363466257,0.0513627477343395,0.0901311307822168,8.89641685245232e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.0453811116235504,0.00635343857159911,0.0329283720232161,0.0578338512238847,9.72659573514941e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,42016,0.0265043804009448,0.00371782903508729,0.0192174354921737,0.0337913253097158,1.06276767070612e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0284861909365025,0.00399747188424924,0.020651146043374,0.036321235829631,1.0956683222047e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42243,0.0736628072457056,0.0103454241835077,0.0533857758460305,0.0939398386453807,1.13058302528618e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,39966,0.0445977565297777,0.00626989107232536,0.03230877002802,0.0568867430315354,1.20365695416783e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42137,0.0476361017534957,0.00669833770849902,0.0345073598448376,0.0607648436621537,1.20435687069086e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0436905771454203,0.00614232038554009,0.0316516291897617,0.0557295251010788,1.20533962242991e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.0361189982983729,0.00508615976662503,0.0261501251557878,0.0460878714409579,1.29666841897231e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,0.0972478897666865,0.0136935769736617,0.0704084788983097,0.124087300635063,1.30841780511054e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,42249,0.0233329851046259,0.00329033245368536,0.0168839334954026,0.0297820367138492,1.3931800370417e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42070,0.016718198367207,0.00236137135239001,0.0120899105165226,0.0213464862178914,1.51440344800079e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0352507083093893,0.0049800079830932,0.0254898926625267,0.045011523956252,1.54397392407914e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,39990,0.0739061199413351,0.0104895800637533,0.0533465430163787,0.0944656968662916,1.9521911265741e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,42088,0.0577326366425305,0.00819593099087648,0.0416686119004126,0.0737966613846484,1.95768661990404e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,41839,0.0362595199891636,0.00515381291893688,0.0261580466680473,0.0463609933102799,2.08348423085851e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,0.019642390903914,0.00279901261074836,0.0141563261868473,0.0251284556209808,2.3857053111708e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,39904,0.0453213818720943,0.00646383093642921,0.0326522732366931,0.0579904905074956,2.49155306085578e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0186310797904276,0.00265937075327969,0.0134187131139994,0.0238434464668558,2.57154844012266e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0329107105695844,0.00470937769962929,0.023680330278311,0.0421410908608578,2.91480682517527e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,42166,0.0461667955197809,0.00660839336455069,0.0332143445252615,0.0591192465143002,2.95842709617549e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,0.0421969319264585,0.00604042194446818,0.0303577049153009,0.0540361589376161,2.9685628956281e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,41843,0.0579894418768619,0.00830804449279339,0.0417056746709868,0.0742732090827369,3.09423479994536e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,39925,0.0246253231752934,0.00352800807962823,0.017710427339222,0.0315402190113647,3.11783876893068e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0509026431441894,0.0072957395384166,0.0366029936488928,0.0652022926394859,3.1580664792326e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,42082,0.0689677628474934,0.00991532366902108,0.0495337284562121,0.0884017972387747,3.67057911278924e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.0668878642313286,0.00963083162907301,0.0480114342383455,0.0857642942243117,3.95251098493549e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0276473971626176,0.00398087261719494,0.0198448868329155,0.0354499074923197,3.95361038252411e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,39919,0.0271517090501905,0.00391115785995303,0.0194858396446826,0.0348175784556985,4.07401344119015e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0347989428782975,0.00501474102540857,0.0249700504684967,0.0446278352880983,4.16040861699819e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,42137,0.0700634269836703,0.0101072866001292,0.0502531452474171,0.0898737087199235,4.33811882520495e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,0.0304728412063665,0.00439508529661489,0.0218584740250014,0.0390872083877317,4.33818284917711e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,39930,0.024366867926416,0.00351699925138519,0.0174735493937011,0.031260186459131,4.48980231266498e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42249,-0.0166425769191931,0.00240283380370526,-0.0213521311744554,-0.0119330226639308,4.51555114922085e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,41883,0.0694904663839179,0.0100403089427057,0.0498114608562147,0.0891694719116211,4.68555742946132e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42310,0.0215453054276843,0.00311357194749803,0.0154427044105881,0.0276479064447804,4.72350968954589e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0559685983722327,0.00810468012530608,0.0400834253266327,0.0718537714178326,5.26968054287498e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0191741565074493,0.00277738254219022,0.0137304867247565,0.0246178262901421,5.33689621588405e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,0.05278364936224,0.00764965123947831,0.0377903329328625,0.0677769657916175,5.42607909744725e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,39736,0.0356694075216089,0.00517381093678399,0.0255287380855123,0.0458100769577055,5.70897452717816e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,42145,-0.0395833964534968,0.00575275642044956,-0.050858799037578,-0.0283079938694157,6.21456257027464e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLG,Plasminogen,39742,0.0169971252121671,0.00247494127748914,0.0121462403082884,0.0218480101160458,6.87242019433094e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,39958,0.021190752326277,0.00308676426631954,0.0151406943642907,0.0272408102882633,6.99383126055342e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,39930,0.0484842073210325,0.00709612688290661,0.0345757986305355,0.0623926160115295,8.77320248214672e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,39713,0.0224837751494674,0.00329185733691434,0.0160317347691153,0.0289358155298195,8.92746946381755e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,0.0393042129114197,0.0057588552793362,0.0280168565639208,0.0505915692589187,9.25584775410029e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41843,0.0552602865808143,0.00810218444362213,0.0393800050713149,0.0711405680903136,9.4716234647125e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,39657,0.0232178851726686,0.00340531182911989,0.0165434739875937,0.0298922963577436,9.70347428067795e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0417235035200968,0.00613107079863415,0.0297066047547739,0.0537404022854197,1.05963791806462e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,39934,0.0449009820195753,0.00664608125017074,0.0318746627692407,0.05792730126991,1.48793012667433e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,42205,0.0508003750698508,0.0075380142414452,0.0360258671566182,0.0655748829830834,1.65644182868603e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.0290770511442731,0.00431459334751239,0.0206204481831488,0.0375336541053974,1.65667686994749e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,39897,0.0709293171185326,0.0105473031744274,0.050256602896655,0.0916020313404103,1.84219565500245e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,0.0360224885438557,0.00536063880567967,0.0255156364847236,0.0465293406029879,1.90685435105529e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0336831839385803,0.0050151692234652,0.0238534522605886,0.0435129156165721,1.95664610706027e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,42115,0.0669422841276335,0.0099793104720735,0.0473828356023695,0.0865017326528976,2.05010482441866e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.0257471166432826,0.00384027429767182,0.0182201790198459,0.0332740542667194,2.11944224258192e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.0284367963185785,0.00424520906878352,0.0201161865437628,0.0367574060933942,2.20698645148913e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,39475,0.0301217005581454,0.00450935462873736,0.0212833654858202,0.0389600356304706,2.50908121508292e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,0.0576465478954235,0.00863965679534258,0.0407128205765521,0.074580275214295,2.61589422255658e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,41751,0.081549491835901,0.0122563810688835,0.0575269849408893,0.105571998730913,2.97264393788037e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,39930,0.0875764362687092,0.0131685686165452,0.0617660417802806,0.113386830757138,3.05715571820528e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39757,0.0394352953234038,0.00593225627629749,0.0278080730218607,0.0510625176249469,3.11799597322493e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,39919,0.064565082365655,0.0097139657195334,0.0455257095553695,0.0836044551759404,3.13670028248466e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,42187,0.0204997978671972,0.0030855146748517,0.0144521891044879,0.0265474066299066,3.17162230612783e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0331434977281593,0.00498956360436104,0.0233639530636117,0.042923042392707,3.22401549023136e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,39929,0.0679939812355422,0.0102483531908072,0.0479072089815602,0.0880807534895243,3.40155380783131e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42016,0.0457500720849196,0.00692562295814377,0.0321758510869578,0.0593242930828814,4.09969469233839e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0639738812931526,0.00968793170687275,0.044985535147682,0.0829622274386232,4.20083192223456e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39575,0.0441961664847127,0.00669354281120259,0.0310768225747556,0.0573155103946698,4.22077550715328e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0425304145934304,0.00644506630769813,0.0298980846303421,0.0551627445565188,4.29950654733201e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POSTN,Periostin,39966,-0.0283492562466323,0.00429595862559643,-0.0367693351528013,-0.0199291773404633,4.32190789646714e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0419928141081506,0.00637373463491165,0.0295002942237238,0.0544853339925774,4.6489473659269e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,41751,0.0560692673464186,0.0085132428324034,0.039383311394908,0.0727552232979293,4.68625828164565e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.0436226539495315,0.00664964931149245,0.0305893412990063,0.0566559666000567,5.57121172187503e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,0.0272111235576509,0.00415096402880716,0.0190752340611889,0.0353470130541129,5.7516703018414e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.0804576805940944,0.0122763217800313,0.056396089905233,0.104519271282956,5.8491794217616e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,42070,0.0222386778998343,0.00340359738593888,0.015567627023394,0.0289097287762745,6.63938974319884e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,42262,-0.0122938641209888,0.00188308169932869,-0.015984704251673,-0.00860302399030459,6.87380935859106e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42236,-0.0186185181095459,0.00285221046529094,-0.0242088506215162,-0.0130281855975757,6.91267075263275e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,39657,0.0472149144111083,0.00724894725826682,0.0330069777849053,0.0614228510373112,7.66837575607597e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,42137,0.0284697644994614,0.00437684568584215,0.0198911469552108,0.0370483820437121,8.06213589400285e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,41839,0.0285760987915419,0.00440222304656313,0.0199477416202781,0.0372044559628056,8.81395439236436e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,-0.0686240036564671,0.0105843368718879,-0.0893693039253674,-0.0478787033875669,9.27040243929685e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,0.0337256132570675,0.00521161957223905,0.023510838895479,0.0439403876186561,1.00549938144626e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41839,0.0258764110473344,0.0040056314979834,0.0180253733112869,0.0337274487833818,1.08359109210971e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.0355484830408076,0.00550552882694464,0.0247576465399961,0.0463393195416191,1.10527028206818e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41839,0.0314985315992134,0.00488342131343712,0.0219270258248767,0.0410700373735502,1.15665526990727e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,39958,0.0260110548161472,0.00403760786558867,0.0180973433995934,0.033924766232701,1.22518139126272e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,0.035314244514803,0.00548685143102739,0.0245600157099894,0.0460684733196167,1.26669385628918e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.026690775793292,0.00415084451302505,0.0185551205477629,0.0348264310388211,1.32559180266346e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREH,Trehalase,39966,0.0549223976803157,0.00854840708614344,0.0381675197914746,0.0716772755691569,1.37257044013222e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,0.0864233437526642,0.0134604820555331,0.0600407989238192,0.112805888581509,1.4033810763027e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,0.0563601834588249,0.00877853092063922,0.039154262854372,0.0735661040632778,1.41654779587945e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0227033231527935,0.00353865361399403,-0.0296390842362218,-0.0157675620693652,1.45381838249468e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0632963139256279,0.00988895021826356,0.0439139714978313,0.0826786563534244,1.60763255188256e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,39575,0.043600524974873,0.00681771978522863,0.0302377941958249,0.0569632557539211,1.66880591492434e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,0.0401051073995453,0.00627138183875819,0.0278131989955792,0.0523970158035113,1.67139257435892e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.0266280467002473,0.00416842350031483,0.0184579366396302,0.0347981567608643,1.73458402920179e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,42119,0.0368007346918331,0.00576248293871521,0.0255062681319513,0.0480952012517149,1.75548661620607e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,0.0420830050244866,0.006592464017695,0.0291617755498044,0.0550042344991688,1.79853163075937e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39736,0.0211929168098347,0.00332125582036615,0.014683255401917,0.0277025782177523,1.8292634014891e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.0263424649011149,0.00413080379403981,0.0182460894647969,0.034438840337433,1.87534690633833e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,0.0184950320669193,0.00290275140635576,0.012805639310462,0.0241844248233766,1.94360247872051e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0374174537946131,0.00587930910285879,0.0258940079530098,0.0489408996362163,2.02698862197403e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0479364092115415,0.00754404904078939,0.0331500730915943,0.0627227453314887,2.17506406293767e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,0.0206421051319931,0.00325275130054292,0.014266712582929,0.0270174976810572,2.28075875820438e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,39945,0.0525434738399382,0.0082926237320747,0.0362899313250717,0.0687970163548046,2.4446979419523e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.01587545484317,0.00250632648249778,-0.0207878547488656,-0.0109630549374743,2.46332321869326e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,0.0470245955081655,0.00742871697694079,0.0324643102333616,0.0615848807829695,2.52846181313e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,41668,0.0263444306619113,0.00416296774939236,0.0181850138731022,0.0345038474507203,2.56002320552265e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.0852654381036979,0.0135112617548442,0.0587833650642033,0.111747511143193,2.86424725106206e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.0280792145753777,0.00447317197796756,-0.0368466316521941,-0.0193117974985613,3.55145333410118e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,0.0291757446910379,0.00464892360250082,0.0200638544301363,0.0382876349519395,3.58362497371907e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42119,0.0487386454187716,0.00776693004228671,0.0335154625358897,0.0639618283016536,3.59957470946783e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,39638,0.0212111685888246,0.00338428495214254,0.0145779700826252,0.0278443670950239,3.80459387178749e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,39959,0.0102865112437299,0.00164151648569842,0.00706913893176101,0.0135038835556988,3.82700754899429e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39649,0.0420382668317453,0.00671543120504963,0.028876021669848,0.0552005119936425,3.99381652052849e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0336306614931129,0.0053747426356374,0.0230961659272636,0.0441651570589622,4.04110982797933e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,0.0224152331530542,0.00358760697644313,0.0153835234792256,0.0294469428268827,4.28360632487098e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,0.0303285819040252,0.00485757203573423,0.0208077407139861,0.0398494230940642,4.40492574248259e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,41797,0.0334816189340614,0.00536769880451577,0.0229609292772105,0.0440023085909123,4.57869291641728e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,42016,0.0258162405319726,0.00414155191454925,0.0176987987794561,0.0339336822844891,4.6987794097465e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0609028172867988,0.00978224540947363,0.0417296162842305,0.0800760182893671,4.93143677884718e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,42119,0.0476981484885438,0.00767680509562069,0.0326516105011272,0.0627446864759603,5.34119344215318e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.0264358234240082,0.00425507986346915,0.0180958668916087,0.0347757799564078,5.38875292269289e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,39757,0.0380889603963327,0.00613550068816966,0.0260633790475202,0.0501145417451453,5.55827243802269e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.0236354771210552,0.00381221284201024,0.0161635399507151,0.0311074142913952,5.84516770311973e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,42145,0.0803970795468543,0.0129786816598792,0.0549588634934912,0.105835295600218,6.01435034720482e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,39586,0.0747901418766611,0.0120819400286188,0.0511095394205682,0.098470744332754,6.22150204038444e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,0.0416017052347278,0.00673640396256982,0.028398353468091,0.0548050570013647,6.77524766615155e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0400639387040308,0.00649136688689338,0.0273408596057198,0.0527870178023418,6.94430740121876e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.0183452451245025,0.0029780760031081,0.0125082161584106,0.0241822740905943,7.51650094224578e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,39930,0.0718011086403292,0.0116591111151398,0.0489492508546552,0.0946529664260033,7.59881109311587e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',39575,0.0301071427595528,0.00488908616927638,0.0205245338677711,0.0396897516513345,7.62319433451136e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.0231300199479802,0.00375990507698007,0.0157606059970992,0.0304994338988611,7.87811309252806e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,0.0172522263085018,0.00280804356942231,0.0117484609124341,0.0227559917045695,8.33158305429117e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,42262,-0.0417944339090845,0.00680399758043845,-0.0551302691667439,-0.0284585986514252,8.34186905474026e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAST,Gastrin,39929,0.0914097746597351,0.0148966080347691,0.0622124229115876,0.120607126407883,8.72975221395059e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,0.0557671630278576,0.0090915825067794,0.03794766131457,0.0735866647411452,8.81319210948819e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.0559191476175811,0.00912421054495721,0.0380356949494649,0.0738026002856972,9.10882956573574e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0255961228329656,0.00418077996440885,0.0174017941027242,0.0337904515632069,9.53221354927029e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,0.0437680438583919,0.00715655314321821,0.0297411996976842,0.0577948880190996,9.93448635494974e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,0.0201161063355765,0.00329624929985553,0.0136554577078596,0.0265767549632933,1.07193616564033e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIT,Vitrin,39958,0.0265969930940777,0.00436425164752577,0.0180430598649271,0.0351509263232282,1.13492078475324e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,39934,0.0317104143266774,0.00520371513834848,0.0215111326555144,0.0419096959978405,1.13841098634987e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0488120288056253,0.00801890928194453,0.033094966613014,0.0645290909982365,1.18740970107661e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0236856409997741,0.00389182419916025,0.01605766556942,0.0313136164301282,1.19500184945244e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,-0.0161483080656688,0.00265765608317243,-0.0213573139886867,-0.0109393021426508,1.26365266258828e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.0672580868351546,0.0110758823457898,0.0455493574374065,0.0889668162329027,1.29395415188438e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0190583393176701,0.00314607940628536,0.0128920236813508,0.0252246549539894,1.42488204579085e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,0.0185592822362904,0.00306483077196581,0.0125522139232374,0.0245663505493434,1.43582202588792e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0275609083704745,0.00456548643084964,0.0186125549660093,0.0365092617749398,1.62288079150459e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,41984,0.0240580074896088,0.00398820567395216,0.0162411243686626,0.031874890610555,1.6591700967274e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,39930,0.0600588028628982,0.00996174062455988,0.0405337912387609,0.0795838144870356,1.70172319604789e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,39518,0.0300611830309982,0.00500472479602672,0.0202519224307858,0.0398704436312105,1.95539164161607e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,42145,0.0290992677040094,0.00485066082307836,0.0195919724907758,0.038606562917243,2.03558145454677e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,39946,0.0324447540486342,0.00540897804102403,0.0218431570882271,0.0430463510090413,2.05453380580245e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0387387011729687,0.006458835415122,0.0260793837593296,0.0513980185866078,2.06341266828299e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,0.0260004389813748,0.00434134182469569,0.0174914090049713,0.0345094689577784,2.16563677040316e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.0187253555677817,0.00312823631907998,0.0125940123823849,0.0248566987531785,2.20601178264521e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,42145,0.0239401594100546,0.0040012662575222,0.0160976775453111,0.0317826412747981,2.24390446241152e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0458475110194929,0.00766434072348779,0.0308254032014568,0.0608696188375289,2.26032733191551e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEO1,Neogenin,39934,0.0153637768330806,0.00257007239692658,0.0103264349351045,0.0204011187310567,2.32759855199754e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,39657,0.0181506437559118,0.00303859267687524,0.0121950021092363,0.0241062854025873,2.39552913494234e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.0275825465725065,0.0046355758835412,0.0184968178407658,0.0366682753042473,2.74484009398101e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0237127022411492,0.00398770966350835,0.0158967913006728,0.0315286131816255,2.80698569462068e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.0744057144990566,0.0125246549927382,-0.0989540382848234,-0.0498573907132898,2.90699455955549e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,42148,0.0634495065702196,0.0106818731565585,0.0425130351833651,0.0843859779570742,2.92145494814106e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,41843,0.0365506527389353,0.00615672040879022,0.0244834807377065,0.0486178247401641,2.98080208451775e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,0.0267620494056576,0.00452219150295174,0.0178985540598721,0.035625544751443,3.35578047659811e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,39649,0.0332915104757479,0.00562952580254744,0.0222576399027549,0.0443253810487408,3.44342299912727e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,0.0117504770582009,0.00198746166062194,0.00785505220338192,0.0156459019130199,3.4547656706541e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,39908,0.0410473597741128,0.00695359204268082,0.0274183193704584,0.0546764001777672,3.67102020060442e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39736,0.0500669550576704,0.00851819161492765,0.0333712994924122,0.0667626106229286,4.28061007326148e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0384181376631361,0.00654201191886121,0.0255957943021682,0.0512404810241041,4.39496127003601e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.0185006296972181,0.00315097924683248,0.0123247103734264,0.0246765490210098,4.42513762427627e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,42200,0.0248395438548415,0.00423827394438803,0.0165325269238409,0.033146560785842,4.71400410634825e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,41814,0.0609706235779181,0.0104078163518219,0.0405713035283471,0.0813699436274891,4.79172606910615e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42123,0.0293707396018997,0.00501857732578742,0.0195343280433564,0.039207151160443,4.95743085838096e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,42262,0.0266445874689622,0.00455639606731357,0.0177140511770276,0.0355751237608968,5.09706667304638e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,39930,0.0384386968215597,0.00657993686414721,0.0255420205678312,0.0513353730752883,5.30590222626962e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,0.0339533166403868,0.00581286944239264,0.0225600925332972,0.0453465407474763,5.30718746754284e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.0137258413496894,0.00235214975323181,0.009115627833355,0.0183360548660237,5.48805772903411e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,39638,0.0154133399335505,0.00264131389326741,0.0102363647027464,0.0205903151643546,5.51434688665436e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0476795454809661,0.00817388464960362,0.031658731567743,0.0637003593941892,5.56441179361589e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,0.0435509221579514,0.00746703631514681,0.0289155309802636,0.0581863133356391,5.58767824716088e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,39822,0.0208261307218168,0.00357041145326011,0.013828124273427,0.0278241371702066,5.59499089425798e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.0335198183476061,0.00577651634295854,0.0221978463154074,0.0448417903798048,6.70311201634247e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,0.0310363128969821,0.00535243937625332,0.0205455317195256,0.0415270940744386,6.8396552458308e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,0.0158738363590507,0.00273819012782576,0.0105069837085122,0.0212406890095892,6.89420481029977e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,41839,0.0329224250778398,0.00567912081138255,0.02179134828753,0.0440535018681495,6.90102108203033e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,39649,0.043181201467037,0.00745304027724814,0.0285732425236306,0.0577891604104433,7.07031601961141e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,39819,0.0397011809187023,0.00685519109336667,0.0262650063757036,0.0531373554617009,7.16743909112204e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,41839,0.0321523610814802,0.00556290948671911,0.0212490584875107,0.0430556636754497,7.64863859982236e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.0323786059821724,0.00560604964810296,0.0213907486718906,0.0433664632924542,7.86696203510048e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,0.0203691148646646,0.00352718103897636,0.013455840028271,0.0272823897010583,7.86761354514127e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.0200579108141704,0.00348499250546307,0.0132273255034628,0.0268884961248781,8.8621144294152e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0388637339959805,0.00675799365870361,0.0256180664249214,0.0521094015670395,9.11237244177293e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,42070,0.0181117079898237,0.00315180562871228,0.0119341689575477,0.0242892470220998,9.31067205190473e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,42119,0.0473713420800224,0.00825419310762725,0.031193123589073,0.0635495605709718,9.72440626543496e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0477797428108949,0.00833376224898024,0.0314455688028936,0.0641139168188962,1.00611630713269e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLPS,Colipase,42115,0.0479062733111963,0.00835925351116719,0.0315221364293087,0.064290410193084,1.02015117726887e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,0.0457814567520565,0.0079953954761476,0.0301104816188072,0.0614524318853058,1.05539238651972e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,41843,0.03991638043639,0.00698645824547226,0.0262229222752643,0.0536098385975156,1.1312961786981e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0246044594589912,0.00430945759944709,0.0161579225640749,0.0330509963539075,1.15802400590744e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TF,Serotransferrin,39979,0.0138806001379165,0.00243168498038801,0.00911449757635596,0.018646702699477,1.17015947187334e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0306007457881446,0.00536383955803969,0.0200876202543869,0.0411138713219024,1.19327599892306e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41913,0.0182783158387352,0.0032111948709816,0.0119843738916113,0.0245722577858592,1.2816370913742e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,0.0361623296320897,0.00635322069965794,0.0237100170607602,0.0486146422034193,1.287794099975e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.0489708921914814,0.00861404161646483,0.0320873706232103,0.0658544137597524,1.33501853107997e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39757,0.0304643156743983,0.00537056028823827,0.0199380175094513,0.0409906138393453,1.44259484898965e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,39919,0.0169769769161236,0.00302051459579116,0.011056768308373,0.0228971855238743,1.94843908209773e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,42145,0.0427497923818435,0.00761646362213115,0.0278215236824665,0.0576780610812205,2.02969712023139e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,-0.033253146155276,0.00594594754208427,-0.0449072033377612,-0.0215990889727909,2.28066727470739e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42119,0.0356622850067804,0.00638090186616634,0.0231557173490944,0.0481688526644664,2.32918523651427e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.057918933791287,0.0103666050212577,0.0376003879496219,0.0782374796329522,2.35394730819994e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0365081487010059,0.00653418299587742,0.0237011500290862,0.0493151473729257,2.36154990476278e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39736,0.0531189076982288,0.00950807689791933,0.0344830769783069,0.0717547384181507,2.36839952204689e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42125,0.0378654237885838,0.00678088097738986,0.0245748970728997,0.0511559505042679,2.39377092053978e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,42077,0.014550859379663,0.00260764902636349,0.00943986728799059,0.0196618514713355,2.45059632839621e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,0.0235496315436317,0.00422937333185225,0.0152600598132013,0.0318392032740621,2.63468658181613e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0395283805750512,0.00710998334580855,0.0255928132172664,0.053463947932836,2.76735309519274e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,39929,0.0309342088907672,0.00556485807374716,0.0200270870662228,0.0418413307153117,2.77703887810527e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,0.063137882618764,0.0113698575289339,0.0408529618620535,0.0854228033754745,2.86104349247987e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,0.0496267821347909,0.00895526051495505,0.032074471525479,0.0671790927441028,3.06538539191975e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.0200145582537039,0.00361736296558685,0.0129245268411537,0.0271045896662542,3.22172262453315e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIM,Vimentin,41900,0.0719487200958757,0.0130262195993944,0.0464173296810626,0.0974801105106888,3.38788161538453e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.031892978998658,0.00577493380651095,0.0205741087378966,0.0432118492594195,3.40176314606806e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.0555908529497577,0.0100884794451608,0.0358174332372426,0.0753642726622728,3.64822933448744e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,39934,0.0183480766993412,0.00333100048730252,0.0118193157442282,0.0248768376544541,3.70268884813942e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39657,0.0353959375392802,0.00643014567283422,0.0227928520205251,0.0479990230580353,3.78079193380442e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,42016,0.0162879239178565,0.0029603499644211,0.0104856379875912,0.0220902098481219,3.82332313364621e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,41913,0.0377679044229371,0.00686849841665958,0.0243056475262843,0.0512301613195899,3.89622668369776e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.0226567831080737,0.00412239581105078,0.0145768873184142,0.0307366788977332,3.97067641154137e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,0.0346144637814514,0.00631654552172698,0.0222340345588665,0.0469948930040363,4.34739331198429e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRTN,Neurturin,41913,0.0307061588352691,0.00561209748211456,0.0197064477703246,0.0417058699002137,4.54505274096454e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALB1,Calbindin,42070,0.027958226976047,0.00512218879239656,0.0179187369429497,0.0379977170091442,4.89337016447987e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,39979,0.0203990578543998,0.00373855287411005,0.0130714942211441,0.0277266214876555,4.96048641026699e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.0148041283962675,0.00271395988381618,0.00948476702398775,0.0201234897685472,4.98948006292978e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,0.0330434559781486,0.00607750527791953,0.0211315456334263,0.0449553663228709,5.53062251441018e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.027546691352408,0.00507221489535318,-0.0374882325473002,-0.0176051501575157,5.70385646405101e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,39919,0.0321671989263418,0.00593107980993063,0.0205422824988778,0.0437921153538058,5.96458241735595e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,0.0190504602047031,0.00351631303572694,0.0121584866546783,0.0259424337547279,6.16237037788163e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,41865,0.0457420152544252,0.00846523303472155,0.029150158506371,0.0623338720024794,6.64763442540664e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.041323266589493,0.00764836000001599,0.0263324809894617,0.0563140521895244,6.69473180478751e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,39919,0.0325472665608312,0.00603099025214437,0.0207265256666282,0.0443680074550342,6.9258286649443e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,39657,0.0751816983497393,0.0139609379771438,0.0478182599145375,0.102545136784941,7.38681042853556e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,42137,-0.0302821993222204,0.00563304268106327,-0.0413229629771045,-0.0192414356673364,7.75015068805876e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42310,0.0154354883056611,0.00287177522692224,0.00980680886089354,0.0210641677504287,7.78818817733532e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39575,0.022289449440851,0.00415834552641576,0.0141390922090761,0.0304398066726258,8.48272537909066e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.0191548158804023,0.00357461591525914,0.0121485686864943,0.0261610630743102,8.55286052825887e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,41846,0.0341308067216351,0.0063737371281843,0.0216382819503939,0.0466233314928764,8.70272514051984e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,0.0414910275497126,0.00776177228749045,0.0262779538662314,0.0567041012331939,9.1590820657427e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,42048,0.0351514915975866,0.00657704660525797,0.022260480251281,0.0480425029438923,9.21110775626695e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0272300420355631,0.00509492267985677,0.0172439935830438,0.0372160904880823,9.24048950668874e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0462317689770237,0.00865294740202983,0.0292719920690453,0.0631915458850022,9.33078159183957e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42137,0.0172519374754359,0.00323756352358374,0.0109063129692118,0.02359756198166,1.00515355854286e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,41756,0.0442407586078574,0.0083181141158557,0.0279372549407802,0.0605442622749345,1.06278545036628e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,0.0123033641320606,0.00231767515404521,0.00776072083013202,0.0168460074339892,1.12675355348516e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.0132576721293679,0.0024985875661568,0.00836044049970057,0.0181549037590352,1.14122010014361e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,41864,0.0298157933959573,0.00563266564133443,0.0187757687389419,0.0408558180529728,1.21995920653934e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0587595153662842,0.0111020452676707,0.0369995066416496,0.0805195240909187,1.2286473642367e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,0.0323225496871423,0.00610782385803501,0.0203512149253937,0.0442938844488909,1.2292613421891e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,39929,0.0240959114077735,0.00456080753975419,0.0151567286298553,0.0330350941856918,1.29262132497052e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,0.0171301167528155,0.00324962533846748,0.0107608510894192,0.0234993824162117,1.37450740943653e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,0.0142283579519796,0.00270533219820799,0.00892590684349195,0.0195308090604673,1.46746060824007e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,42015,0.0301242433850795,0.00573283736910461,0.0188878821416344,0.0413606046285245,1.50551010224644e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.029962089354164,0.0057063943196972,0.0187775564875575,0.0411466222207705,1.53936937058835e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0334931651864296,0.0063789700259225,0.0209903839356215,0.0459959464372377,1.53973365571431e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,42070,0.011344512935251,0.00216461479787257,0.00710186793142071,0.0155871579390812,1.62215041477922e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0234262316515746,0.0044756408923601,0.0146539755025488,0.0321984878006004,1.6877445199201e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,41839,0.0391974711621447,0.00749094453769784,0.0245152198682569,0.0538797224560325,1.6965117964793e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.030826972504516,0.00590209620538707,0.0192588639419573,0.0423950810670746,1.79222782279945e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,0.0283465939444939,0.0054364243986987,0.0176912021230444,0.0390019857659433,1.87379324498256e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,0.0241105902681682,0.00462514447296101,0.0150453071011646,0.0331758734351718,1.8914538017854e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42145,0.0201421932489173,0.00386731099876637,0.0125622636913352,0.0277221228064993,1.93350899698076e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.0665162302575486,0.0127761550155327,-0.0915574940879927,-0.0414749664271046,1.95511351688452e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,0.0212713969331228,0.00409026317860711,0.0132544811030529,0.0292883127631927,2.01704267610279e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,0.0242053622786653,0.00466788264222569,0.015056312299903,0.0333544122574277,2.19202002842516e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,0.0127645852580524,0.00246211989641009,0.00793883026108861,0.0175903402550161,2.19869107255985e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42137,0.0260692345389329,0.00503047914118393,0.0162094954222124,0.0359289736556534,2.223697754162e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,39575,0.0371308086049989,0.00717127579808955,0.0230751080407433,0.0511865091692544,2.28598593406312e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.0238437535685103,0.00461815754678456,0.0147921647768126,0.0328953423602081,2.47083235712201e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39657,0.0198363273367279,0.00384582787626632,0.012298504699246,0.0273741499742099,2.54081734370369e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,39736,0.0200855161344573,0.00389641836342891,0.0124485361421366,0.027722496126778,2.58163799065582e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,0.0307388608176673,0.00596613510895935,0.019045236004107,0.0424324856312276,2.61821135404245e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.0184268251923938,0.00357655835804491,0.0114167708106257,0.0254368795741618,2.62017337433759e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,42070,0.111255786396386,0.0216123625474743,0.0688955558033366,0.153616016989436,2.67292953568356e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,0.0306430913530565,0.00595624131248738,0.0189688583805813,0.0423173243255318,2.71774240638357e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,41814,0.0212519370838744,0.00414550157391507,0.0131267539990009,0.029377120168748,2.9933942461949e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,41900,0.0354029961901432,0.00690808388908081,0.0218631517675448,0.0489428406127415,3.01925362686423e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,0.0265063470100866,0.00517667773650248,0.0163600586465418,0.0366526353736315,3.10008498915948e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,39929,0.0222034216040377,0.00434226400274689,0.0136925841586538,0.0307142590494216,3.21700395239978e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,0.0372853165956482,0.00732532764956768,0.0229276744024955,0.0516429587888008,3.64107093307142e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0134164382062633,0.00264342077800741,0.00823533348136882,0.0185975429311579,3.91729226021607e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,0.0250699008780194,0.00494801145196361,0.0153717984321707,0.0347680033238681,4.10281744497618e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,39934,0.014691138178798,0.00290214400221576,0.00900293593445508,0.0203793404231408,4.21023938159155e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39736,-0.0185169233817095,0.00366123207467356,-0.0256929382480697,-0.0113409085153493,4.31402125424407e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0299204653227879,0.00591698396603879,0.0183231767493519,0.041517753896224,4.33230157401311e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,41913,0.0276262243444118,0.00546868501843809,0.0169076017082731,0.0383448469805504,4.43665765621858e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.0402285389682121,0.00796621499915029,0.0246147575698776,0.0558423203665467,4.48929810455335e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.022472588610622,0.00445889691719257,0.0137331506529246,0.0312120265683195,4.72855008743024e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,42249,0.0213805759644511,0.0042475742475289,0.0130553304392945,0.0297058214896078,4.87493203528283e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,39649,0.0158293786277881,0.00314868897913123,0.00965794822869091,0.0220008090268853,5.05253799704822e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0364844240411792,0.00726862026135564,0.0222379283289222,0.0507309197534362,5.2609008268832e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.0171618534149941,0.00342129597003214,0.0104561133137311,0.023867593516257,5.33815711428648e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,0.0235971488245901,0.00470523214898873,0.0143748938125722,0.032819403836608,5.36744714047315e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,39649,0.0401060107933174,0.00800322115827736,0.0244196973230938,0.055792324263541,5.49196325098979e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.0369727440894355,0.00737857458761582,0.0225107378977085,0.0514347502811625,5.50361909826821e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,42262,-0.0208383074248138,0.00416114820657401,-0.0289941579096989,-0.0126824569399287,5.57348970655858e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0369785501765855,0.00742176017860429,0.0224319002265211,0.0515252001266499,6.37120190145675e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.0184474794093965,0.00370857420633445,0.011178673964981,0.025716284853812,6.62950843216443e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,39929,0.0389919163468469,0.00784573066061853,0.0236142842520345,0.0543695484416592,6.7992785109253e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.0128487095146738,0.00258747487957794,0.00777725875070102,0.0179201602786466,6.926546470061e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,39757,-0.0188886479472614,0.00382078158582504,-0.0263773798554785,-0.0113999160390443,7.77843487130945e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,39979,0.0144835100472992,0.00293101721046686,0.00873871631478416,0.0202283037798142,7.86428363189222e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,41913,0.0452380817472781,0.00919926569594015,0.0272075209832354,0.0632686425113208,8.86683040764108e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,39560,0.0420340341384094,0.0085475935027743,0.0252807508729718,0.058787317403847,8.88623053016121e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.019379530347098,0.00394121642580931,0.0116547461525118,0.0271043145416843,8.904882487429e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,39966,0.024106514872227,0.00491119868659819,0.0144805654464946,0.0337324642979595,9.30602227455652e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,39934,0.0151953015320249,0.00310162436697396,0.00911611777275593,0.0212744852912939,9.75862553401782e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,42208,0.0619487023540969,0.0126659784993726,0.0371233844953265,0.0867740202128672,1.0149602625493e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,39575,-0.0309574496512457,0.00633658848695889,-0.0433771630856851,-0.0185377362168063,1.04620162795197e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,41843,0.0173194269989518,0.00355463588872128,0.0103523406570581,0.0242865133408455,1.11555489874561e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.0267990105669466,0.00550089542749109,0.016017255529064,0.0375807656048291,1.12110053398684e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,39757,0.0160019110559221,0.00328833945079875,0.00955676573235653,0.0224470563794876,1.15286788726841e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0281605418277028,0.00581625513459669,0.0167606817638933,0.0395604018915123,1.30189424467745e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,42137,0.0154285926672706,0.00318878080398541,0.00917858229145924,0.021678603043082,1.32331808653744e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41820,0.0249700480994527,0.0051638358436909,0.0148489298458186,0.0350911663530869,1.34264973386926e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASN,Vasorin,41975,0.014948804501319,0.0031025519981543,0.0088678025849366,0.0210298064177015,1.46428075467066e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0208233973592502,0.00432389616123366,0.0123485608832323,0.0292982338352682,1.48490784548288e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,42210,0.0230671361096326,0.00479261370383731,0.0136736132501115,0.0324606589691538,1.50233236000534e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,42070,0.036227315169148,0.00753098562240382,0.0214665833492365,0.0509880469890595,1.52233301874622e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,39649,0.0172191399978422,0.00358480352248981,0.0101929250937622,0.0242453549019222,1.58066753225424e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0460628642673397,0.00964872593454385,0.0271513614356338,0.0649743670990456,1.82549301256873e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,0.0562548241232909,0.0117996035495169,0.0331276011662377,0.0793820470803441,1.88460305115394e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0342291033136064,0.0071803030392554,0.0201557093566658,0.048302497270547,1.89273833237315e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,39736,0.0187753446003981,0.00393864865719374,0.0110555932322984,0.0264950959684979,1.8940254949509e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,0.0321549380625259,0.00675911039328996,0.0189070816916776,0.0454027944333742,1.9828492706952e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39575,0.0671687070807362,0.0141276694644693,0.0394784749303764,0.094858939231096,2.01559304737663e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0211500206411698,0.00444916466580324,-0.0298703833861442,-0.0124296578961955,2.0177600708041e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,0.0209086671375033,0.00440441234285912,0.0122760189454994,0.0295413153295072,2.08767812939428e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,41913,0.016507790535667,0.00348057427009201,0.00968586496628669,0.0233297161050474,2.12934132193189e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.0403023090128808,0.00850281838569903,0.0236367849769107,0.0569678330488509,2.16444683256312e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,42137,0.0131624097891934,0.00278360698502376,0.00770654009854682,0.01861827947984,2.28415448644641e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,39657,0.0159194831684882,0.00336886231650385,0.00931651302814071,0.0225224533088358,2.32405103407642e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,39699,0.0238757208736216,0.00505828644854709,0.0139614794344693,0.0337899623127739,2.38586874206347e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,0.0147824007836811,0.00313769557120815,0.00863251746411317,0.0209322841032491,2.48665011556561e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.0324385166435033,0.00694350718437583,0.0188292425621267,0.0460477907248799,3.01483340442919e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,0.0184207320537547,0.00394712729182982,0.0106843625617683,0.0261571015457412,3.09326212755108e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,39638,0.0165242464730115,0.00354092373610426,0.00958403595024716,0.0234644569957758,3.09754342828499e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REN,Renin,42145,0.0428881841834861,0.0091953099615077,0.024865376658931,0.0609109917080412,3.12877766806881e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0191649959918581,0.00411302963146449,0.0111034579141877,0.0272265340695285,3.20580721147892e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,41839,0.0203286686475443,0.0043654130753271,0.0117724590199032,0.0288848782751854,3.24351939959767e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39657,0.0138115467927405,0.00296653360350606,0.00799714092986858,0.0196259526556123,3.26503141512573e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41814,0.0384648627148504,0.00829184341578334,0.0222128496199151,0.0547168758097858,3.53665098200736e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.0302464973683496,0.00652474671627678,0.0174579938044471,0.0430350009322521,3.59839265290292e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,0.0303650797754536,0.00655218071527471,0.0175228055735152,0.043207353977392,3.61396924812369e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,42196,0.0184135683985147,0.0039827261139973,0.01060742521508,0.0262197115819494,3.8105372950659e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,0.016839498770453,0.00364244434449999,0.00970030785523304,0.023978689685673,3.8148487458032e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,42230,0.0362068930676009,0.00784110250237995,0.0208383321629362,0.0515754539722656,3.91795527494702e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,42070,0.049541093474358,0.0107424615793537,0.0284858687788248,0.0705963181698912,4.03049914540624e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.02507965137066,0.00544505901512041,0.014407335701024,0.035751967040296,4.15213154466099e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.0313334578246009,0.00681701790136065,0.017972102737934,0.0446948129112678,4.33781556471923e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,39929,0.0513053563112644,0.0111663454677135,0.029419319194546,0.0731913934279829,4.38173141352153e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0131104353178389,0.00285650137923639,0.00751169261453562,0.0187091780211423,4.47908877134739e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39657,0.0224284377310917,0.00489246123215927,0.0128392137160596,0.0320176617461239,4.60537605507013e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,39900,0.0273613784770644,0.00598570492706848,0.0156293968200102,0.0390933601341186,4.9027098799499e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,0.0247909782752726,0.00542643835598062,0.0141551590975506,0.0354267974529946,4.95515150702251e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.0207749012007385,0.00455269633127172,0.0118516163914459,0.029698186010031,5.08306545149289e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,0.0230329923130989,0.00504922576833903,0.0131365098071544,0.0329294748190434,5.11886922753598e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.026757712006882,0.00587155995182074,0.0152494545013134,0.0382659695124506,5.23975503365502e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,0.0244567804839106,0.00538308266226879,0.0139059384658638,0.0350076225019575,5.59768601821956e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.0161735951502802,0.00356049321711745,0.00919502844472997,0.0231521618558304,5.60753651311501e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,42262,0.0191562319479015,0.00423357984942839,0.0108584154430218,0.0274540484527811,6.0953669098637e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,0.123770585619224,0.0274804935861347,0.0699088181903995,0.177632353048048,6.73709306519874e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,38503,0.0546262424530344,0.0121363462768958,0.0308390037503186,0.0784134811557503,6.8392094936463e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,39979,0.0168620894582935,0.00376718585220453,0.00947840518797265,0.0242457737286144,7.67778926205189e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,39649,0.0251588169579244,0.00562192761617776,0.014139838830216,0.0361777950856328,7.71312742253268e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,0.0246130411887437,0.005501618337022,0.0138298692481806,0.0353962131293069,7.7475234073508e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,0.0205242031315982,0.00460195224149638,0.0115043767382653,0.0295440295249311,8.26651655018316e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,39919,0.0226977951766377,0.00510790312920241,0.012686305043401,0.0327092853098744,8.92809102901789e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,0.0485912112800129,0.0109429418914145,0.0271430451728405,0.0700393773871852,9.06578028344203e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0427455216978075,0.00963762024452878,0.0238557860185311,0.061635257377084,9.28203412750822e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,39657,0.0228409862220289,0.00516355725539531,0.0127204140014541,0.0329615584426037,9.80438955665137e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.0213905073582459,0.00483722187894832,-0.0308714622409846,-0.0119095524755072,9.85280012828435e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,0.0170863660340375,0.00386717570131483,0.00950670165946041,0.0246660304086145,1.00264080307622e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,39990,0.0114444517993608,0.00259161147476979,0.00636489330881202,0.0165240102899096,1.01489947012068e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,39575,-0.0324372603049625,0.00734620764906873,-0.0468358272971372,-0.0180386933127878,1.01735607018755e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0585417699575506,0.0133212394934119,0.0324321405504633,0.0846513993646379,1.1182280848827e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARTN,Artemin,41913,0.0224982657770159,0.00512151744431363,0.0124600915861612,0.0325364399678706,1.12717723445178e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,39919,0.0180584962701307,0.00411697800144617,0.00998921938729623,0.0261277731529652,1.1631207166459e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,0.0344856557542332,0.00786983170622541,0.0190607856100314,0.049910525898435,1.18649351759333e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.0193865157658081,0.00442823349232998,0.0107071781208414,0.0280658534107749,1.20727997592191e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.0220218296563407,0.00503540982490476,0.0121524263995273,0.031891232913154,1.23449355974049e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,41839,0.0273519619503599,0.00626280508222815,0.0150768639891927,0.0396270599115271,1.26709492672583e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.021071074268211,0.00482826301204603,0.0116076787646008,0.0305344697718212,1.28602707051836e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0230201776812838,0.00528255234933769,-0.0333739802859857,-0.012666375076582,1.32351237745276e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,0.021666814580101,0.00497159371691303,0.0119224908949514,0.0314111382652505,1.32376400156685e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.0277625885557776,0.0063751293316738,0.015267335065697,0.0402578420458582,1.3434192087385e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,39657,0.0127643975292219,0.002932173706033,0.00701733706539721,0.0185114579930466,1.35358523903138e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42137,0.0206120356226413,0.00473574944040618,0.0113299667194452,0.0298941045258374,1.35622031594449e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,0.0516820710814213,0.0118898193355539,0.0283780251837356,0.0749861169791071,1.39404857536561e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,42083,0.0173466307367915,0.00399168393311547,0.00952293022788515,0.0251703312456978,1.39853307780944e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,0.0141858028003938,0.00327299543319923,0.0077707317513233,0.0206008738494643,1.47359401252243e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.0122954080837224,0.00284806470411726,0.00671320126365255,0.0178776149037922,1.59195174972157e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,0.0217547455742269,0.00504890009773089,0.0118589013826743,0.0316505897657795,1.65565736476348e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.0138214439370699,0.00323164488930844,0.00748741995402532,0.0201554679201144,1.91057103865056e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,39649,0.0195341938950179,0.00457653449560178,0.0105641862836384,0.0285042015063974,1.98578575099153e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0187090052991213,0.00440760378661703,0.0100701018773519,0.0273479087208906,2.20665026898515e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.0136206056270172,0.00320916518420721,0.00733064186597107,0.0199105693880633,2.20753384169528e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0228606472898521,0.00538704504699257,-0.0334192555819575,-0.0123020389977466,2.21394143978652e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42143,0.0299221993001422,0.00705548358992401,0.0160934514638911,0.0437509471363932,2.24018615817876e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,0.0159246914528714,0.00375618842230414,0.00856256214515528,0.0232868207605875,2.2573712328118e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,41913,-0.0131204497754309,0.0030996824171649,-0.0191958273130741,-0.00704507223778767,2.32309184955428e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,42262,0.0141742516588704,0.00335126454851382,0.00760577314378329,0.0207427301739575,2.35712377585931e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,39990,0.0254638414362453,0.00602432165394592,0.0136561709945113,0.0372715118779793,2.38844497384785e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLU,Clusterin,39979,0.014426342959719,0.00341694453367018,0.00772913167372545,0.0211235542457126,2.44024875133145e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,41994,0.0130074229169794,0.00309873851294785,0.00693389543160159,0.0190809504023571,2.71438772745187e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,39586,0.0206092532631832,0.00491303686611294,0.0109797010056018,0.0302388055207646,2.75246063039343e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,41839,0.0389031107848807,0.00927972267062613,0.0207148543504535,0.0570913672193079,2.77970923467943e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,42119,0.0282865083663237,0.00676032734104541,0.0150362667778747,0.0415367499547727,2.8799001854131e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.0129848383094435,0.00312932286459824,0.00685136549483096,0.0191183111240561,3.35409415258322e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,39990,0.025114424754267,0.00607088400089465,0.0132154921125135,0.0370133573960205,3.54613012913141e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.0265374488827467,0.00642312213991138,0.0139481294885204,0.039126768276973,3.62915070329259e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0488096782589992,0.0118236125740943,0.0256353976137744,0.071983958904224,3.68375802836584e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.026088161164158,0.00634005796396159,0.0136616475547933,0.0385146747735227,3.90233444882746e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,0.0363360637330653,0.00885879484053101,0.0189728258456245,0.053699301620506,4.13003953476822e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,39657,0.0153755502185314,0.00375015898867729,0.00802523860072394,0.0227258618363389,4.16153844912365e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,0.0198071476872754,0.00483989792709518,0.0103209477501688,0.029293347624382,4.29852541214303e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,0.026198311226155,0.00643378709669429,0.0135880885166342,0.0388085339356758,4.6955774404884e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.015591791369105,0.00382996571772739,0.00808505856235935,0.0230985241758507,4.70788613243231e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,-0.021429282296008,0.00526511942578551,-0.0317489163705477,-0.0111096482214684,4.73330957036948e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,39638,-0.0363418753855462,0.00893453457782009,-0.0538535631580736,-0.0188301876130188,4.78354831565183e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,42070,0.00696803741129367,0.00171401154266318,0.00360857478767384,0.0103275000349135,4.82352912856032e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,42137,-0.0144981401760425,0.00358175841740434,-0.021518386674155,-0.00747789367792994,5.1995134949977e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,39347,0.0567804829972241,0.0140762389658911,0.0291910546240776,0.0843699113703706,5.52658575196577e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.014286613788692,0.00354918615003332,-0.0212430186427573,-0.00733020893462671,5.72804880931541e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,41839,0.0164695743634162,0.00410818118127391,0.00841753924811932,0.0245216094787131,6.13185800512107e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41843,0.0164250187832189,0.004097343794957,0.00839422494510316,0.0244558126213346,6.1388693092125e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.0162057757671346,0.00404762862163122,0.00827242366873738,0.0241391278655318,6.26794314170706e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39657,0.0184774053615682,0.00462504600601387,0.00941231518978101,0.0275424955333554,6.50929747073954e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0175926811053263,0.00440614004252885,0.00895664662196975,0.0262287155886828,6.56599375571419e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,42144,0.0150438555219958,0.0037694408715704,0.00765575141371784,0.0224319596302738,6.61406756280806e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,-0.0156588969657832,0.00392916047120995,-0.0233600514893547,-0.00795774244221173,6.774763625228e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,42287,0.026476999803525,0.00665723040948274,0.0134288282009388,0.0395251714061112,7.00963710500568e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSPN,Claspin,41820,0.0160419445689106,0.00403393505875158,0.0081354318537575,0.0239484572840637,7.02360777142464e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.0320497992334992,0.00807745472707618,0.0162179879684299,0.0478816104985685,7.29903382144054e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,42079,0.0128923555236424,0.00325413373067059,0.00651425341152802,0.0192704576357568,7.47574856281517e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,0.0144072391885761,0.00365283621920739,0.00724768019892964,0.0215667981782226,8.04956621192003e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,39575,0.034018571357174,0.00862532263029039,0.0171129390018048,0.0509242037125431,8.06203707141127e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,0.0199701683692516,0.00509164102662949,0.00999055195705777,0.0299497847814454,8.8288845188084e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,42103,0.0310006867511484,0.00791332299753219,0.0154905736759853,0.0465107998263115,8.99012456868709e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42181,0.035244591475626,0.0090035194057294,0.0175976934403964,0.0528914895108556,9.10209070196556e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.0223833375571334,0.00575708019813135,0.011099460368796,0.0336672147454709,0.000101678902031017
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.0358139431672804,0.00922850626269168,0.0177260708924047,0.0539018154421561,0.000104720466494477
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,41800,0.0211204778406691,0.00545421059869764,0.0104302250672218,0.0318107306141165,0.000108321784916446
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,0.0376672880428721,0.00974895033905578,0.0185593453783227,0.0567752307074214,0.000112202195305142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,42119,0.0193264532987501,0.0050068396016318,0.00951304767955178,0.0291398589179485,0.000113909620845224
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,41913,0.0223521347301899,0.00579596373730287,0.0109920458050763,0.0337122236553035,0.000115563563814152
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.0378235449530202,0.00981993010462695,0.0185764819479514,0.0570706079580891,0.000117956796724836
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,42310,0.0248511968211692,0.00646262710551853,0.0121844476943528,0.0375179459479855,0.000120914614124322
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,39638,-0.0187657687137122,0.00488345415678107,-0.0283373388610031,-0.00919419856642132,0.000122357903336519
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.0212990662180432,0.00555444866300909,0.0104123468385454,0.032185785597541,0.00012647408787769
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,42018,0.0208029124941619,0.00542713085968477,0.0101657360091797,0.031440088979144,0.000127099255600363
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.0102531756956443,0.00268492224802648,-0.0155156233017762,-0.0049907280895124,0.000134837495404953
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39575,0.0205932519389468,0.00540199413442898,0.010005343435466,0.0311811604424276,0.000138512452957993
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0303172060215304,0.00795634096247761,0.0147227777350743,0.0459116343079866,0.000139325139013586
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,0.0338103619505999,0.00888355312468748,0.0163985978262124,0.0512221260749873,0.000141896808935432
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.0101000434786574,0.00265491648085692,-0.015303679781137,-0.00489640717617788,0.000142841107285932
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,42262,0.0199819231941287,0.0052534070243776,0.00968524542634857,0.0302786009619088,0.000143222294684304
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,0.0223787620475019,0.00590261196071004,0.0108096426045102,0.0339478814904936,0.00015048511833315
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,39649,0.0261752953982501,0.00691933875798479,0.0126133914325999,0.0397371993639003,0.000155817952158869
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,41839,0.0194640241014211,0.00515619512739437,0.00935788165172813,0.0295701665511141,0.000160783038991435
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_A,,39934,0.0140489727365953,0.00373731958941574,0.00672382634134044,0.0213741191318501,0.000171379455367653
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,0.0223947077361684,0.00596195689811266,0.0107092722158675,0.0340801432564692,0.000173330924276554
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,39929,0.0163297385535879,0.00435145507823451,0.00780088660024826,0.0248585905069275,0.000175808236378197
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,39649,0.00956302887457995,0.00254850068294842,0.00456796753600104,0.0145580902131589,0.000176036470740617
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,39575,0.0277942976172148,0.0074303016680985,0.0132309063477417,0.0423576888866879,0.000184465764419185
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,0.042424880055795,0.0113501974097241,0.0201784931327358,0.0646712669788542,0.000186572722753858
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0315963121777589,0.00846925219269046,0.0149965778800856,0.0481960464754322,0.00019187396608433
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.017271179864919,0.00464783329972663,0.00816142659745479,0.0263809331323832,0.000203405401726679
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.0167476088360147,0.00451842624642654,0.00789149339301868,0.0256037242790107,0.000211134064239947
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,0.00997878050991112,0.00270642793628399,0.00467418175479449,0.0152833792650277,0.000227742157256859
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,0.0119423959232559,0.00324288651991717,0.00558633834421828,0.0182984535022936,0.000231898374587164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.0136342397146383,0.0037122490895813,0.00635823149905893,0.0209102479302176,0.000241075133821448
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.0258472750057576,0.00705757897274703,0.0120144202191735,0.0396801297923418,0.000251092942574134
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.0125120517229547,0.00342835305137802,0.00579247974225378,0.0192316237036556,0.000263678870583248
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.0191248919602312,0.00525126176791766,0.00883241889511262,0.0294173650253498,0.000271814715302316
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41839,0.0229546434834171,0.00630718033854242,0.0105925700198739,0.0353167169469602,0.000274265046757855
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39560,0.0150364453864718,0.00413926477864652,0.00692348642032456,0.0231494043526189,0.000281821029684166
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,42171,-0.015985952638879,0.00441710560691465,-0.0246434796284317,-0.00732842564932626,0.000296702809064953
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,39624,0.0274908327652697,0.007630481857725,0.0125350883241287,0.0424465772064107,0.000316236149656341
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.0142572207777712,0.00396139959991674,0.00649287756193439,0.022021563993608,0.00032078248545232
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0164091821408597,0.00458510319533251,0.007422379878008,0.0253959844037114,0.000346398041722762
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.121290586447674,0.0339075450890515,0.0548317980731326,0.187749374822215,0.000348644425903839
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,0.0172598068422303,0.00483434303184072,0.00778449449982245,0.0267351191846381,0.000358155449936773
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0283332198712537,0.00793944805809468,0.0127719016773882,0.0438945380651193,0.000360031910023667
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,39750,0.0402648504696553,0.0112897968688054,0.0181368486067967,0.062392852332514,0.000363322536126272
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39657,0.00890043852359932,0.00249849028345706,0.00400339756802347,0.0137974794791752,0.000369129084625626
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39575,0.0274971695533388,0.00773060344569208,0.0123451867997823,0.0426491523068953,0.000376803943721105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,39990,-0.0261297943882672,0.00736941034204321,-0.0405738386586719,-0.0116857501178625,0.000393127732498846
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41839,0.0116875124163963,0.00329638378771644,0.00522660019247207,0.0181484246403205,0.000393138369926602
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,-0.0116575265215824,0.00329349141003723,-0.0181127696852554,-0.00520228335790946,0.000402125395381841
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0226748266327253,0.00640852555542032,0.0101141165441015,0.0352355367213491,0.000404177493270124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,0.0245349629456557,0.00697746807788944,0.0108591255129924,0.038210800378319,0.000439029420801174
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0184249539059829,0.0052545000489166,0.00812613381010638,0.0287237740018595,0.000455784237447655
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.0124595369060437,0.00356275091090046,-0.0194425286914086,-0.00547654512067879,0.000472086553313994
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,42249,0.0118813409019294,0.00341222602477666,0.00519337789336713,0.0185693039104917,0.000499257356639793
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,39649,0.0229613177021361,0.00659538065668535,0.0100343716150328,0.0358882637892394,0.000500682021739504
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,0.0120484950806393,0.00346092884150816,0.00526507455128328,0.0188319156099953,0.000500885802906933
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,39657,0.0121413346477017,0.0034995222510847,0.00528227103557566,0.0190003982598277,0.000523559066310319
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCT,Secretin,39649,0.0190286453339406,0.00548960673500515,0.00826901613333049,0.0297882745345507,0.000529672385235528
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,0.0223457253805976,0.00645270394300921,0.00969842565229959,0.0349930251088957,0.000536210337466342
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.0113719138779835,0.00329627704249741,0.00491121087468862,0.0178326168812785,0.000562783298201297
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,0.0246728991718615,0.00716907748408966,0.0106215073030458,0.0387242910406772,0.000580068475935801
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,39657,0.0181911514085714,0.00528548937383914,0.00783159223584667,0.0285507105812961,0.00058017586539342
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0321740076940352,0.00936247041423252,0.0138235656821394,0.0505244497059309,0.00059147994054222
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,39875,0.0284952172848421,0.00829636159525333,0.0122343485581456,0.0447560860115386,0.000595424076935301
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,39919,-0.015232705435375,0.00444188213388648,-0.0239387944177925,-0.00652661645295752,0.000607217661234093
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0425991193471959,0.0124406934923186,0.0182153601022514,0.0669828785921405,0.000618489409213983
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0202523604440845,0.00591593039001831,0.00865713687964864,0.0318475840085204,0.000620393005284212
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.0335454107894445,0.00983113443547221,0.014276387295919,0.0528144342829701,0.000646834748844149
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,0.00913657401726751,0.00268061550064755,0.0038825676359983,0.0143905803985367,0.000655750254460662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.0133665589136639,0.0039367474070203,0.00565053399590407,0.0210825838314237,0.000687401636002806
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.0139931908745598,0.00412862821345362,0.00590107957619074,0.0220853021729289,0.000703141808608496
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.0100530924938633,0.00296822312880172,-0.0158708098263147,-0.00423537516141196,0.000709341204652711
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,0.0153183695722308,0.00452608095717544,0.00644725089616694,0.0241894882482947,0.000715236737927354
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,39990,0.0100948656015875,0.0029983891890676,0.00421802279101502,0.01597170841216,0.00076307669858751
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,0.0153992385308791,0.0045741716889884,0.00643386202046187,0.0243646150412964,0.000763709082108148
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,-0.0189532750318072,0.00563444323234633,-0.029996783767206,-0.00790976629640835,0.000771250742745255
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,39919,0.0147515132803472,0.00438734302032,0.00615232096051999,0.0233507056001744,0.000775553804337371
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,39657,0.0126984149876218,0.00378516525010277,0.00527949109742035,0.0201173388778232,0.000796938826198739
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0194528505964992,0.00580292127106033,-0.0308265762877775,-0.00807912490522098,0.000803761346374948
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,39966,0.0353480719298281,0.010544604770322,0.0146806465799971,0.0560154972796592,0.000804213180028878
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39649,0.0252441694515785,0.00753695612009989,0.0104717354561827,0.0400166034469743,0.000812620839315176
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41843,0.0281805713765732,0.0084189995110675,0.0116793323348809,0.0446818104182655,0.000818421887345744
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,41997,-0.0174124040947162,0.00520918106828803,-0.0276223989885607,-0.00720240920087164,0.000832134680868909
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.0112165955232986,0.00335843691096362,0.00463405917780988,0.0177991318687873,0.000841081610347396
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,39575,-0.0131551386649172,0.00393994383752814,-0.0208774285864724,-0.00543284874336207,0.000843862404206363
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.0169554285971619,0.0050803119198259,0.00699801723430319,0.0269128399600207,0.000848213995027788
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.0276797592588713,0.00829639821460639,0.0114188187582428,0.0439406997594998,0.000851123287888805
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,39919,0.0267379439522622,0.00801635717555423,0.0110258838881759,0.0424500040163485,0.000854435431360227
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39657,0.0104824155567991,0.00317045180823369,0.0042683300126611,0.0166965011009372,0.000948433164285106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.025615473449776,0.00779404498778823,0.010339145273711,0.0408918016258409,0.00101688814889534
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCN,Decorin,41900,0.00858047451088125,0.00261121543965527,0.00346249224915693,0.0136984567726056,0.00101881261646217
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0325924890461873,0.00993054167908188,0.0131286273551868,0.0520563507371878,0.00103378951202007
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,39586,0.0306275539678935,0.00935506828920332,0.012291620121055,0.048963487814732,0.0010640232549901
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,0.0307760920851396,0.00948942350661658,0.0121768220121711,0.0493753621581081,0.0011848032231501
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0248682137966443,0.0076746240496833,0.00982595065926498,0.0399104769340235,0.00119741417908334
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,0.0193264844498003,0.00598283841115218,0.00760012116394202,0.0310528477356586,0.00124009909109747
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.00973819018977162,0.0030220269673475,-0.0156613630457727,-0.00381501733377052,0.00127477898058046
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,39638,0.0188160254227462,0.00586354179465729,0.00732348350521796,0.0303085673402745,0.00133584551348501
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42119,-0.0160623611018109,0.00502773412544966,-0.0259167199876922,-0.00620800221592954,0.00140272529384202
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,0.0276406526481343,0.00866315925440689,0.0106608605094968,0.0446204447867718,0.00142378191516616
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.0166925190275746,0.00523527709057183,0.0064313759300538,0.0269536621250954,0.00143417125207701
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,41780,0.0109951672404208,0.00345028315388687,0.00423261225880257,0.0177577222220391,0.00144219987079115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0198046080572253,0.00622947693781736,0.00759483325910328,0.0320143828553473,0.00148101467111973
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F3,Tissue factor,42174,-0.0094207575107177,0.0029648368358896,-0.0152318377090613,-0.00360967731237408,0.00148885571118373
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,39919,0.0127395636016274,0.00401052380142549,0.00487893695083349,0.0206001902524214,0.00149446662021656
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41913,0.0220453105772951,0.00694632800575355,0.00843050768601817,0.0356601134685721,0.00150870281980831
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASPN,Asporin,39958,0.00996659269209668,0.00316313095283706,0.00376685602453604,0.0161663293596573,0.00163211465239842
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39575,0.0117888333776981,0.00374793417798143,0.00444288238885447,0.0191347843665417,0.00166290466067803
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,0.0125024723133648,0.00397878307104741,0.00470405749411188,0.0203008871326177,0.00167994861052445
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41913,0.020298959640783,0.00647905827488571,0.00760000542200698,0.032997913859559,0.001733984061805
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,39720,0.0129967286688785,0.00414924914873289,0.00486420033736203,0.021129257000395,0.00173887607544562
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,0.00682035366937094,0.00217803187566648,0.00255141119306463,0.0110892961456772,0.00174325338106247
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,39930,0.015587618900583,0.00498502515399928,0.00581696959874443,0.0253582682024216,0.00177113926248054
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.0127134257358665,0.00408661621479243,-0.0207231935168597,-0.00470365795487338,0.00186935663534967
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,0.0136244394567395,0.00438083356874174,0.00503800566200567,0.0222108732514733,0.00187543569169998
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.0175381836701404,0.00564576905189259,0.00647247632843094,0.0286038910118499,0.00189840849037003
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,42145,0.0137047907589291,0.00441197105054879,0.00505732749985346,0.0223522540180047,0.00189852532939443
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,42105,0.0175212579150691,0.00564346825086089,0.00646006014338174,0.0285824556867564,0.00190868112435685
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,41900,-0.0494284202903444,0.0159210414299149,-0.0806336614929775,-0.0182231790877113,0.00190938444718204
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,41839,0.0258512598432088,0.00832812829810116,0.00952812837893054,0.0421743913074871,0.00191267668377604
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41913,0.0199959413742277,0.00646261244518636,0.00732922098166245,0.032662661766793,0.00197822830623038
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,0.0117625864982684,0.00381240246188592,0.00429027767297203,0.0192348953235648,0.00203803154425241
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRL,Prolactin,42249,0.0257315943016085,0.00834693527796741,0.00937160115679234,0.0420915874464246,0.00205499736925558
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,0.0117628853653098,0.00382699612071085,0.0042619729687165,0.019263797761903,0.00211875253482812
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,39560,0.0217015654478041,0.00706623772154057,0.00785173951358457,0.0355513913820236,0.00213749220911782
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39570,0.0355930895720751,0.0116093167836963,0.0128388286760304,0.0583473504681199,0.00217538279028982
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00635101569838055,0.00208410814922773,0.0022661637258942,0.0104358676708669,0.00231394827020519
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39695,0.0119416970508919,0.0039212530593773,0.0042560410545124,0.0196273530472714,0.00232933352141522
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,0.0197557363614743,0.00653599118867114,0.0069451936316789,0.0325662790912698,0.002511860394774
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,42119,0.0212407077202773,0.00703126960443497,0.00745941929558479,0.0350219961449699,0.00252502107200209
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0420714756909249,0.014040483876237,0.0145521272935003,0.0695908240883495,0.00273657398516469
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.0132469498588438,0.00443985381462948,0.00454483638217003,0.0219490633355176,0.00285459960929382
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.0181989352469017,0.00610413299882187,0.0062348345692108,0.0301630359245925,0.00287441548034042
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42119,0.00917979794385891,0.00308090367181834,0.00314122674709496,0.0152183691406229,0.00289157194680333
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0182969583709144,0.00614130624788839,0.00625999812505318,0.0303339186167757,0.00289406485962642
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,42217,0.00996321373368961,0.00335758015084779,0.00338235663802794,0.0165440708293513,0.00300872340645123
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,41774,0.0214031660744373,0.00721867743468317,0.00725455830245827,0.0355517738464163,0.00303254226361256
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,41654,0.0105615301761025,0.00356428273428024,0.00357553601691328,0.0175475243352918,0.00305050306875711
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,0.0149885340103747,0.00508326921828468,0.00502532634253668,0.0249517416782126,0.00319877403960736
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0299897160827127,0.01017745030027,0.0100419134941836,0.0499375186712419,0.00321749041494347
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.0148037574107944,0.00502559671630335,0.00495358784683985,0.024653926974749,0.00322812243120613
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,39657,0.00948872386134258,0.00322697471397546,0.00316385342195067,0.0158135943007345,0.00328425825559761
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.0250769404601422,0.00852892746235334,0.00836024263392969,0.0417936382863548,0.00328660623056982
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,39560,-0.0133653760765115,0.00455849251911951,-0.0223000214139858,-0.00443073073903729,0.00337512667577173
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,0.0108752949344742,0.00370948135249774,0.00360471148357859,0.0181458783853697,0.00337608145753494
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0124914906918652,0.00426697118819909,0.00412822716299499,0.0208547542207354,0.00342415487852571
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,42247,0.0101583503544811,0.003474352654268,0.00334861915211585,0.0169680815568464,0.00346342997612929
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,0.0118371079702203,0.00405112808465203,0.00389689692430227,0.0197773190161382,0.00348558830266189
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,0.0112625242631557,0.00387835544756526,0.00366094758592775,0.0188641009403836,0.0036909351731179
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39757,-0.0100554862851952,0.00346691192990591,-0.0168506336678108,-0.00326033890257961,0.00373395635720724
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41989,0.00913360224032764,0.00315543806575223,0.00294894363145328,0.015318260849202,0.00380304605548988
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.0183578842207056,0.00635211468931919,0.00590773942963997,0.0308080290117712,0.00385811386404835
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0133048260733075,0.00461179301806057,-0.0223439403887062,-0.00426571175790877,0.00392228917902324
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,0.0454014988829835,0.0157592511492459,0.0145133666304614,0.0762896311355055,0.00397229419347697
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,39649,0.0117926307974519,0.00410067671428633,0.00375530443745069,0.0198299571574531,0.00403805151513457
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,0.0192948642112774,0.00673345845916695,0.00609728563131019,0.0324924427912446,0.00417115097385929
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.021322670399056,0.00744334103136638,0.00673372197757788,0.0359116188205341,0.00418244302610421
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42249,-0.0417248860476552,0.014578971867277,-0.0702996709075182,-0.0131501011877923,0.00421629091477539
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,0.027270540836546,0.00953178934480368,0.00858823372073081,0.0459528479523612,0.00422952496684539
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0482905645887865,0.0168889964974608,0.0151881314537634,0.0813929977238096,0.00425251806697903
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,39990,0.00707862258423744,0.00247596791437776,0.00222572547205702,0.0119315196964179,0.00425842288576121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.0191378112380077,0.0067053326911825,0.00599535916329003,0.0322802633127254,0.00432372234445732
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,39575,0.0362420314073312,0.0127442511761836,0.0112632991020113,0.061220763712651,0.00446621835119721
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39854,0.02178276782985,0.00766151426843313,0.00676619986372111,0.036799335795979,0.00447517054916931
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0105020778614991,0.00369461270041991,0.0032606369686761,0.0177435187543221,0.00448378365256194
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,-0.00853047136678169,0.00300499070823418,-0.0144202531549207,-0.00264068957864271,0.004537124389082
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,39649,0.0130721248588747,0.00461370559396983,0.00402926189469386,0.0221149878230556,0.00461500528161549
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTG,Protogenin,42262,0.0078911422934732,0.00278705292873335,0.00242851855315584,0.0133537660337906,0.00464186593840778
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,42016,0.0110774652040203,0.00391588360240949,0.00340233334329766,0.0187525970647429,0.00467842140501061
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0219628340350034,0.00779817032289925,0.00667842020212082,0.0372472478678859,0.00486344683681562
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,42286,0.00965230167770994,0.00342788898439419,0.00293363926829733,0.0163709640871226,0.00487232257200034
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,39575,0.0124538398665352,0.00442740255176861,0.00377613086506872,0.0211315488680017,0.00491841711832507
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENG,Endoglin,42310,0.00549813913423331,0.00195793697949526,0.0016605826544226,0.00933569561404402,0.00499007296859846
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,39990,0.0239333615358141,0.00852391218315319,0.00722649365683389,0.0406402294147944,0.00499674662714766
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,42145,-0.0224069455705269,0.0079993318635496,-0.0380856360230841,-0.00672825511796972,0.00510006009301661
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,0.0064538543597679,0.00230847099287221,0.00192925121373837,0.0109784575057974,0.00518558376752759
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.0116758892289636,0.00417833411566799,0.00348635436225431,0.0198654240956729,0.00520723104170063
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,39657,0.012612019215541,0.00452176788748149,0.00374935415607727,0.0214746842750047,0.00529322584960368
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,41913,0.0149659375861938,0.00537690141329959,0.00442721081612665,0.025504664356261,0.00538722872900517
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.0159766055641764,0.00574737890811997,0.0047117429042613,0.0272414682240916,0.00544837650465041
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,41913,0.0242153020491846,0.00871721015434776,0.00712957014666304,0.0413010339517062,0.00547926025681804
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,-0.0114317565388546,0.00411627750064878,-0.0194996604401262,-0.00336385263758301,0.00549206641143121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,0.0189624552638496,0.00683876504506163,0.00555847577552877,0.0323664347521704,0.00556689802069099
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42137,-0.00891124494343151,0.00321701453045118,-0.0152165934231158,-0.00260589646374719,0.00561265343353325
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,41814,-0.0190558066653013,0.00691207705576786,-0.0326034776946063,-0.00550813563599632,0.0058434816677228
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,0.0126318950184553,0.00458341818260627,0.00364839538054705,0.0216153946563636,0.00586082062299676
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,39958,0.00940000652650993,0.00341919844177389,0.0026983775806331,0.0161016354723868,0.00598382219565308
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD248,Endosialin,39966,-0.0126320737380705,0.00460347859433548,-0.0216548917829681,-0.00360925569317297,0.00607855919278887
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.0120991227482225,0.00441075673070919,0.00345403955603253,0.0207442059404126,0.00609619251602098
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,41900,0.0333911023039842,0.0122082218979295,0.00946298738404248,0.057319217223926,0.00624378302891927
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,0.00853795872062239,0.00312321597025876,0.00241645541891522,0.0146594620223295,0.00627229066016408
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,39649,0.0191746816443151,0.00702354583105228,0.00540853181545261,0.0329408314731775,0.00634236810027297
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.0157307497490447,0.00578282887265019,0.00439640515865036,0.0270650943394391,0.00653174041422308
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.0155136167076497,0.00571467516151403,0.00431285339108217,0.0267143800242172,0.00664398449910801
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.0150234235864609,0.00553601233605794,0.00417283940778737,0.0258740077651345,0.00666275656564494
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,0.0142821813997279,0.00528570121664665,0.00392220701510048,0.0246421557843554,0.00690212017288467
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,0.0109627689021764,0.0040600622367512,0.00300504691814404,0.0189204908862087,0.00693942873398207
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,39736,0.0144163388645479,0.00534039447205288,0.00394916569932428,0.0248835120297715,0.00695507986945257
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,0.0162582492634419,0.00604336094035278,0.00441326182035047,0.0281032367065333,0.00715013391198072
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.00783881239405135,0.0029250114352067,0.00210578998104621,0.0135718348070565,0.00737450032991931
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.0104618828972653,0.00390425649140719,0.00280954017410717,0.0181142256204233,0.0073817239497119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,39954,-0.0108217549598708,0.00404014561816037,-0.0187404403714651,-0.00290306954827651,0.00740469228373398
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.0129059700073057,0.00485672649580433,-0.0224251539390822,-0.00338678607552923,0.00788741892236698
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,39929,0.0286406520439364,0.0108252678297244,0.0074231270976765,0.0498581769901963,0.00816292924568089
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,42075,0.0176522324522941,0.00667409845065463,0.00457099948901103,0.0307334654155772,0.00818131082718884
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.0149217108008831,0.00565259852406655,0.00384261769371264,0.0260008039080535,0.00830730961893532
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,0.00724177621189967,0.00275124608255608,0.00184933389008975,0.0126342185337096,0.00849537697553012
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,0.00981873682098814,0.00373191357012017,0.00250418622355261,0.0171332874184237,0.00852481559312053
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,39649,0.0273512584560506,0.0104059518432461,0.00695559284328829,0.047746924068813,0.00859000598863953
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,42262,0.018642178437408,0.00710134424269002,0.00472354372173552,0.0325608131530804,0.00867042252870359
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,42262,0.0137332519176093,0.00523350635628566,0.00347557945928937,0.0239909243759292,0.00869745037848826
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,0.0188744750481115,0.00722250667898398,0.00471836195730289,0.0330305881389201,0.00897747946314342
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,0.00725670579607326,0.00277724600057131,0.00181330363495349,0.012700107957193,0.00898717917661204
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,39657,0.0182363170654206,0.00701294625395603,0.00449094240766675,0.0319816917231744,0.00932447826910869
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.0252698378219057,0.00976889335015315,0.00612280685560549,0.0444168687882058,0.0097008053947997
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.009640538094438,0.00373050478344163,-0.0169523274699836,-0.0023287487188924,0.00976961286288785
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,0.0222919691269491,0.00864415107902125,0.00534943301206747,0.0392345052418308,0.00992586835959404
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0178029414640324,0.00691952810097805,0.00424066638611545,0.0313652165419494,0.0100970907937027
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,0.00450434427677952,0.0017507859786237,0.00107280375867707,0.00793588479488198,0.0101018018107302
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.0120204607715783,0.00467960713039134,0.00284843079601133,0.0211924907471454,0.0102212538763684
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39649,0.00916573090713554,0.00357085525298322,0.00216685461128843,0.0161646072029826,0.0102767329047944
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,39990,0.0421084617277857,0.0164847932780965,0.00979826690271651,0.0744186565528549,0.0106505373369029
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.0219354465817609,0.00859147168743093,0.00509616207439629,0.0387747310891255,0.0106859978497839
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,39649,0.0214491194494498,0.00840762750288216,0.00497016954380072,0.0379280693550988,0.0107501643532957
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.0151817727880601,0.00595799782943509,0.00350409704236733,0.0268594485337529,0.010841303220197
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,39657,0.0126824198292067,0.00498204749280178,0.00291760674331519,0.0224472329150982,0.0109217158320256
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.011461078737958,0.00450534379561794,0.00263060489854681,0.0202915525773691,0.0109737309333418
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39586,0.0214264237799743,0.00842458826072704,0.00491423078894927,0.0379386167709993,0.0109940501232391
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,39575,0.0202148844273413,0.00795278342255162,0.00462742891914008,0.0358023399355425,0.0110399754250268
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,42185,-0.0117387657346572,0.00464983470272808,-0.0208524417520042,-0.00262508971731014,0.0115957639610082
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,39806,0.0102267911264909,0.00405592858237762,0.0022771711050308,0.0181764111479511,0.0117012261034557
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,42246,0.0124779143810901,0.00496334295570022,0.00274976218791767,0.0222060665742625,0.0119479782917268
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSC1,Hamartin,39657,0.021031700722254,0.00841253740909047,0.00454312740043671,0.0375202740440714,0.0124322110096817
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,-0.0169543854653953,0.006803501341102,-0.0302892480939552,-0.00361952283683533,0.0127143194833211
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.0284370594147324,0.0114191454185127,0.00605553439444746,0.0508185844350174,0.0127778811260012
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.0133642258246514,0.00536771069481503,0.00284351286281391,0.0238849387864888,0.0127977518722611
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42249,0.00802982562641895,0.00322644794834338,0.00170598764766593,0.014353663605172,0.0128310959065765
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,0.0110862697075592,0.00445586142278946,0.00235278131889186,0.0198197580962265,0.0128603944116367
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,0.0100114122706593,0.00402502365707074,0.00212236590280063,0.0179004586385179,0.0128838893245192
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,0.00675206895721832,0.00272049016687578,0.00141990823014179,0.0120842296842949,0.0130793093829844
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,0.0201228849403512,0.00812647778847092,0.00419498847494822,0.0360507814057542,0.0132933103158795
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,39638,0.0248281914215545,0.0100312872153814,0.00516686847940697,0.0444895143637021,0.0133357108377552
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,0.017209442322644,0.00697474163860735,0.00353894871097354,0.0308799359343144,0.0136221823199228
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,0.00843365648819014,0.00341885396890614,0.00173270270913411,0.0151346102672462,0.0136470203266823
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.0187207346455215,0.00759085387100797,0.00384266105834586,0.0335988082326971,0.0136672248345305
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,-0.00762695544055585,0.00309398968954316,-0.0136911752320604,-0.00156273564905125,0.0137126499937549
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,39934,0.0104338220773023,0.00426277510548402,0.00207878287055366,0.018788861284051,0.0143938097123139
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,39586,0.0159015902460499,0.00650489962742198,0.00315198697630282,0.028651193515797,0.014518669217684
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,42167,0.00583258740291041,0.00238763685755335,0.00115281916210586,0.010512355643715,0.0145853252879716
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39560,0.010139592421734,0.00415378412167238,0.00199817554325612,0.0182810093002118,0.0146603654487773
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,0.0128074625794219,0.00525248724157248,0.00251258758593981,0.0231023375729039,0.014767064593202
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,0.0100442557969855,0.00412504163876101,0.00195917418501397,0.0181293374089571,0.0149070335112473
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.0133703311720381,0.00550378600420049,0.00258291060380514,0.0241577517402711,0.0151440714521443
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,0.0252895056901509,0.0104144788662941,0.00487712711221455,0.0457018842680873,0.0151855247036435
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,41913,-0.00878356765353153,0.00362511355082553,-0.0158887902131496,-0.00167834509391349,0.0154071401721961
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,-0.00739329842549695,0.00305694145949656,-0.0133849036861102,-0.00140169316488369,0.0155965532095574
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,0.0156913378098918,0.00649157655215318,0.00296784776767158,0.028414827852112,0.0156571634003057
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.00746721901289854,0.0030907432439968,0.00140936225466481,0.0135250757711323,0.0157079988405458
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,0.0402380378287877,0.0167045442483195,0.0074971311020815,0.0729789445554938,0.0160211129666217
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,0.0070820308542916,0.00294044682304695,0.00131875508111958,0.0128453066274636,0.0160320962832901
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00804532864531352,0.0033464291624877,0.00148632748683763,0.0146043298037894,0.0162263207516833
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.00785497541093426,0.00326832345466979,0.00144906143978147,0.014260889382087,0.0162608760140128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,39919,0.013136248420455,0.00548195634524739,0.00239161398377014,0.0238808828571399,0.0165790057858779
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,0.00806039693739776,0.00336512074651882,0.00146476027422086,0.0146560336005747,0.0166212637280854
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.00766924567944218,0.00321607304785249,-0.0139727488532331,-0.0013657425056513,0.0171083527487323
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,41839,0.0111876251343606,0.00469680998539072,0.0019818775629948,0.0203933727057264,0.0172346916607283
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42181,0.00750004067156328,0.00315013604085947,0.00132577403147872,0.0136743073116479,0.0172858638006582
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,39757,0.0445519852798183,0.0189144719755618,0.00747962020771729,0.0816243503519194,0.0185177821285003
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,0.00760593304843984,0.00323068852346846,0.00127378354244167,0.013938082554438,0.0185730133914489
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,0.0112265981874867,0.00478753282527154,0.00184303384995453,0.020610162525019,0.0190465959507147
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLC,Galectin-10,42119,0.0178280898014482,0.00761261396047476,0.00290736643891767,0.0327488131639787,0.0191995547503294
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,39960,0.00995437307630508,0.00425759720087705,0.00160948256258607,0.0182992635900241,0.0194031589622437
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,0.0199454838773306,0.00853342326494247,0.00321997427804333,0.0366709934766178,0.0194395439715335
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,0.023696696047566,0.0101572108699446,0.00378856274247459,0.0436048293526574,0.0196659697967492
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.0173159841019015,0.00745675076730088,-0.0319312156058112,-0.00270075259799173,0.0202374945337686
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,0.00886898099308779,0.00383667131515935,0.00134910521537548,0.0163888567708001,0.0208161659485335
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39575,0.0242553818185629,0.0105056208604538,0.00366436493207355,0.0448463987050523,0.0209731450634775
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,0.0133424926648638,0.00578485462893649,0.00200417759214832,0.0246808077375794,0.021103770727474
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,0.013815981571737,0.00600906003077581,0.00203822391141638,0.0255937392320575,0.0215092045141261
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.0164348476863814,0.00715228333051019,0.00241637235858144,0.0304533230141814,0.0215892574178696
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,39958,0.0278646129488557,0.0122081179763557,0.00393670171519846,0.051792524182513,0.0224802496565718
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39649,0.0161830843853302,0.00709205410960388,0.00228265833050662,0.0300835104401538,0.0225164538363517
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00767976076570076,0.00338782403190852,0.00103962566316006,0.0143198958682415,0.0234145983567578
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,-0.0100767946261823,0.00444686936600424,-0.0187926585835506,-0.001360930668814,0.0234682020711265
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,0.0271796185625296,0.0120361854206866,0.00358869513798381,0.0507705419870754,0.0239551823734934
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,41913,0.010076333019668,0.00447158673896358,0.00131202301129935,0.0188406430280366,0.0242493047220724
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NENF,Neudesin,39919,0.0288451707845503,0.0128011149214288,0.00375498553854976,0.0539353560305508,0.0242572389370432
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,42119,0.0201184055857567,0.00892913579109967,0.0026172994352014,0.0376195117363121,0.0242676071751173
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,41913,0.0240308196725466,0.0106993905193362,0.00306001425464773,0.0450016250904455,0.0247204073781433
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42054,0.0159945618652617,0.00712559594953255,0.00202839380417786,0.0299607299263455,0.0248059551409458
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),39775,-0.0464406505017847,0.0207017237204158,-0.0870160289937996,-0.00586527200976973,0.0248955117496941
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,41839,0.0149344057536037,0.00668575738129868,0.00183032128625833,0.0280384902209492,0.0255152240130532
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0424147167136841,0.0191757971071284,0.00483015438371234,0.0799992790436559,0.0269912878643402
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,39586,0.0123568772777069,0.00559005108712741,0.00140037714693714,0.0233133774084766,0.0270901492833957
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42119,-0.0124405613794747,0.00563429208170774,-0.0234837738596218,-0.00139734889932748,0.0272604471851847
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0194649671729962,0.0088309970639389,0.00215621292767593,0.0367737214183164,0.0275333437176155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,41839,0.0115489649988565,0.00526824699198513,0.0012232008945656,0.0218747291031473,0.0283835955065001
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,0.00789745008991231,0.00360798996234652,0.000825789763713139,0.0149691104161115,0.0286231026770616
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.00934622914042254,0.00427508680419308,-0.017725399276641,-0.0009670590042041,0.0288214167697264
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0209661983340229,0.00959924257354395,-0.039780713778169,-0.00215168288987676,0.0289687992711707
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,0.0108470566069317,0.00496772818247638,0.00111030936927799,0.0205838038445854,0.0290198150443746
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.0110732831654097,0.00509572676093904,0.00108565871396915,0.0210609076168502,0.0297940175556205
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,0.0204058724339988,0.00939356520962166,0.00199448462314032,0.0388172602448572,0.0298525017414862
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,39575,0.0117199546714421,0.0054158495302351,0.00110488959218132,0.0223350197507029,0.0304850527064692
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,41900,-0.00570362409211264,0.00263972587220986,-0.010877486801644,-0.000529761382581311,0.0307372436576747
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,39586,0.0118090160705612,0.00547348813896968,0.00108097931818065,0.0225370528229418,0.0309888297250337
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,0.010119286641636,0.00469214961984575,0.000922673386738277,0.0193158998965336,0.031055100298035
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00651872956312196,0.00302597481974061,0.000587818916430374,0.0124496402098135,0.0312417328560639
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.0135780158000786,0.00631837223984083,0.00119400620999056,0.0259620253901666,0.0316579321952054
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.00826137754669178,0.00384867912692333,-0.0158047886354615,-0.000717966457922051,0.0318509473042335
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,0.0132045392536083,0.00615963603033762,0.00113165263414661,0.0252774258730701,0.032077018660485
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,41913,0.0113157627022737,0.00528890843309943,0.000949502173398778,0.0216820232311485,0.03241113648245
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,42007,-0.0119024130317116,0.00558650964498935,-0.0228519719358907,-0.000952854127532456,0.0331432747569291
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,39657,0.0242270666573248,0.011394162720719,0.0018945077247156,0.046559625589934,0.0335028718354464
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,39757,0.0104810838502257,0.00493016210063231,0.000817966132986384,0.020144201567465,0.0335326028622715
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCIN,Adseverin,39586,0.0178752955173877,0.00842325732602231,0.00136571115838398,0.0343848798763914,0.0338486533877287
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,41839,0.0121857539635705,0.00575507904168003,0.000905799041877681,0.0234657088852634,0.0342452499049382
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,41900,0.00777318033702072,0.00368922068712313,0.00054230779025938,0.0150040528837821,0.0351364342803742
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,39575,-0.00744054015822149,0.0035431885828783,-0.014385189780663,-0.000495890535780016,0.0357554786564622
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,42119,0.00818963813366543,0.00390055890160679,0.000544542686516122,0.0158347335808147,0.0357819745742796
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,39575,-0.00988286799736892,0.00475115322469032,-0.019195128317762,-0.000570607676975893,0.0375396212594836
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0218159801823186,0.0104933271535598,0.00124905896134132,0.0423829014032959,0.0376374024902885
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,39919,0.0247600124544365,0.0119306503318646,0.00137593780398181,0.0481440871048912,0.0379786790479259
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,39757,0.0165880014130659,0.00800812036500758,0.000892085497651022,0.0322839173284808,0.0383445847292144
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,39919,0.0100673842121729,0.00486196437891438,0.000537934029500701,0.0195968343948451,0.0384149467071234
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,39649,0.0141570764977589,0.00685169293499282,0.000727758345173021,0.0275863946503449,0.0388313550244342
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39638,-0.0147692850666147,0.00715149051555901,-0.0287862064771103,-0.000752363656119004,0.0389270188612284
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,39966,-0.0199345220877198,0.00966814187491204,-0.0388840801625474,-0.000984964012892199,0.0392421020084293
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39586,0.0226721978421068,0.0110006019293534,0.00111101806057418,0.0442333776236395,0.0393268926689248
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,41839,-0.00753567736393709,0.00366445455716355,-0.0147180082959777,-0.000353346431896521,0.0397610876267578
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.0195395468973919,0.00953365104779955,-0.038225502951079,-0.000853590843704788,0.040433593212941
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.0163077823131537,0.00796826622340366,0.000689980515282575,0.0319255841110249,0.0407218663462733
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00892196038406753,0.00436054316217318,0.000375295786208091,0.017468624981927,0.0407729575364742
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,0.0253427817409014,0.0124030150705908,0.00103287220254334,0.0496526912792594,0.0410489417603013
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.0141114343779688,0.00691587317239036,0.000556322960083655,0.0276665457958538,0.0413302346689253
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,0.00429019657565533,0.0021033979942588,0.000167536506908069,0.00841285664440258,0.0414082469968772
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,41913,-0.0102696699992776,0.00503571081790156,-0.0201396632023647,-0.000399676796190579,0.0414329686281881
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39586,0.00812266497418267,0.00399906069901963,0.000284506004104196,0.0159608239442611,0.0422644961479894
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39657,0.0151947959819672,0.00751199448718094,0.000471286787092521,0.0299183051768418,0.0431241980324995
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,0.0271664079848055,0.0134318741351713,0.000839934679869713,0.0534928812897413,0.0431447610365829
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0182395268236876,0.0090663083434279,-0.0360094911768063,-0.000469562470568952,0.0442616300244824
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0158354796812664,0.00790116030168887,0.000349205489956162,0.0313217538725765,0.04506905345915
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,0.0140503845906129,0.00701780396564011,0.000295488817958276,0.0278052803632675,0.0452979714513167
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALLD,Palladin,39657,0.00867276984987508,0.00433511107041753,0.000175952151856716,0.0171695875478934,0.0454612469267225
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,39929,-0.00610051921669509,0.00305001296888317,-0.0120785446357061,-0.000122493797684088,0.0455066297473043
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0132379889989495,0.0066226402297898,0.000257614148561529,0.0262183638493375,0.0456395955975071
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.0133421355992709,0.006695713786745,0.00021853657725069,0.0264657346212911,0.0463257947239092
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41839,0.0106853568529211,0.00537866565016804,0.000143172178591756,0.0212275415272505,0.0469852668010018
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,39934,0.00826957329198558,0.00416580412025355,0.000104597216288626,0.0164345493676825,0.0471564626878703
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,0.0178551566695796,0.0090021576204534,0.000210927733490952,0.0354993856056683,0.0473438040815201
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,0.00821639440201686,0.00418574378598738,1.23365814816093e-05,0.0164204522225521,0.0496773492746609
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_DRA,,42060,0.00808630945910912,0.00412384610759669,3.57108821960085e-06,0.0161690478299986,0.0499152511525071
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.00565559027635183,0.00289323458114609,-0.0113263300553982,1.51495026944979e-05,0.0506363389645231
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00608480756117665,0.00311685606880935,-0.012193845456043,2.42303336896767e-05,0.0509363516299456
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLGN,Calmegin,39649,0.010149177571521,0.00520976112646945,-6.19542363591383e-05,0.0203603093794011,0.0514273223801871
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,42262,0.00969568883031051,0.00499372422729862,-9.20106551947943e-05,0.0194833883158158,0.052209135446975
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,41900,0.0106866628038174,0.00552843531167688,-0.000149070407069272,0.0215223960147041,0.0532530012111151
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,41843,0.0355482922299058,0.0183917437550365,-0.000499525529965641,0.0715961099897773,0.0532772441792753
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39736,0.006218447531299,0.00322000588734429,-9.27640078958137e-05,0.0125296590704938,0.053484741318459
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39649,-0.00620363981748004,0.00321723896963537,-0.0125094281979654,0.00010214856300528,0.0538496779522607
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.0142969389474184,0.00742032619574999,-0.000246900396251623,0.0288407782910883,0.0540394892353341
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00910933868217038,0.00473368588075772,-0.000168685644114741,0.0183873630084555,0.0543302762453949
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOC,Myocilin,42137,0.00975361267583565,0.00507477495650608,-0.000192946238916265,0.0197001715905876,0.0546293221340366
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0251369750272625,0.0131297737691304,-0.000597381560233163,0.0508713316147581,0.0555774850999429
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.0150731433508313,0.00788293555878757,-0.00037741034439237,0.0305236970460549,0.055886237093771
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,0.00661387563168644,0.00346732833668906,-0.000182087908224114,0.013409839171597,0.0564839662743499
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,42170,0.00800849907963335,0.00420024310157818,-0.000223977399459882,0.0162409755587266,0.0565837675400905
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,39586,0.0101181805533513,0.00531069851941648,-0.000290788544705023,0.0205271496514076,0.0567743438624625
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,41913,0.00681022449981553,0.00357629169810048,-0.000199307228461404,0.0138197562280925,0.0568965819531447
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,0.0142549929760243,0.00748856512662972,-0.000422594672169938,0.0289325806242186,0.0569921754591143
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,39657,0.00638803288721376,0.00336784360777816,-0.000212940584031433,0.012989006358459,0.0578840160740043
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,0.0111756070619493,0.00593444204849096,-0.000455899353093002,0.0228071134769916,0.0597027903503421
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.00966591238320875,0.00514317572377201,-0.000414712035384398,0.0197465368018019,0.0602205034192132
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.0052450270343534,0.00279182734534608,-0.00022695456252491,0.0107170086312317,0.0603107267603846
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.00711926592409235,0.00379601889791424,-0.0145594629640043,0.00032093111581957,0.0607565359271945
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,39657,0.00999844319927754,0.00533338537595817,-0.000454992137600479,0.0204518785361556,0.0608617509479497
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,41913,0.00908349336205736,0.00484869884079958,-0.000419956365909829,0.0185869430900245,0.0610367420743866
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,39657,0.00831570669252529,0.00444256862490342,-0.000391727812285409,0.017023141197336,0.0612573323836025
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,0.0102074319175484,0.00549085463559207,-0.000554643168212056,0.0209695070033088,0.0630547723432117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,39934,0.0128348446504386,0.00690942258522232,-0.000707623616597196,0.0263773129174743,0.0632537862569972
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,41839,0.0111041623234265,0.00600048641136327,-0.000656791042845498,0.0228651156896985,0.0642574880944459
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.00502151581477393,0.00272046850519326,-0.000310602455404855,0.0103536340849527,0.0649389456992542
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,39539,0.00861782953691033,0.00469085454731045,-0.000576245375818163,0.0178119044496388,0.0662140441634273
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.00776834568407131,0.00422938279615646,-0.016057935964538,0.000521244596395349,0.0662729000822066
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39560,0.0133884367236466,0.0073412647230442,-0.00100044213352002,0.0277773155808132,0.0682211100985287
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,0.0101449974911185,0.00556926726823058,-0.000770766354613426,0.0210607613368504,0.0685377042466389
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,42181,0.00832229488161982,0.00456981721536409,-0.000634546860493804,0.0172791366237334,0.0686069723916041
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,42181,-0.00793237818124117,0.00435609397911192,-0.0164703223803005,0.000605566017818193,0.068631255987406
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.00906194944291965,0.00500951518445719,-0.000756700318616438,0.0188805992044557,0.0704865662545905
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,39575,0.00881557987862966,0.00487357479269242,-0.000736626715047482,0.0183677864723068,0.0705012135381393
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSN,Gelsolin,39943,-0.00388038593998242,0.00215394706508137,-0.0081021221875419,0.000341350307577056,0.0716469743045751
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,39934,0.0071120039948846,0.00395258573006261,-0.000635064036038106,0.0148590720258073,0.0719931673850304
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,-0.00647606406718136,0.00360946433413929,-0.0135506141620944,0.000598486027731651,0.0728103942537546
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39574,-0.0129410775446569,0.00722090654887013,-0.0270940543804423,0.0012118992911286,0.0731335986509355
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,39929,-0.00890530350395174,0.00497966216905908,-0.0186654413553075,0.000854834347404044,0.0737487104928778
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,41913,0.00836274476695664,0.00468255460341823,-0.000815062255743093,0.0175405517896564,0.0741323073759856
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,0.0102352899004766,0.00573115582568766,-0.00099777551787123,0.0214683553188244,0.0741416577245004
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,39638,-0.00370153047493677,0.00207548311911715,-0.00776947738840637,0.000366416438532839,0.0745397559330014
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,41913,0.027890739689751,0.0156609717710959,-0.002804764981597,0.058586244361099,0.074950383330838
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00610199968338087,0.00343577096693566,-0.000632111411813024,0.0128361107785748,0.075757052321919
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.00596987525492704,0.00337217266286899,-0.000639583164296185,0.0125793336741503,0.0766991464457541
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.00804867876360357,0.00455629622937356,-0.000881661845968603,0.0169790193731757,0.0773402896844516
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,42199,-0.00566580098303979,0.00321099117332882,-0.0119593436827643,0.000627741716684694,0.0776699108371427
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.00659686224433993,0.00375832533235373,-0.000769455407073376,0.0139631798957532,0.0792367681872492
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00584710151376894,0.00334370835218018,-0.000706566856504207,0.0124007698840421,0.0803680942158232
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39649,0.00669170938248446,0.00383100340754475,-0.000817057296303251,0.0142004760612722,0.0807128394900587
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,39560,0.0144641140294287,0.00832299131337683,-0.00184894894478989,0.0307771770036473,0.082265259395522
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,42122,0.0128716837102948,0.00740754613977247,-0.00164710672365928,0.0273904741442488,0.0822961953693926
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.0165407569264162,0.0095347398928627,-0.00214733326359468,0.0352288471164271,0.0828063901085984
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGN,Cingulin,39649,0.00739458403821203,0.00426889755567929,-0.000972455170919377,0.0157616232473434,0.0832658791486782
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,39586,0.0121453022448626,0.00701980048566927,-0.00161350670704914,0.0259041111967744,0.0836317043660131
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,39897,0.00530178323314299,0.00307631923663432,-0.000727802470660279,0.0113313689369463,0.0848403662869286
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,42158,-0.00373882740764111,0.00217418634868598,-0.00800023265106564,0.000522577835783411,0.0855199203906956
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.0111762087079287,0.00655920555376225,-0.0240322515933027,0.00167983417744535,0.0884286670389277
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.012019965825235,0.00708336428255369,-0.00186342816857025,0.0259033598190402,0.089738241155192
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41839,0.00648871541707964,0.00383110168958116,-0.00102024389449943,0.0139976747286587,0.0903468957443022
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,39657,0.0109891017891103,0.00649866012441824,-0.00174827205474947,0.02372647563297,0.0908688792223874
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,0.00621763748423024,0.00370563953970048,-0.0010454160135827,0.0134806909820432,0.093392474237268
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0122221829447278,0.00731297750741409,-0.00211125296980384,0.0265556188592594,0.0946898672339517
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,41647,0.0116419765215295,0.00698511354267773,-0.00204884602211888,0.0253327990651778,0.0956012720204839
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41839,0.0111162118642511,0.00667379893796835,-0.00196443405416685,0.0241968577826691,0.0958068453753439
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,39560,-0.00580843120497791,0.00349057821389812,-0.0126499645042182,0.00103310209426239,0.0961347732267675
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,39757,0.00671225699657391,0.00404395521758414,-0.001213895229891,0.0146384092230388,0.0969778146893342
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,42310,-0.00785673523723248,0.00473376086977981,-0.0171349065420009,0.00142143606753596,0.0969929143069398
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,0.0129327787842493,0.0077999900347076,-0.00235520168377757,0.0282207592522762,0.0973353493878427
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,0.0151179733137929,0.00912536910852205,-0.00276775013891033,0.0330036967664961,0.0976088308680755
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,0.0156978247909366,0.00950345068314216,-0.00292893854802204,0.0343245881298953,0.0986033723383013
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,42070,0.0061134869798053,0.00370888001743801,-0.00115591785437319,0.0133828918139838,0.0993067018307603
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,39575,0.00738887408458854,0.00450346513708432,-0.00143791758409672,0.0162156657532738,0.100886569818601
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,41759,-0.0129989660147783,0.00793788426413917,-0.0285572191724911,0.00255928714293448,0.101532051626348
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,39575,-0.00749790172522944,0.00458031373351669,-0.0164753166429221,0.00147951319246327,0.101662418222695
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,39757,0.016054897109965,0.00984756421130097,-0.0032463287441849,0.0353561229641149,0.103057472055454
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,39575,0.0104323141338479,0.00639921838562729,-0.00211015390198155,0.0229747821696774,0.103077750498798
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.006723542898902,0.0041306518627512,-0.00137253475209036,0.0148196205498944,0.103612872867172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,42137,-0.00433315677583298,0.00266696827050831,-0.00956041458602928,0.000894101034363319,0.104239112987381
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00555168630170246,0.00343043108309252,-0.00117195862115889,0.0122753312245638,0.105607981441067
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39657,0.0195311200114911,0.012085972000934,-0.00415738511033954,0.0432196251333218,0.106119456852282
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,39934,-0.00856957477299782,0.00533944457882378,-0.0190348861474924,0.00189573660149679,0.108531301077501
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00379147009004798,0.0023692736791419,-0.00843524650116611,0.000852306321070142,0.109568183969748
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,0.0126495517053776,0.00790758632966797,-0.0028493175007716,0.0281484209115268,0.109699946801866
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,39560,-0.00770965570840403,0.00485223399194185,-0.0172200343326101,0.001800722915802,0.112114555649496
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,42016,0.0188247019716676,0.0118825873812165,-0.00446516929551679,0.042114573238852,0.113165905010653
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.00926242577951451,0.00584757897194328,-0.00219882900549431,0.0207236805645233,0.113226962036792
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39575,0.00760883505922492,0.0048291527905321,-0.001856304410218,0.0170739745286678,0.11514579215585
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,39757,0.0104673825683922,0.00664960456575484,-0.00256584238048727,0.0235006075172717,0.115484343448814
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,-0.00942213890624791,0.00602504123714784,-0.0212312197310577,0.00238694191856185,0.11788071021161
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,0.00857079964367478,0.00550290232589142,-0.00221488891507242,0.019356488202422,0.119379482130158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00953539019224515,0.00612500096259475,-0.0215403920789309,0.00246961169444057,0.119547220720834
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0135886733190673,0.00876388692224887,-0.0307658916866751,0.00358854504854045,0.121042118289408
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,39586,0.0117978734874616,0.00761689200505634,-0.00313123484244886,0.026726981817372,0.121432373178873
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,41913,0.0128688310638159,0.00832027223255789,-0.00343890251199752,0.0291765646396294,0.121963257915769
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,41877,0.00751008019379076,0.00486629817087094,-0.00202786422111628,0.0170480246086978,0.122785712329547
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,0.0089526271145218,0.00584053663577823,-0.00249482469160354,0.0204000789206471,0.12534311381021
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,0.00900183934422404,0.0058735026088117,-0.0025102257690469,0.020513904457495,0.125399321019335
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41979,0.00990439282524895,0.00649881610951352,-0.00283328674939755,0.0226420723998955,0.127524771933745
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPTC,Opticin,42070,0.00783063482554033,0.00514248664242261,-0.00224863899360798,0.0179099086446886,0.127848958183075
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,42016,0.00576762898520951,0.00379164700164173,-0.00166399913800828,0.0131992571084273,0.128248072661818
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0217931719279736,0.0143284250223455,-0.00629054111582362,0.0498768849717708,0.128290061502819
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,39560,0.00631653187859003,0.00416240637846279,-0.00184178462319704,0.0144748483803771,0.12916447471094
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.0118933150856135,0.00788579891088678,-0.00356285077972462,0.0273494809509516,0.131533181584113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,39990,-0.010405423671687,0.00690766754988133,-0.0239444520694544,0.00313360472608042,0.132002901826356
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.0131699944771801,0.00879783964229616,-0.00407377122172034,0.0304137601760806,0.134432808913801
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.0108042543960048,0.00721748115581414,-0.00334200866939091,0.0249505174614005,0.134432898495209
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41900,0.0102312707226734,0.00683822588611988,-0.00317165201412159,0.0236341934594684,0.134628428855818
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42310,-0.00524916797239964,0.00350912898534143,-0.0121270607836689,0.00162872483886957,0.134712989604527
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,41843,0.0150699634110459,0.0100861857801656,-0.00469896071807869,0.0348388875401705,0.13516830260583
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.00626729429296053,0.00419677018271009,-0.00195837526515126,0.0144929638510723,0.135366328378665
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.00652457263475522,0.00437827077541873,-0.00205683808506548,0.0151059833545759,0.136195081475878
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00837936049571278,0.00563166842306285,-0.00265870961349041,0.019417430604916,0.136805948569596
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,0.010471310279161,0.00705617348048007,-0.00335878974257993,0.024301410300902,0.137834518383534
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,39586,0.0164221832421604,0.0111378398392958,-0.00540798284285928,0.0382523493271801,0.140389238705998
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.00796141746997109,0.00540401647728295,-0.0185532897654457,0.00263045482550348,0.140709142911452
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00814530765746862,0.00557746840171276,-0.00278653040988839,0.0190771457248256,0.144210108242975
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,41913,0.0117015463854483,0.00803666031857967,-0.00405030783896786,0.0274534006098644,0.14541038912566
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.00984266782921445,0.00677521078770471,-0.00343674531468677,0.0231220809731157,0.146322612411886
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,39657,0.0099264803913277,0.00684609506794551,-0.00349186594184549,0.0233448267245009,0.147101443396232
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,42134,-0.00642172655758847,0.00443646934303792,-0.0151172064699428,0.00227375335476585,0.147784061534324
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39554,0.0135833161472489,0.00938673640115109,-0.00481468719900724,0.031981319493505,0.147904398225531
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,39649,0.0127592616825939,0.00886261136193241,-0.00461145658679366,0.0301299799519814,0.149988285483267
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39586,0.0123674553250433,0.00860749113939954,-0.00450322730817982,0.0292381379582664,0.150796305490624
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,0.00312091026432639,0.00219991449977522,-0.00119092215523304,0.00743274268388581,0.156028262005883
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,39919,-0.00641629510718988,0.00454054118860728,-0.0153157558368602,0.0024831656224804,0.157650171932604
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.00551850911071584,0.00392331892733498,-0.00217119598686072,0.0132082142082924,0.159576688078042
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41843,0.0134205989518605,0.00955920138386544,-0.00531543576051573,0.0321566336642368,0.160358491972267
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.0121112098015798,0.00862844284526161,-0.00480053817513295,0.0290229577782926,0.160450036570432
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0304705178222195,0.0217881791758577,-0.0122343133624616,0.0731753490069006,0.16198942274657
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.00668502317715804,0.00480767545396529,-0.00273802071261393,0.01610806706693,0.164407961123817
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,39560,0.0104696487114176,0.00755511227812025,-0.00433837135369804,0.0252776687765333,0.165845310514925
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00854677505997018,0.0061685490957861,-0.00354358116777058,0.0206371312877109,0.165915428753905
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00868208882348888,0.00628355937466865,-0.00363368755086168,0.0209978651978394,0.167087294706215
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.0046884468739828,0.00339671104965097,-0.00196910678333311,0.0113460005312987,0.167525224463879
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,-0.00629487411596012,0.00456188474999145,-0.0152361682259434,0.00264641999402312,0.167649367292219
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00417043499161719,0.00303690248857403,-0.00178189388598791,0.0101227638692223,0.169701847279008
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,0.00932970042232027,0.00679402918296175,-0.00398659677628476,0.0226459976209253,0.169711821149004
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,39586,0.0117682139684781,0.00857174348870435,-0.00503240326938239,0.0285688312063386,0.169809016554649
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.00724611858422626,0.00529927520602681,-0.0176326979880388,0.0031404608195863,0.171534486872074
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39736,0.00330661484086107,0.0024206851796845,-0.00143792811132055,0.0080511577930427,0.171971879395701
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00571239247483575,0.0041868982465022,-0.0139187130379801,0.00249392808830856,0.172485385301189
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,41900,0.00419997630831575,0.00309953340693242,-0.0018751091692718,0.0102750617859033,0.175429413862631
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,0.0230128293185752,0.0170003795582049,-0.0103079146155064,0.0563335732526569,0.175865712034338
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,0.00523054367818181,0.00387171212392803,-0.00235801208471713,0.0128190994410807,0.176734816754882
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,0.00529834304283955,0.00392779496599159,-0.00240013509050398,0.0129968211761831,0.17738057002666
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,0.00824899907196537,0.0061185658053805,-0.00374338990658042,0.0202413880505112,0.17762374076203
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,39934,0.00795534622505152,0.00590083969102214,-0.00361029956935187,0.0195209920194549,0.177630043863126
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,-0.00739806623970502,0.00548940481770776,-0.0181572996824122,0.00336116720300219,0.177783020206987
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.00862023321602081,0.00640772721424038,-0.021179378555932,0.00393891212389034,0.178560123516428
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,-0.00555747047263362,0.00414655862905678,-0.0136847253855849,0.00256978444031767,0.180183229414752
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.00737527147801242,0.0055091053279169,-0.00342257496470471,0.0181731179207295,0.180682398415212
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39757,0.00932792924912528,0.00697168997802175,-0.00433658310779735,0.0229924416060479,0.180932680793502
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00473720542190354,0.00355268674419279,-0.00222606059671432,0.0117004714405214,0.18242339913775
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTTG1,Securin,39757,0.00630612021932374,0.00474344966662348,-0.00299104112725828,0.0156032815659058,0.183730829938634
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39586,-0.00522845938101081,0.00394493529410435,-0.0129605325574553,0.00250361379543371,0.185079343567001
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,-0.00437013386790958,0.00330638407312703,-0.0108506466512386,0.00211037891541939,0.186286745321006
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42070,-0.012538584485499,0.0094907571514252,-0.0311404685022924,0.00606329953129437,0.186478338123691
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.0094024289148842,0.00711931013024021,-0.00455141894038662,0.023356276770155,0.186630808267449
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,41538,0.00423443712455666,0.00322230104405169,-0.00208127292178466,0.010550147170898,0.188834669549091
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,39930,0.0180192265119578,0.013752262813977,-0.00893520860343711,0.0449736616273527,0.190129866724441
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,39575,-0.00496415135016888,0.00384215773291959,-0.0124947805066913,0.00256647780635352,0.196376818078046
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,0.0100079717323281,0.00777148927141717,-0.0052241472396496,0.0252400907043057,0.197849599068576
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,0.00640885527645014,0.00499092275021464,-0.00337335331397056,0.0161910638668708,0.199132428160865
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00659159727186502,0.00513543055106165,-0.00347384660821582,0.0166570411519459,0.199325303776797
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESPL1,Separin,39560,0.00777621684883924,0.00607734063906359,-0.0041353708037254,0.0196878045014039,0.200733098928429
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,39657,0.0125099463389727,0.00977807693164615,-0.0066550844470537,0.0316749771249992,0.200787589887694
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.00476855608120224,0.00375163447768464,-0.0121217596574641,0.00258464749505965,0.203732978569936
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BSND,Barttin,39560,0.00481541775064732,0.00382091062177732,-0.00267356706803622,0.0123044025693309,0.207595155390494
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,39575,-0.00565359138230893,0.00449212301526599,-0.0144581524922303,0.0031509697276124,0.208217277476327
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,42299,0.00634650280615862,0.00505015536616246,-0.00355180171151981,0.016244807323837,0.208885684218592
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,0.0123335346575996,0.00982163659865187,-0.00691687307575808,0.0315839423909573,0.209232386300988
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,39934,0.00699315149737564,0.00557359396819364,-0.0039310926802839,0.0179173956750352,0.209615959108978
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00364629305310948,0.00291431339050581,-0.00935834729850087,0.00206576119228191,0.2109000334116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.0116567153046463,0.00933281177343054,-0.0299490263805702,0.00663559577127751,0.211689969403397
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39657,-0.00311413677609241,0.00249478623249199,-0.0080039177917767,0.00177564423959188,0.211963035042168
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,39657,0.00370351775240567,0.00297936789600789,-0.00213604332376979,0.00954307882858112,0.213873974894146
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00358968704377854,0.00289022920018298,-0.00925453627613719,0.0020751621885801,0.214259415934261
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,39919,0.00562822297199858,0.00453855009874829,-0.00326733522154806,0.0145237811655452,0.21496680497923
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,0.00964007808193638,0.00777907297678799,-0.00560690495256809,0.0248870611164409,0.215285569300208
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.00788278724649337,0.00637816046827336,-0.00461840727132242,0.0203839817643092,0.216521070706227
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,0.00917227939715388,0.0074450039597928,-0.00541992836404,0.0237644871583478,0.21797331595453
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,0.00421385053247931,0.0034224996510426,-0.00249424878356419,0.0109219498485228,0.218266030344558
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,39990,0.00336939939969806,0.00274592611925787,-0.00201261579404737,0.00875141459344349,0.219827688703341
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,39657,0.00631777489004214,0.00515516221649577,-0.00378634305428957,0.0164218928343738,0.220403965617869
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,39560,0.00911732087173582,0.00744228759708204,-0.00546956281854498,0.0237042045620166,0.22057529570489
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42217,-0.00799825888638784,0.00663767516792241,-0.0210081022155158,0.00501158444274007,0.228232367156303
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,0.0137754564192496,0.0114507001350098,-0.00866791584536954,0.0362188286838688,0.228992937015439
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.00556652761254847,0.00463825171023389,-0.00352444573950995,0.0146575009646069,0.230112677678766
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,39979,0.00407407369408123,0.0034345605808631,-0.00265766504441045,0.0108058124325729,0.235568330712424
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,39919,0.0071803105485447,0.00607278186573176,-0.00472234190828954,0.0190829630053789,0.237081442647584
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,0.0358420350696202,0.0303298046420119,-0.0236043820287232,0.0952884521679636,0.237333139627903
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,0.00599062863972302,0.00507968227742213,-0.00396554862402436,0.0159468059034704,0.238291791820247
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,42249,-0.00427879398335629,0.00364931299178355,-0.011431447447252,0.00287385948053946,0.24101963917322
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,0.00533055107403569,0.0045510113093552,-0.0035894310923005,0.0142505332403719,0.241507954466412
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.00827994191118909,0.0070790938835876,-0.0055950821006426,0.0221549659230208,0.242170027841047
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,-0.00416246137813342,0.0035934508315982,-0.0112056250080659,0.00288070225179905,0.246747677644818
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,39560,0.0093802345851306,0.00810641148358993,-0.00650833192270565,0.0252688010929669,0.24724131195259
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42137,0.00810101085597434,0.00702036285139785,-0.00565890033276545,0.0218609220447141,0.248549033101627
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,0.00602851384800651,0.00522774879902957,-0.00421787379809145,0.0162749014941045,0.248858440871873
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MB,Myoglobin,42310,0.00733079148373121,0.00635777034987582,-0.0051304384020254,0.0197920213694878,0.24891226411717
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39539,0.0101027869507246,0.00879248474673306,-0.00713048315287218,0.0273360570543214,0.250570693395137
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,42153,0.00657457070776612,0.00575267883348206,-0.00470067980585871,0.0178498212213909,0.253112277990583
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,0.00838543049895624,0.00734816011994618,-0.00601696333613828,0.0227878243340508,0.253827846991873
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,39657,0.00476797053119773,0.00418161284026068,-0.0034279906357132,0.0129639316981087,0.254218165692291
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,0.0088333117669976,0.00776521817601183,-0.00638651585798558,0.0240531393919808,0.255333923315411
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,0.00567670005437427,0.00502384646852555,-0.00417003902393582,0.0155234391326844,0.258520840067208
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,39757,-0.00533460091079259,0.0047232215844084,-0.0145921152162331,0.00392291339464787,0.258736055982451
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,39929,0.00885008903120437,0.00797192359398491,-0.00677488121300604,0.0244750592754148,0.266954819430792
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00584628465361552,0.00529791595955886,-0.00453763062711984,0.0162301999343509,0.269826728850493
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00674394979783146,0.00614166514792256,-0.00529371389209675,0.0187816134877597,0.272195916595418
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LXN,Latexin,41960,-0.00846164379074908,0.00777650906526136,-0.0237036015586613,0.00678031397716319,0.276569214175703
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00345336366725827,0.00318254265970272,-0.00278441994575906,0.0096911472802756,0.27790288569755
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,42123,-0.00440846821693845,0.00406884448285853,-0.0123834034033412,0.00356646696946426,0.278619473074878
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.00655814061017431,0.0061294549630349,-0.0054555911173741,0.0185718723377227,0.284670082225804
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,41913,-0.0041310117328389,0.00386527060514407,-0.0117069421189213,0.00344491865324348,0.285201272689401
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,42262,0.00565116548605634,0.00529810198292218,-0.00473311440047114,0.0160354453725838,0.286153450565758
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42042,0.00402465990096038,0.00377448964161628,-0.00337333979660753,0.0114226595985283,0.286316587391219
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00695078557112316,0.00652448373499172,-0.0197387736917069,0.00583720254946062,0.286746084030398
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,0.00667769696294993,0.00626900632128208,-0.00560955542676294,0.0189649493526628,0.286812348831812
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,39934,-0.00634933376437113,0.00597633986520022,-0.0180629599001636,0.00536429237142131,0.2880714326222
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,42137,0.0031266257596277,0.00296660863326005,-0.00268792716156201,0.00894117868081741,0.291929467787102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,39934,0.0059154734156414,0.00563037474860296,-0.0051200610916204,0.0169510079229032,0.293448281405013
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.00797450829980416,0.00763772763108129,-0.0229444544567235,0.00699543785711516,0.296464734029036
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00467890206515514,0.00449412778834172,-0.0134873925303049,0.00412958839999462,0.297845296957788
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCLN,Nicalin,41913,0.00602566608027715,0.00580606808252833,-0.00535422736147837,0.0174055595220327,0.299371710008506
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00700127629186376,0.00675499998041822,-0.00623852366975595,0.0202410762534835,0.300010491112046
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,39586,0.00490005859546172,0.00474894595440832,-0.00440787547517859,0.014207992666102,0.302179045811216
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.00252874508115057,0.00245975576659993,-0.00229237622138529,0.00734986638368643,0.303950142529441
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00807741207393173,0.00786067363474049,-0.00732950825015963,0.0234843323980231,0.304173241377217
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,41843,0.0155079717074029,0.0151379124804899,-0.0141623367543573,0.0451782801691632,0.305643444548367
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,0.00685153888797598,0.00668996455409844,-0.00626079163805697,0.0199638694140089,0.305786011152591
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.0106523492783149,0.0104227127786765,-0.00977616776789111,0.0310808663245209,0.306788163704193
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,0.00590684303987592,0.00578437533007835,-0.00543053260707765,0.0172442186868295,0.307191540234792
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.0200145591945624,0.0196216706799604,-0.01844391533816,0.0584730337272849,0.307739240281435
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,0.00465842685670923,0.00458786996104806,-0.00433379826694498,0.0136506519803634,0.309947578263919
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,42070,0.00402010682237881,0.00395998390157407,-0.00374146162470638,0.011781675269464,0.310037018906416
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39575,0.00553433089837069,0.00550487876281291,-0.00525523147674262,0.016323893273484,0.314750421035041
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,39966,0.0130439219475921,0.0130216684370947,-0.0124785481891135,0.0385663920842978,0.316505502846776
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",39919,0.00480656178789725,0.00480377500548087,-0.00460883722284525,0.0142219607986397,0.317051232844329
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,0.00652230315025976,0.00652439042443169,-0.00626550208162635,0.0193101083821459,0.317487372345299
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,0.00965922517183504,0.00975742130766503,-0.00946532059118841,0.0287837709348585,0.322227127960413
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,0.00535638809910929,0.00546414645365668,-0.0053533389500578,0.0160661151482764,0.32696631824081
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41839,0.00361816175650418,0.00370229769648024,-0.00363834172859709,0.0108746652416054,0.328451046963632
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,0.00804965993231096,0.0082394810649516,-0.00809972295499419,0.0241990428196161,0.328609145556504
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00448538652338485,0.00459900036816096,-0.00452865419821064,0.0134994272449803,0.329434943400405
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,0.00467393697778159,0.00479258439751219,-0.0047195284413423,0.0140674023969055,0.329460819568212
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,-0.00461828405868249,0.00477702984110554,-0.0139812625472493,0.00474469442988436,0.333676771641171
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,42132,0.0210492614140861,0.021775301409605,-0.0216303293487396,0.0637288521769119,0.333732486361314
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,42207,0.0171219185259009,0.0177413592913653,-0.0176511456851751,0.0518949827369769,0.33451942469619
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39757,0.00804351433994384,0.00834661693243785,-0.00831585484763436,0.024402883527522,0.335224474571129
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,39560,-0.0043637046630045,0.0045502128656743,-0.0132821218797261,0.00455471255371712,0.337574306104109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,39929,-0.00238356592623271,0.00249189141231832,-0.00726767309437661,0.00250054124191119,0.338825546924659
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C7,Complement component C7,39722,0.00362546860978867,0.00379126108156046,-0.00380540311006982,0.0110563403296472,0.338956710261984
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,39649,0.00641628321876867,0.00671858743892072,-0.00675214816151594,0.0195847145990533,0.339596165302549
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,39649,0.00724830298150747,0.00766217120475487,-0.00776955257981206,0.022266158542827,0.344176660570455
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0102439177423363,0.0108378977892098,-0.0109983619245149,0.0314861974091876,0.344580594741747
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,0.00947731004138235,0.0100823540283737,-0.01028410385423,0.0292387239369947,0.347243321901224
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,39586,0.00627641826051282,0.00668309459269993,-0.00682244714117905,0.0193752836622047,0.347675153398947
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.00539587963926103,0.00575201217083612,-0.00587806421557778,0.0166698234940998,0.348220939722124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,0.00586082526306742,0.00626750563358528,-0.00642348577875972,0.0181451363048946,0.349750730064221
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,0.00298300107566401,0.00320001099425704,-0.00328902047307979,0.0092550226244078,0.351260980495589
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,39966,0.00361600773147236,0.00389273240619075,-0.0040137477846615,0.0112457632476062,0.3529541689045
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,42145,0.00711414685437361,0.00773517186534655,-0.00804679000170563,0.0222750837104528,0.357738545569718
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00638388850642,0.00699825278781156,-0.00733268695769065,0.0201004639705307,0.361676681057592
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39560,-0.00647576748231236,0.00710630217052103,-0.0204041197365336,0.00745258477190887,0.362172614736152
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,39757,0.00534787538524768,0.00588670939006453,-0.00619007501927879,0.0168858257897741,0.363651687121438
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,0.00345579822446798,0.0038062543496196,-0.00400446030078644,0.0109160567497224,0.363937152048997
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.0171884860371958,0.0189333253172881,-0.0542978036590804,0.0199208315846889,0.363980507748005
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,0.00426776115768625,0.00470402750489808,-0.00495213275191399,0.0134876550672865,0.364290760470863
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,39958,0.00501396630091833,0.00553066414211695,-0.00582613541763089,0.0158540680194675,0.364650392832236
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,0.00450320105493645,0.00497587302254718,-0.00524951006925602,0.0142559121791289,0.365480801040133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,39930,0.0267542757140344,0.0296229603993718,-0.0313067266687344,0.0848152780968032,0.366460134571793
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.00516680870161256,0.00577945665691591,-0.00616092634594263,0.0164945437491677,0.371343860154885
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.00653437701953686,0.00731033336387943,-0.00779387637366682,0.0208626304127405,0.371419178373598
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,39560,0.00610851046832395,0.00683413526007735,-0.00728639464142765,0.0195034155780756,0.371435977944818
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,42310,-0.00307497862938783,0.00344289115597073,-0.00982304529509047,0.0036730880363148,0.37179868635384
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.00386344183747575,0.00433710817230726,-0.00463729018024647,0.012364173855198,0.373059632342195
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,39690,0.00860750731949037,0.00971554194993938,-0.0104349549023908,0.0276499695413716,0.375662409189903
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39649,0.00513274776639639,0.00579510444200811,-0.00622565693993951,0.0164911524727323,0.375796273466613
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,39586,-0.00523532981499024,0.00599927413170011,-0.0169939071131224,0.00652324748314197,0.382867203100301
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,42296,0.00395394316864718,0.00453970977558474,-0.00494388799149891,0.0128517743287933,0.383786744265359
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41913,0.00630233325480843,0.00726383353099547,-0.00793478046594268,0.0205394469755595,0.385611548474929
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00363657660480034,0.00419395218008957,-0.0118567228777759,0.00458356966817522,0.385905399527556
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,39652,0.00698821680149865,0.00808035328529812,-0.00884927563768567,0.022825709240683,0.387145107612299
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,0.00218326234281254,0.00253586222629801,-0.00278702762073156,0.00715355230635665,0.38927817232555
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,-0.00267128940260964,0.00310329626970486,-0.00875375009123117,0.00341117128601189,0.38937146113488
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39560,-0.00657644981270673,0.00764153183301946,-0.0215538522054249,0.0084009525800114,0.389466575895039
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,39919,0.00553492569787147,0.00651797615928244,-0.00724030757432212,0.018310158970065,0.395799892971755
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,39638,0.00396092554977941,0.00466752637003229,-0.00518742613548387,0.0131092772350427,0.396114835548107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,41843,0.00950251881564793,0.0112303489153272,-0.0125089650583933,0.0315140026896892,0.397486391823422
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTN,Titin,39575,-0.00665419402366281,0.0078813692045535,-0.0221016776645877,0.00879328961726205,0.39852344935102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,0.00344568540973077,0.00409031016357741,-0.00457132251088096,0.0114626933303425,0.399580762662475
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00563696866632676,0.00669408674565982,-0.00748344135516648,0.01875737868782,0.399760537656983
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39575,-0.00465865548152416,0.00557640659365916,-0.0155884124050961,0.0062711014420478,0.403498057504828
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,42137,0.0032272471059435,0.00387209266446057,-0.00436205451639921,0.0108165487282862,0.404598196488844
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39657,0.0025105971722965,0.00302935575701187,-0.00342694011144676,0.00844813445603977,0.407260302640828
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,0.00456907925618556,0.00553544007795217,-0.00628038329660069,0.0154185418089718,0.409146013837726
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,42296,0.000857269432778814,0.00104302204471964,-0.00118705377487168,0.00290159264042931,0.411142874043084
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,39586,0.00845713904994074,0.0104119436030262,-0.0119502704119905,0.028864548511872,0.416663708148519
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,39586,0.00855153353124053,0.0105785030539942,-0.0121823324545881,0.0292853995170692,0.418884838219485
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00548972856097415,0.00685818819034133,-0.00795232029209485,0.0189317774140432,0.423456730834616
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,41913,0.00522627213910438,0.00656103685494781,-0.00763336009659333,0.0180859043748021,0.425719702822289
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,-0.00526723592796499,0.00663435106637561,-0.0182705640180612,0.00773609216213121,0.427251086608448
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,0.0034217558204267,0.00432955330396559,-0.00506416865534585,0.0119076802961992,0.429354309022949
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,39966,0.003863281172221,0.004936340509277,-0.00581194622596193,0.0135385085704039,0.433866316799153
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,0.00645018895846387,0.00824203922740122,-0.00970420792724253,0.0226045858441703,0.433880602595668
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,39560,-0.00372025359742495,0.0047692476916443,-0.0130679790730478,0.00562747187819787,0.4353780513244
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,0.00628556447409858,0.00807692076486673,-0.0095452002250402,0.0221163291732374,0.436460233174282
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39575,0.00457740811065033,0.00588226733406692,-0.00695183586412082,0.0161066520854215,0.436485160708762
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,42310,0.00140090933536395,0.00180948181218224,-0.00214567501651324,0.00494749368724113,0.4388230957669
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00492098202882571,0.00639483425133805,-0.00761289310379687,0.0174548571614483,0.441598552748514
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.0036955026118016,0.00485463565947656,-0.00581958328077245,0.0132105885043757,0.446534914671242
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,39657,0.0048100968185199,0.0063221076638201,-0.00758123420256749,0.0172014278396073,0.446770335890963
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,-0.00399309010996055,0.00530535797899056,-0.0143915917487821,0.00640541152886095,0.451674998047249
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,42119,0.00280651783263868,0.00373276663183655,-0.00450970476576095,0.0101227404310383,0.452148358298332
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00423363565341771,0.00566547099320463,-0.0153379588000988,0.00687068749326335,0.45491669785304
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39560,-0.00222321440893101,0.00299900243783472,-0.00810125918708706,0.00365483036922503,0.45851654973197
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.00336728689234163,0.00454257447690652,-0.0122707328670784,0.00553615908239515,0.458543821493307
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAG,S-arrestin,39586,-0.00439493146139336,0.00596975243624126,-0.0160956462364262,0.00730578331363951,0.461624739788359
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,39649,0.00402649102330657,0.00547225423482443,-0.00669912727694931,0.0147521093235624,0.461867333437811
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,0.00330306579027723,0.00449171740081806,-0.00550070031532617,0.0121068318958806,0.462130788178404
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,-0.00350795287816407,0.00478483264212887,-0.0128862248567367,0.00587031910040853,0.463488362840194
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.00840373004771125,0.011517483267644,-0.0309779972522934,0.0141705371568709,0.465619809042231
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.00510283859359812,0.00706768177174888,-0.0189554948662259,0.00874981767902969,0.470312050352083
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.005950070321997,0.00826165909857921,-0.0221429221552123,0.0102427815112183,0.471415439691502
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00259119820763238,0.0035994568373879,-0.00964613360891267,0.00446373719364791,0.471610567533925
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,39539,-0.00295063663245447,0.00411024982436942,-0.0110067262882185,0.00510545302330959,0.472851038306699
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.00328675597066551,0.00464417957254979,-0.0123893479328631,0.00581583599153207,0.479136714916705
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,39575,-0.00283983036386834,0.00401573419491884,-0.0107106693859093,0.00503100865817258,0.479472200415713
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,39560,-0.00345164609174933,0.00488418038922401,-0.0130246396546284,0.00612134747112974,0.479768486254035
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39757,0.00297562281130027,0.00423223426385397,-0.00531955634585351,0.0112708019684541,0.482017098727159
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.0040013739275261,0.00574774270679766,-0.0152669496328495,0.00726420177779732,0.486340401755941
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39649,-0.00539811970627612,0.00784889316483052,-0.0207819503093439,0.00998571089679169,0.491621179282184
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.00201852258773931,0.00294590964318826,-0.00375546031290969,0.0077925054883883,0.493232646284122
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,39757,0.00214215061890438,0.00314213909217622,-0.004016442001761,0.00830074323956977,0.495411741542612
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,0.00230972278182702,0.00344113202213029,-0.00443489598154836,0.00905434154520239,0.502100296071795
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39586,0.00644756926881016,0.00964380258231277,-0.0124542837925229,0.0253494223301432,0.503783056281395
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41839,0.00496914293313694,0.00746816832039952,-0.00966846697484611,0.01960675284112,0.505821368651336
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,0.00317759294316476,0.00477777123752149,-0.00618683868237735,0.0125420245687069,0.506013815786743
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,39649,0.00287452759776356,0.00432544922374669,-0.00560335288077996,0.0113524080763071,0.506344784985842
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,42070,-0.00585718083783201,0.00882971054637741,-0.0231634135087317,0.0114490518330677,0.507118327610251
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.00478540181851096,0.00723125592461282,-0.00938785979373017,0.0189586634307521,0.508134889314816
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,-0.00130283072797533,0.00197324921530573,-0.00517039918997455,0.00256473773402389,0.509106973068239
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,42016,0.000900129102189718,0.00138214102929548,-0.00180886731522942,0.00360912551960886,0.514891717322003
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,0.00526296517557289,0.0080951463254821,-0.010603521622372,0.0211294519735178,0.515616445637877
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39575,0.00536708663740769,0.00825728826219131,-0.0108171983564873,0.0215513716313026,0.51571761737115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,0.00246511418664723,0.00382081620850853,-0.00502368558202949,0.00995391395532395,0.518824052955272
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,-0.00195246576697348,0.00303185778257771,-0.0078949070208258,0.00398997548687884,0.51959723074384
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,39398,0.00511143430688201,0.0080385332440432,-0.0106440908514427,0.0208669594652067,0.524876890292342
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,42310,0.00173290687719486,0.00274956759897724,-0.00365624561680054,0.00712205937119025,0.528543462272944
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,0.00386261362888612,0.00614584487101014,-0.00818324231829375,0.015908469576066,0.529694826694542
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,39575,-0.00359506327782591,0.00572352081248974,-0.0148131640703058,0.00762303751465397,0.529937785705474
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,0.000578473042519237,0.000928456219151437,-0.00124130114701758,0.00239824723205605,0.533265492961464
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRN1,Neuritin,39934,0.00243970986225172,0.00396248538257961,-0.00532676148760431,0.0102061812121078,0.538103632494884
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,39575,-0.00319236025715642,0.00521496076987194,-0.0134136833661054,0.00702896285179258,0.540448407061885
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.00340199924014017,0.00556698140423701,-0.0143132827924447,0.00750928431216438,0.541144043216479
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,39560,0.00423003430941075,0.00697417036911119,-0.00943933961404718,0.0178994082328687,0.544176309777998
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,-0.00430366248694129,0.00714827574292183,-0.0183142829430681,0.0097069579691855,0.547149298601945
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.00487962067912657,0.00810868436168,-0.0207726420280194,0.0110134006697662,0.547334552716288
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,0.00238147583722049,0.00402640053422259,-0.00551026920985578,0.0102732208842968,0.554220940746928
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,0.00200621190621964,0.00340342910469645,-0.0046645091389854,0.00867693295142468,0.555557211925457
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,39757,0.00355976828261109,0.00606501233366397,-0.00832765589137029,0.0154471924565925,0.557259208495354
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,-0.00234623155707692,0.00400678314684399,-0.0101995265248911,0.00550706341073729,0.558177922199957
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39575,0.00315994183074332,0.00547296780543784,-0.00756707506791484,0.0138869587294015,0.563699601137479
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.00431138945588873,0.00750822719345383,-0.0190275147550582,0.0104047358432808,0.565829332166447
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41992,-0.00305933739571699,0.00537171684424221,-0.0135879024104317,0.00746922761899774,0.569008153831151
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,0.00381994741537972,0.00671673654232042,-0.0093448562075683,0.0169847510383277,0.569557291986284
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,0.00408153221872402,0.0072249813808556,-0.010079431287753,0.018242495725201,0.572137978059063
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,39560,0.003384864536902,0.00601034461495875,-0.00839541090841715,0.0151651399822211,0.573328524407692
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,39575,-0.00371475371396083,0.00661023203147754,-0.0166708084956568,0.00924130106773516,0.574147768389713
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,42310,0.00187189092591423,0.00334139911537221,-0.00467725134021531,0.00842103319204377,0.575344191251642
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39657,0.00440057220676256,0.00786436869736111,-0.0110135904400652,0.0198147348535903,0.575792138643541
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNC,Tenascin,42217,-0.00304738918567433,0.00546859502497583,-0.013765835434627,0.00767105706327829,0.577363966690888
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.00477490662751633,0.00861148752329473,-0.0121036089181413,0.021653422173174,0.579260627434631
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,39560,-0.00294259718490806,0.00532668441935351,-0.0133828986468409,0.00749770427702482,0.580668015579383
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,39990,0.00168633054868301,0.00307332412657389,-0.00433738473940182,0.00771004583676783,0.583222637054793
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,41843,0.00486305448046097,0.00888626782229549,-0.0125540304512382,0.0222801394121601,0.584212778060675
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00280872170585578,0.00518222835915088,-0.0129658892897915,0.00734844587807994,0.587835559104019
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,-0.00253513131355951,0.00472160971257973,-0.0117894863502158,0.00671922372309676,0.591333071596547
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0025983865832345,0.00486945969178964,-0.0121425275791422,0.00694575441267319,0.593620922498446
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.00468570146781933,0.00880647861882297,-0.0125749966250737,0.0219463995607123,0.594685193559133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,39586,-0.00282578217781139,0.00533781466156428,-0.0132878989144774,0.00763633455885459,0.596546088567163
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,39934,0.0092187435408887,0.0177960780074652,-0.0256615693537431,0.0440990564355205,0.604453673296278
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,0.00179245016533609,0.00346037542785345,-0.00498988567325668,0.00857478600392886,0.604473601066625
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39586,0.00429700177187957,0.0083122458107854,-0.0119950000172598,0.020589003561019,0.605202619956391
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,39560,-0.00200215903004425,0.00389819895291622,-0.00964262897776005,0.00563831091767154,0.60753413153146
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.00236621159134072,0.00461463612187931,-0.00667847520754273,0.0114108983902242,0.608127830661437
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,0.00444890771522774,0.00869268332807815,-0.0125887516078054,0.0214865670382609,0.608801732717839
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.00156557220196109,0.00306266847261377,-0.0044372580043619,0.00756840240828408,0.609233963726729
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42275,0.00223499060334835,0.00437546087068177,-0.00634091270318791,0.0108108939098846,0.609498524132114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,0.00452984100969485,0.0089235793668057,-0.0129603745492443,0.022020056568634,0.611725522259473
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,39560,0.00285565144078848,0.00569102909432513,-0.00829876558408878,0.0140100684656657,0.615831514254042
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,39657,0.00310890107004049,0.00621892950901693,-0.0090802007676327,0.0152980029077137,0.617148849461282
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00269827165448388,0.00546973942689988,-0.00802241762223988,0.0134189609312076,0.621803983790625
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.00309728496360084,0.00630508824536988,-0.0154552579245258,0.00926068799732413,0.623269515770702
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.00158405127285629,0.00324289009548608,-0.00794011586000901,0.00477201331429643,0.625227084256997
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,42070,-0.00739173117195866,0.0151551426366571,-0.0370958107398065,0.0223123483958892,0.625743734164894
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,39757,0.00222096794737609,0.00455609006778899,-0.00670896858549033,0.0111509044802425,0.625933208167607
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.00478024561461738,0.00993604885302277,-0.0146944101373073,0.024254901366542,0.630454053089823
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,39657,0.00313993510991976,0.00653247731717655,-0.00966372043174627,0.0159435906515858,0.630763913516215
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,39560,0.00505616290979448,0.010551121916402,-0.0156240360463535,0.0257363618659425,0.631801513576205
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,39586,0.00264032003548033,0.00553095950839015,-0.00820036060096436,0.013481000671925,0.633107410559886
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41665,0.00262655815379861,0.00553900551603483,-0.00822989265762966,0.0134830089652269,0.63537014347434
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,39826,0.00586109239298959,0.0125235870883842,-0.0186851383002434,0.0304073230862226,0.639790612565282
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,39657,0.00250638214078695,0.00536571982572328,-0.00801042871763068,0.0130231929992046,0.640430283916736
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42137,0.00193188319720298,0.00415292484334946,-0.00620784949576196,0.0100716158901679,0.64180562548935
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,39575,0.0025135858881728,0.00541557514668779,-0.00810094139933527,0.0131281131756809,0.642556540013908
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41913,0.00334012277372676,0.00724500996643204,-0.01086009676048,0.0175403423079336,0.644788987059808
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,39560,-0.00244703497447755,0.00533203503406294,-0.0128978236412409,0.00800375369228581,0.646292978397059
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,39959,0.00200680284038807,0.00438306929833772,-0.00658401298435387,0.01059761866513,0.647066581611316
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,41830,0.00445269319025406,0.00972866540789779,-0.0146154910092256,0.0235208773897337,0.647184143114478
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.00239015271648708,0.00533264092209169,-0.0128421289237868,0.00806182349081264,0.654009189721233
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00206907471947635,0.00474536990730332,-0.00723185029883816,0.0113699997377909,0.66283074750991
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.00194405206304627,0.00448291528090772,-0.0107305660136254,0.00684246188753285,0.664545335493944
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,0.00146199938358395,0.00344856994414026,-0.00529719770693097,0.00822119647409886,0.671613649167546
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,0.00239633969494996,0.00570717692668589,-0.00878972708135439,0.0135824064712543,0.674580018273691
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39560,-0.00239626562121681,0.00573711329102826,-0.0136410076716322,0.00884847642919858,0.676190790365274
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,0.00184115628484948,0.00442360023938198,-0.00682910018433921,0.0105114127540382,0.677262888812055
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,41992,-0.00154189498236158,0.00374491788748566,-0.00888193404183347,0.00579814407711032,0.680543934534394
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,0.00190980348028617,0.00465334722019699,-0.00721075707129993,0.0110303640318723,0.681509505697725
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,-0.00207789719615614,0.0051843988753483,-0.0122393189918388,0.00808352459952654,0.688575086079359
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,39575,-0.0020172119779116,0.00508892085103069,-0.0119914968459318,0.00795707289010856,0.691822926357258
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,41913,0.00273463425045943,0.00690728655994825,-0.0108036474070391,0.016272915907958,0.692180926478293
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,42286,-0.00197066894753859,0.00498582833984484,-0.0117428924936345,0.00780155459855731,0.692661551910356
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.0011514922986631,0.00296152513982391,-0.00695608157271796,0.00465309697539177,0.697418563139647
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.0014912027956056,0.00391433336798599,-0.00618089060564694,0.00916329619685814,0.703240615241463
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,39649,0.00210636195703791,0.00554920299965269,-0.00877007592228137,0.0129827998363572,0.704265108661701
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,39757,0.00240641907093306,0.00640064858483358,-0.0101388521553408,0.0149516902972069,0.706950154451496
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00259725676792124,0.00699810836808116,-0.0163135491693603,0.0111190356335178,0.71054255961607
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00123951350516796,0.00335846816378778,-0.00782211110619201,0.0053430840958561,0.712081849713671
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.00235244250517166,0.00644988660818728,-0.0149942202572187,0.0102893352468754,0.715321518869366
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,0.000609808632722291,0.00169000423985872,-0.00270259967740079,0.00392221694284537,0.718231301827466
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,0.00147330103072075,0.00412928402768306,-0.00662009566353804,0.00956669772497954,0.721253337587765
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,-0.00130288650674651,0.00365508976228434,-0.00846686244082382,0.0058610894273308,0.721503172416951
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,0.00211065010813474,0.00596574485113906,-0.00958220980009782,0.0138035100163673,0.723499384485403
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,0.00171511908823065,0.00484953654581154,-0.00778997254155996,0.0112202107180213,0.723595551671608
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.00145977959894157,0.0041476119799331,-0.00958909907961044,0.0066695398817273,0.724877534042195
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,39978,-0.00454275696281995,0.0129649522975758,-0.0299540634660685,0.0208685495404286,0.726054407360089
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00170869141945031,0.00498933281453267,-0.0114877837359343,0.00807040089703373,0.732004581539668
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.00124444630469815,0.00363509570459204,-0.00836923388569855,0.00588034127630224,0.732098702516573
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,39757,0.00149422445996978,0.00439630427407078,-0.00712253191720895,0.0101109808371485,0.73395182981581
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,42310,0.00283930646571392,0.00839235750387182,-0.0136097142418748,0.0192883271733027,0.735126868281818
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39560,-0.00306095148751402,0.00908842794036567,-0.0208742702506307,0.0147523672756027,0.736276696673262
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,39934,0.00167649482914233,0.00504966777310074,-0.00822085400613513,0.0115738436644198,0.739894631253023
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,39966,0.00178137881017999,0.00541608000236654,-0.00883413799445842,0.0123968956148184,0.742233133674131
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,0.00140885434800562,0.00430087600618577,-0.00702086262411849,0.00983857132012972,0.743240181996798
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEB,Nebulin,39575,0.00148311106690787,0.00452998996862748,-0.00739566927160199,0.0103618914054177,0.743372887801701
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,0.00111594733832794,0.00346316002012417,-0.00567184630111545,0.00790374097777132,0.747280639383625
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRNN,Cornulin,41749,0.0024521503789552,0.00765507415542894,-0.0125517949656855,0.0174560957235959,0.748723226651452
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00152528255002779,0.00476738880015194,-0.0108693645983256,0.00781879949827002,0.749019199889448
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,0.0011311031295388,0.00363182390196722,-0.00598727171831695,0.00824947797739456,0.75546926982933
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,41913,-0.00170064360062339,0.00546735542715383,-0.0124166602378449,0.00901537303659811,0.755764325555555
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.00189440080259492,0.00617060854568561,-0.0139887935521387,0.0101999919469489,0.758846199929158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39649,0.00231321030116594,0.00768211916656451,-0.0127437432653005,0.0173701638676324,0.763331577210837
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,-0.00130867940307975,0.00437312540236887,-0.00988000519172272,0.00726264638556323,0.764750188465559
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.000881966901599431,0.00299186618548205,-0.00498209082194539,0.00674602462514425,0.768161243014172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00112245212209237,0.00387131882352777,-0.00646533277202205,0.0087102370162068,0.771867059873287
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,-0.00132509799496522,0.00459505201944026,-0.0103313999530681,0.00768120396313768,0.773065170032229
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00149977088544665,0.00521667977362298,-0.0117244632417477,0.00872492147085439,0.773738492512985
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,0.00223774651650992,0.00791421044771548,-0.0132741059610124,0.0177495989940323,0.777373471759961
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,39657,0.0013855664729218,0.00490793501786315,-0.00823398616208998,0.0110051191079336,0.777709956074425
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,39979,0.0010974982822209,0.00390863606703902,-0.00656342840917557,0.00875842497361737,0.778878078046363
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,39560,-0.000965743421834678,0.00346690540290134,-0.00776087801152131,0.00582939116785196,0.780587269857946
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.0011312839459374,0.00406976311956319,-0.00684545176840645,0.00910801966028125,0.781038381280798
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39657,0.0014288882931775,0.00515195582906947,-0.00866894513179866,0.0115267217181537,0.781517547202611
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39586,0.00145832428960096,0.00531916015278051,-0.00896722960984884,0.0118838781890508,0.783963448594049
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,41900,0.00161094730428597,0.00590663492330807,-0.00996605714539785,0.0131879517539698,0.785061002490249
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,-0.00127680856706947,0.00476718268484069,-0.0106204866293572,0.00806686949521829,0.788832908031529
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39757,0.00125398960358765,0.00506173891208001,-0.00866701866408917,0.0111749978712645,0.804340995006511
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,39649,0.000934133580995813,0.00390905054020585,-0.00672760547780766,0.00859587263979929,0.811135702819934
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,41900,0.00186409555820822,0.00798136733881283,-0.0137793844258649,0.0175075755422814,0.815333349771123
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,39575,0.001532563096854,0.00663449624520784,-0.0114710495437534,0.0145361757374614,0.8173197562204
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,39966,-0.00130389537910795,0.0056586780362689,-0.012394904330195,0.00978711357197909,0.817766439772003
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,39966,-0.00133891380944499,0.00583155809292098,-0.0127687676715701,0.0100909400526801,0.818408327943381
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPGN,Epigen,39919,0.00118225869970704,0.00527537709949001,-0.00915748041529339,0.0115219978147075,0.822676650478828
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,0.000784566002694101,0.00356999365086264,-0.00621262155299667,0.00778175355838487,0.826056167027606
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.00080434416119102,0.00370200511814266,-0.00806027419275064,0.0064515858703686,0.827999968312267
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,39657,-0.00105122712789533,0.00485127413511344,-0.0105597244327177,0.00845727017692701,0.828453210752368
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,39575,0.00124647855457829,0.00579561813535239,-0.0101129329907124,0.012605890099869,0.829714726583967
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.000763109581066441,0.00357901163016363,-0.00777797237618715,0.00625175321405427,0.831160889196441
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,39757,0.000561763479468608,0.00263841350703081,-0.00460952699431179,0.00573305395324901,0.83139547678093
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,0.0014924384868441,0.00707632370282073,-0.0123771559706845,0.0153620329443727,0.832964604393843
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39560,0.00182778300613808,0.00891306921488268,-0.015641832655032,0.0192973986673081,0.837523004730007
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.00125495703072182,0.00612246657579255,-0.0132549915192752,0.0107450774578316,0.837594904005964
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39638,0.00144910325225874,0.00714104944914227,-0.0125473536680601,0.0154455601725776,0.839196759855068
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,-0.000676078101691373,0.00350425930984593,-0.0075444263489894,0.00619227014560666,0.847016430393685
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,42137,0.000435182342915405,0.002261858349315,-0.00399806002174199,0.0048684247075728,0.847431502653598
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,0.00131586858244359,0.0070047490649822,-0.0124134395849215,0.0150451767498087,0.850994749511722
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,42016,0.000888709984225687,0.00475161877232312,-0.00842446280952764,0.010201882777979,0.851637509771913
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,0.000937040988950661,0.00502045693001224,-0.00890305459387332,0.0107771365717746,0.851942669504856
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERVV_1,,39575,0.000916198907497231,0.004959836210859,-0.00880508006578641,0.0106374778807809,0.853449230796562
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,39510,-0.000712062713352537,0.00391072753782552,-0.00837708868749055,0.00695296326078547,0.855523839914136
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,0.000698987123534975,0.0039413824085587,-0.00702612239724008,0.00842409664431003,0.85924014537059
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,0.00161458012929629,0.00929336048188981,-0.0166004064152077,0.0198295666738003,0.862077095138096
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,39575,-0.000626060760353769,0.00364141665048698,-0.00776323739530825,0.00651111587460071,0.863497459229638
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00091871455928741,0.00539215607947947,-0.0114873404750672,0.00964991135649234,0.864714585355503
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,0.000876783149550252,0.00517356540499123,-0.00926340504423255,0.0110169713433331,0.865427196319422
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,39586,0.000651661830320248,0.00386123966874675,-0.00691636792042339,0.00821969158106388,0.865980579521081
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.000792526085740514,0.00495086251213341,-0.00891116443804096,0.010496216609522,0.872821706179907
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,0.000656909560518791,0.00412857109445116,-0.00743508978460549,0.00874890890564307,0.873582637715054
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.00106041068496122,0.00679869984447833,-0.0122650410102163,0.0143858623801387,0.876057492249347
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,42123,0.00215697207374298,0.0146083510849396,-0.0264753960527386,0.0307893402002246,0.882618545286169
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,0.00207653166350398,0.0142565486046553,-0.0258663036016204,0.0300193669286283,0.884196730270224
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.000577747931602037,0.00399979831404586,-0.00841735262713192,0.00726185676392785,0.885151800610473
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,39649,0.00099566677594029,0.00739731841256885,-0.0135030773126947,0.0154944108645752,0.892931906089008
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,39586,0.00059935584970025,0.00445800806632584,-0.00813833996029839,0.0093370516596989,0.893053347896545
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,-0.000692722462071811,0.00527561489309322,-0.0110329276525345,0.0096474827283909,0.895535266568508
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,39560,0.00115194556988194,0.00885078211953846,-0.0161955873844134,0.0184994785241773,0.89644868578334
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,39575,0.00119953881155536,0.00939184669613513,-0.0172084807128695,0.0196075583359802,0.898371878075871
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPHS2,Podocin,39657,-0.00147802576966449,0.0115871928749485,-0.0241889238045636,0.0212328722652346,0.898502004103666
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00107770961915408,0.0085045159947799,-0.0177465609689227,0.0155911417306145,0.899162722206696
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,41843,-0.00122494239771259,0.0100401006927241,-0.0209035397554518,0.0184536549600266,0.902896916508372
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.000527507664664189,0.00434913489242013,-0.00905181205380764,0.00799679672447926,0.903463361700533
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,39915,0.000325027281313084,0.0027965303100762,-0.00515617212643627,0.00580622668906244,0.907476131743064
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,39649,0.000776335254444546,0.00680427255155496,-0.0125600389466032,0.0141127094554923,0.909164351713881
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,0.000508320791344724,0.00463613088187758,-0.00857849573713534,0.00959513731982478,0.912694242924462
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39586,0.000356772191013234,0.00326814513143938,-0.00604879226660794,0.00676233664863441,0.913072369669999
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,0.00095890054684068,0.00878681165510876,-0.0162632502971725,0.0181810513908538,0.913101758208314
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,-0.00144574693774548,0.0134167846400912,-0.0277426448323242,0.0248511509568332,0.914190747640453
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,42016,0.00155752243066995,0.0144921873090825,-0.0268471646951317,0.0299622095564716,0.914415154996238
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,0.000645437460995745,0.00602414656013345,-0.0111618897968658,0.0124527647188573,0.914678474695
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,0.000445160782825242,0.00418502516916436,-0.0077574885487369,0.00864781011438738,0.915290790917671
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,42310,0.000304867189282553,0.00302698435959689,-0.00562802215552736,0.00623775653409247,0.919777006825357
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,39657,-0.000605282525742994,0.00615689784257595,-0.0126728022971919,0.0114622372457059,0.921688190798408
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,0.000722977985902405,0.00753982528372022,-0.0140550795701892,0.015501035541994,0.923611329678511
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,-0.000584916078352408,0.00610638361332308,-0.0125534279604656,0.0113835958037608,0.923690956156461
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,-0.00042133790831163,0.0045615661674766,-0.00936200759656577,0.00851933177994251,0.926408193377959
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,0.00085913937684196,0.0100115363627183,-0.0187634718940859,0.0204817506477698,0.931615087563367
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,0.000508288490221276,0.00637290476242071,-0.0119826048441233,0.0129991818245659,0.936431387370604
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,39979,0.000193053366390883,0.00256904978268227,-0.00484228420766636,0.00522839094044813,0.9401000084579
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.000402324106751617,0.00541908158587903,-0.0110237240150745,0.0102190758015713,0.940819075173921
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,39919,0.000625215687755025,0.00884147309793275,-0.0167040715841932,0.0179545029597032,0.943626649288093
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,39721,-0.000464903956620161,0.00660687493678383,-0.0134143788327165,0.0124845709194761,0.943903063917147
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,41913,0.000368269124275071,0.00550997086819451,-0.0104312737773862,0.0111678120259363,0.946712586551862
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,-0.000416660741738123,0.00676309806014272,-0.0136723329396179,0.0128390114561416,0.950876116717004
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,39560,-0.000758535009949716,0.013322827198338,-0.0268712763186922,0.0253542062987928,0.954598020791357
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,39757,0.000216580723364283,0.00380633288182935,-0.00724383172502125,0.00767699317174981,0.954625793211417
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,39757,-0.000372865869681938,0.00659295596482871,-0.0132950595607462,0.0125493278213823,0.954900544218165
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,-0.000285438888688069,0.00505329515465892,-0.0101898973918196,0.00961901961444342,0.95495572585042
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42262,0.000213759231874329,0.0038187455673023,-0.00727098208003818,0.00769850054378683,0.955361509219629
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,41300,0.00029601830259867,0.00566887776562961,-0.0108149821180354,0.0114070187232327,0.958355693289889
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39560,-0.00023543306318433,0.00454161913754,-0.00913700657276273,0.00866614044639408,0.958657912471191
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.0003062886737959,0.00614080038141199,-0.0123422574213634,0.0117296800737716,0.960220799113982
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,-0.000159731273893342,0.00339150622019109,-0.00680708346546789,0.0064876209176812,0.962436256658809
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,42200,0.000201538306206733,0.00454281157207604,-0.00870237237506231,0.00910544898747578,0.964614730687792
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,39560,-0.000236314781325865,0.00594654886882342,-0.0118915505642198,0.011418921001568,0.968301278837604
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,0.000159138428723086,0.00417085507570993,-0.00801573751966837,0.00833401437711455,0.969564893367015
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,0.000386834495320214,0.0120585126416546,-0.0232478502823229,0.0240215192729633,0.974409007534322
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,42169,-9.88863329428693e-05,0.00309481886741867,-0.00616473131308345,0.00596695864719771,0.974510624382207
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.000187215611359482,0.00702526399806476,-0.0139567330475664,0.0135823018248474,0.97874024847272
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.000113754227616771,0.0055941166269633,-0.0108507143612313,0.0110782228164648,0.983776804962825
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39649,-5.62623985799999e-05,0.00387698088268068,-0.00765514492863414,0.00754262013147414,0.988421839278272
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,39657,-4.92606247816099e-05,0.00377445830706804,-0.00744719890663496,0.00734867765707174,0.989587303851848
